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ABSTRACT
The use o f biotransformations in organic synthesis is a small but growing field. 
Biotransformations can be used for many steps which prove difficult with traditional 
chemistry, particularly stereospecific syntheses and chiral resolutions. However, to 
enable the increasing use of biotransformations in chemical synthesis, a broader range of 
biocatalysts will be required than those of which we are currently aware. Bioprospecting 
and genome sequencing are increasing the awareness o f Nature's library of biocatalysts. 
These enzymes need to be characterised for their use as biocatalysts, and where necessary 
modified to meet needs that may not be catered for in nature.
One currently used biocatalyst is transketolase. Transketolase is an enzyme which is 
produced by most organisms. As a biocatalyst it is most often extracted from spinach, or 
produced by recombinant Escherichia coli. Transketolase carries out a stereospecific 
carbon-carbon bond formation, removing a 2-carbon ketol group from a ketose sugar, and 
adding it to the aldehyde group o f the aldose sugar. It is a useful biocatalyst as it has a 
broad substrate specificity. Significantly it will use hydroxypyruvate as the ketol donor, 
thus liberating carbon dioxide and driving the reaction in a forward direction.
In this thesis the transketolase-like enzyme, 1-Deoxy-D-xylulose 5-Phosphate Synthase 
(DOX-P Synthase), is identified as another possible biocatalyst. Significantly DOX-P 
Synthase catalyses the addition o f a carbonyl unit, not from hydroxypyruvate, but from 
pyruvate, a reaction which cannot be catalysed by transketolase.
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This thesis therefore describes studies that aimed to produce recombinant DOX-P 
Synthase as a biocatalyst, and to optimise its production. Further studies aimed to 
characterise the properties o f DOX-P Synthase, with the aim of optimising its use as a 
biocatalyst. Analysis o f the substrate range of DOX-P Synthase could then be used to 
describe the set of reactions for which it would be a useful biocatalyst. Finally, this thesis 
describes modifications made to the enzyme, carried out by site-directed mutagenesis, 
and the effects on enzyme properties.
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5.4 Apparent specific activity o f DOX-P Synthase mutants, and 
percentage pyruvate turnover achieved within 24 h.
5.5 Percentage substrate turnover with mutant DOX-P Synthase 
extract in 24 h, for variety o f acceptor and donor substrates.
44
122
137
139
164
172
173
174
182
189
197
204
206
210
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LIST OF ABBREVIATIONS
bet Glycyl Betaine
BSA Bovine Serum Albumin
cfu Colony Forming Units
DABA 3,5-Diaminobenzoic Acid
DOX-P Synthase 1 -Deoxy-D-Xylulose-5-Phosphate Synthase
DTT Dithiothreitol
Dx 1 -Deoxy-D-Xylulose
DxP 1 -Deoxy-D-Xylulose-5-Phosphate
DxpR 1 -Deoxy-D-Xylulose-5-Phosphate Reductase
dxs E. coli gene 1-Deoxy-D-Xylulose-5-Phosphate Synthase
ECD Electrochemical Detection
HMBPP (E)-4-Hydroxy-2-Methylbut-2-enyl-Diphosphate
HMG-CoA 3-Hydroxy-3-Methylglutaryl-Coenzyme A
HPA Hydroxypyruvate
HPLC High Performance Liquid Chromatography
IPP Isopentenyl Pyrophosphate
IPTG lsopropyl-p-D-1-Thiogalactopyranoside
LB Luria-Bertani
MEP Methylerythritol-Phosphate
MOPS 3-Morpholinopropanesulfonic Acid
NB2 Nutrient Broth 2
OD600 Optical Density at 600 nm
PMS Phenazine Methosulphate
PMSF Phenylmethylsulphonylfluoride
PNK Polynucleotide Kinase
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Rl Refractive Index
SAP Shrimp Alkaline Phosphatase
sorb Sorbitol
TEMED N.N.N’.N’.-Tetramethylethylenediamine
TFA Trifluoroacetic Acid
TK Transketolase
tkt E. coli gene Transketolase
TLC Thin Layer Chromatography
TPP Thiamine Pyrophosphate
v/v VolumeA/olume
Vrel Relative Rate of Reaction
w/v WeightA/olume
XTT 2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-
Carboxanilide
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1 Introduction
1.01 Introduction to Biocatalysis
The ability o f a substance to accelerate a transformation without itself being altered is 
known as catalysis. The term is most commonly applied to those substances which 
catalyse chemical transformations, or chemical reactions. Those catalysts we may be 
most aware o f include platinum and rhodium catalysts in catalytic converters, which 
catalyse the completion of combustion in the internal combustion engine; and the use of 
iron as a catalyst in the Haber process, to produce ammonia.
Perhaps unknowingly, humankind have utilised the ability of biological extracts to 
catalyse chemical transformations for centuries. Rennet, an extract from the stomachs of 
young calves, is used in cheesemaking to separate the milk into curds and whey, (Ash, 
1983). The gastric enzyme present in rennet, renin, is a protease present in the stomachs 
o f suckling mammals, which breaks down those milk proteins which normally keep milk 
from coagulating. Papaya juice can be used in the tendering of leather, (Lamb, 1981). 
The enzyme, papain, present in papaya juice, is another type of protease, which can be 
used to remove hairs from animal hides. The rennet and papaya juice extracts detailed 
above, can be described as biocatalysts. The active components of these biocatalysts are 
enzymes, in these cases renin and papain.
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Both chemical and biological catalysts work on the same principle. They accelerate the 
rate o f reaction by lowering the activation energy in a chemical reaction. They do so by 
forming interactions with the reactant, and stabilizing the formation of an intermediate on 
the reaction pathway to the product. While chemical catalysts are usually metals which 
bind the reactant molecule on its surface, biological catalysts, enzymes, are far more 
complex. These are globular three-dimensional proteins, with a central active site, that 
are able to form many more interactions with the reactant, or substrate, than a 
conventional chemical catalyst might. This multiplicity of interactions enables enzymes 
to distinguish between various, similar compounds, and catalyse specifically only the 
transformation o f those compounds for which it has evolved to interact with. Unlike 
most conventional chemical catalysts, enzymes are so specific that they can distinguish 
even between D- and L- stereoisomers.
1.02 Catalysis in the Chemicals Industry
While small-scale usage of catalysis has been employed unknowingly in cottage 
industries such as cheese or leather making for centuries, the large-scale usage of 
catalysis did not take off until the growth of the chemicals industry in the late nineteenth 
and early twentieth century. An early example would be the use of iron in the production 
o f ammonia by the Haber process. Since then the chemicals industry has grown 
massively and is responsible for the production o f tens of thousands of different 
chemicals, often produced via a number of sequential steps and requiring a series of 
different catalysts.
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A particularly complex branch o f the chemicals industry is the pharmaceuticals industry. 
Pharmaceuticals act on the biological systems of the human body through specific 
interactions with the enzymes and other components involved in various physiological 
processes. The vast number o f very different and very specific interactions a compound 
could make in a system such as the human body emphasises the importance of ensuring 
drug purity. For example, whilst the R-enantiomer of the drug, thalidomide, is an 
effective sedative and antiemetic, the S-enantiomer is teratogenic, and induces severe 
deformation in foetus development, (Eriksson et al., 2001).
The need for such a high level o f purity poses a considerable challenge for production. 
For example the conversion of pyruvate to L-lactate requires a catalyst which specifically 
catalyses proton transfer onto the pro-S-face, rather than the pro-R-face of pyruvate. 
Designing catalysts to act in a specific manner on a specific compound therefore adds a 
considerable burden into the pharmaceutical development process - a burden which is 
increasing with the growth in regulatory safety legislation on drug purity, (Cartwright, 
1991;Cayen, 2001).
Increasingly therefore research focus is turning to the use of biocatalysts for these 
processes, (Whitesides and Wong, 1985). While the chemist faces problems developing 
increasingly specific catalysts, biological systems have already evolved such highly 
specific catalysts over millions o f years. For example, the previously related problem of
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creating L-lactate from pyruvate has been solved in the evolution o f L-lactate 
dehydrogenase, (Grau et al., 1981).
1.03 Industrial Biocatalysis and its Limitations
The growth o f biocatalysis as a field o f synthetic organic chemistry can be dated at least 
to the late 1970s, and the early use o f hydrolases for the cleavage o f amide and ester 
bonds, (Jones and Beck, 1976). This field has grown considerably in the following 
decades, and enzymes utilised as catalysts in synthetic chemistry embrace not just lipases, 
but also other hydrolases; dehydrogenases and oxidases; lyases - in fact all six major 
classes of enzymes, (Faber, 1994). The biocatalysis industry is now a significant sector 
in the world economy, (Kircher, 2006), stretching from pharmaceuticals, as described 
earlier, to gold ore extraction, by microbial oxidation of metal minerals coating the ore 
surface, (Rawlings et al., 2003). Currently, the most valuable industrial application of a 
single biotransformation is the production of acrylamide from acrylonitrile, (Yamada and 
Kobayashi M., 1996). This in itself is a multi-million dollar industry. Other large 
biocatalysis industries include: starch processing, (converting cornstarch to high fructose 
syrups using amylases, glucamylases and glucose isomerase), (Guzman-Maldonado and 
Paredes-Lopez, 1995); amino acid production, (using hydrolases, such as proteases and 
esterases for resolution of cheaply produced racemates), (Leuchtenberger et al., 2005); 
and the production o f semi-synthetic penicillins, (Schmid et al., 2001).
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This being so, there are still various obstacles to the expansion of use of biocatalysts in 
synthetic chemistry. Firstly, biological extracts can be very expensive when compared to 
chemical catalysts, (Faber, 1994). For example the production of rennet for 
cheesemaking requires the rearing o f calves. However the cost of rennet can be reduced 
when renin is overexpressed in microbes, and produced by large-scale fermentation, 
(Johnson and Lucey, 2006).
Secondly, enzymes can be very sensitive to denaturation, and consequently work within 
narrow operational parameters, akin to their natural environmental conditions, (Faber, 
1994). While it is true to say that enzymes usually exhibit their highest activity in the 
physiological conditions in which they have evolved, when studied, enzymes often 
exhibit a certain amount of activity outside of these conditions. Therefore, further 
enzymatic characterisation is useful to describe the applicability of any given biocatalyst.
And thirdly, enzymes are thought of as active only on their natural substrates. As above, 
while it is true that enzymes usually exhibit their highest activity towards those substrates 
with which they have evolved, when studied, enzymes often exhibit a certain amount of 
activity towards a broader range o f substrates, (Faber, 1994). Again, further enzymatic 
characterisation is useful to describe the applicability o f said biocatalyst.
1.04 Formation of Carbon-Carbon Bonds
In designing a chemical synthesis for a compound as chemically complex as a 
pharmaceutical there will be many steps employed in moving from simple starting
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materials to the final product. For example, the synthesis of the antiretroviral drug, 
azidothymidine, AZT, from mannitol involves no less than seven steps, (Horwitz et al., 
1964). One key, useful type of synthetic step is the formation of carbon-carbon bonds to 
lengthen the carbon backbone o f a molecule. We will now look at how such a step can 
be carried out by conventional chemical catalysis, and then look at how biocatalysis 
might be employed for such a step.
1.04.1 Chemical Catalysis
In conventional organic synthesis many types of carbon-carbon bond forming reactions 
have been developed, which enable chain length extension, such as the Aldol 
Condensation and the Diels-Alder reaction, (Vogel et a l , 1989), shown in Figure 1.1. In 
the Aldol Condensation, the a-carbon atom of an aldehyde adds to the carbonyl carbon 
atom of another, to form an aldol, in a reaction catalysed by a base, such as imidazole. In 
the Diels-Alder reaction a double bond adds 1,4 to a conjugated diene to form a six- 
membered ring, in a reaction catalysed by a Lewis acid, such as aluminium chloride or 
niobium pentachloride. There are many other types o f synthetic reactions which also 
carry out such carbon-carbon bond forming reactions. However, it is not simple to adapt 
conventional methods to be selective towards their reagents - either chemoselective or 
regioselective. Similarly, it is not simple to adapt these methods to be stereoselective in 
the formation o f the product. Enzymes on the other hand have all evolved over millions 
of years to be chemo-, regio- and stereo-selective.
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1.
R R
Figure 1.1. Carbon-Carbon bond forming reactions.
1. Aldol condensation. Aldehyde combines with aldehyde to form 3-hydroxyaldehyde 
in condensation reaction. 2. Diels-Alder reaction. Cycloaddition between conjugated 
diene and alkene.
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1.04.2 Biological Catalysis
There are three groups of enzymes that have proved useful for the formation o f carbon- 
carbon bonds, (Faber, 1994). There are two groups of transferases: the aldolases - which 
transfer, (usually), a three-carbon unit; and transketolases - which transfer a two-carbon 
unit. Both of these groups add a ketone unit within the group transferred, which is added 
across the carbonyl group o f an aldehyde, see Figure 1.2. The other group o f carbon- 
carbon bond forming enzymes are a type of lyase, the oxynitrilases, which add a one- 
carbon cyanide unit across the C =0 group of an aldehyde.
Transaldolases and transketolases catalyse an aldol addition reaction, whereby an 
aldehyde adds to another carbonyl, thus extending carbon chain length. Transaldolases 
are useful for 3-carbon chain length extension, (Takayama et al., 1997), transketolases for 
a 2-carbon extension. This is shown in Figure 1.2. The aldolases, as a group of enzymes, 
are capable of carrying out a significant number of different reactions which prove 
difficult by conventional chemical catalysis. Transketolase, on the other hand, carries out 
a smaller set o f reactions, but possesses the advantage over the aldolases in in vitro 
biocatalysis, that phosphorylated substrates are not a necessity, and its stereospecificity 
with non-native substrates is greater, making transketolase better for chiral resolution of 
racemates.
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Figure 1.2. Reactions catalysed by: 1. Transaldolases; 2. Transketolases.
1. Transaldolase commonly transfers 3-carbon dihydroxyacetone group from ketone in 
chain length extension of aldehyde. 2. Transketolase transfers 2-carbon ketol group from 
ketone in chain length extension of aldehyde.
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1.05 Transketolase
Transketolase, (TK), was first discovered as an extract from yeast or rat liver in the 
1950s, as an enzyme capable of splitting ribose-5-phosphate into a triose phosphate, and 
using the two-carbon fragment to produce a hexose or heptulose monophosphate, (de la 
Haba and Racker, 1952;Horecker and Smymiotes, 1952). This enzyme was later purified
2_j_
from yeast, and at the same time thiamine pyrophosphate, (TPP), and Mg , were 
discovered to be cofactors necessary for activity, (Racker et al., 1953). The native 
reaction first observed in the yeast and rat liver extracts is shown in Figure 1.3. The non­
native substrate, hydroxypyruvate, was also found to act as a ketol-donor. This useful 
reaction, shown in Figure 1.4 liberates carbon dioxide, driving the reaction forward.
1.05.1 Cellular Function
Transketolase is a cytosolic enzyme, and was discovered to play an essential part in 
primary metabolism, connecting the main pathways of carbohydrate metabolism - 
glycolysis, which produces energy in the form of ATP from glucose-6-phosphate; and the 
pentose phosphate pathway, which produces reducing power in the form of NADPH from 
glucose-6-phosphate, and the pentose sugar, ribose-5-phosphate, which is essential for 
nucleotide production. (Boiteux and Hess, 1981). A link, which transketolase, along 
with transaldolase, forms between these two pathways is shown in Figure 1.5.
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erythrose-4-
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Figure 1.3. Native reactions catalysed by transketolase.
Ketol group transferred from ketose sugar, xylulose-5-phosphate, to either aldose sugar, 
erythrose-4-phosphate or ribose-5-phosphate, to produce either ketose sugar, fructose-6- 
phosphate or sedoheptulose-7-phosphate, and leaving the aldose sugar, glyceraldehyde-3- 
phosphate.
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HO
O
-OOC
hydroxypyruvate
+
o =
OH
OPO
HO
HO
OH
OPO
xylulose-5-phosphate
CO*
glyceraldehyde-3 -phosphate
Figure 1.4. Non-native reaction catalysed by transketolase, using hydroxypyruvate.
Ketol group transferred from hydroxypyruvate, liberating carbon dioxide, driving 
reaction forward.
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Pentose Phosphate Pathway
Glucose-6-Phosphate
F rue tose-6- Phosphate
Glycolysis
-► Ribu!ose-5-Phosphate
NADPH CO,
Dihydroxyacetone Phosphate <-----► Glyceraldehyde-3-Phosphate
Xylulose-5-Phosphate
Transketolase
RJbose-5-Phosphate
Fructose-1,6-Bisphosphate w  Transketolase % Glyceraldehyde-3-Phosphate + Sedoheptulose-7-Phosphate
Transaldolase
Erythrose-4-Phosphate + Fructose-6-Phosphate
ATP
Pyruvate
Figure 1.5. The glycolytic and pentose phosphate pathways.
The enzymes, transketolase and transaldolase, connect the products of the NADPH- 
generating pentose phosphate pathway, the 5-carbon sugars, ribose-5-phosphate and 
xylulose-5-phosphate, with the products of the ATP-generating glycolytic pathway, 
fructose-6-phosphate and glyceraldehyde-3-phosphate.
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In different circumstances the cell will have different requirements for these three most 
essential components of metabolism. For example, at cell division, production of ribose- 
5-phosphate for nucleotide synthesis may be most pressing, whilst adipose tissue laying 
down fat stores may require a larger amount of NADPH. By regulating the activity of 
transketolase, the cell can divert glucose-6-phosphate use preferentially towards either 
ATP, NADPH or ribose-5-phosphate production.
The ability o f transketolase to interconvert essential sugar molecules ensures it plays 
other important roles in metabolism as well. In photosynthetic cells, the link 
transketolase makes between ffuctose-6-phosphate, glyceraldehyde-3-phosphate and 
pentose phosphates makes it a vital part of the Calvin cycle in photosynthesis, (Benson 
and Calvin, 1950). The ability to convert various triose, tetrose, pentose and heptose 
sugars into the hexose sugars necessary for the essential glycolytic and pentose phosphate 
pathways, means transketolase enables organisms to grow on different carbohydrate 
sources, (Josephson and Fraenkel, 1969). The pentose phosphate pathway has been 
shown to be essential for the ability o f E. coli to grow on D-xylose, D-ribose or 
L-arabinose. Transketolase has been shown to be necessary for the production of 
erythrose-4-phosphate, an essential precursor in the shikimic acid pathway, (responsible 
for production of aromatic amino acids and vitamins), and the pyridoxine pathway, 
(responsible for production of the essential transaminase cofactor, pyridoxal phosphate). 
Transketolase deficient yeast mutants have been shown to be auxotrophic for aromatic 
amino acids and pyridoxine.
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1 .0 5 .2  E n zy m a tic  D ata
Since the initial discovery of TK, much enzymological work has also been carried out, 
purifying it from a variety o f sources, most commonly from yeast or spinach, due to the 
large quantities which can be isolated from these organisms. Most studies of the enzyme 
kinetics o f the TK reaction have been confined to the yeast enzyme. The Michaelis 
constants, (Km), for the native phosphorylated sugars with this enzyme fall between 10"4 
and 10’3 M, with turnover number, (£cat), o f 45 to 69 s '1. Specific activity has been 
determined as 18 to 24 pmol.min‘1.mg“1. The pH and temperature optima for maximal 
activity are given as 7.6 and 30 °C, (Racker, 1961).
Lately, however, much research has also focussed on transketolase from Escherichia coli, 
which can be easily overexpressed for high levels of production. The Michaelis 
constants, (K m), for the native phosphorylated sugars with the E. coli enzyme again fall 
between 10"4 and 10'3 M. Specific activity of the native reaction between xylulose-5- 
phosphate and ribose-5-phosphate has been determined as 50 pmol.min^.mg'1. The pH 
and temperature optima for maximal activity are given as 8.0 and 30 °C. (Sprenger et al., 
1995).
1 .0 5 .3  S tru ctu re
E. coli TK was found to be a homodimer comprising two 72 kDa subunits, encoded by 
the tkt gene. The crystal structure o f this enzyme has since been elucidated to 1.9 A,
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Figure 1.6. E. coli transketolase.
Ribbon diagram of E. coli transketolase from its X-ray crystal structure, (Littlechild et 
al., 1995), showing C2 symmetry. Dimer shown with polypeptide chain 1 in red, chain 2 
in yellow.
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(Isupov and Littlechild, 1999), as has that of S. cerevisiae to 1.86 A, (Fiedler et a l , 
2002). Each subunit consists of three separate domains, all of the a /p  type. These are 
the 300 residue TK N-terminal domain; the central 100 residue TK pyrimidine-binding 
domain; and the 50 residue TK C-terminal domain. The two subunits combine to form an 
active enzyme with a C2 axis of symmetry, as shown in Figure 1.6. Each complete 
enzyme molecule binds two molecules of TPP, one in each of the two separate active site 
clefts formed between the N-terminal domain of each subunit and the central domain of 
the other. An Mg2+ ion is also required as a cofactor, binding TPP into the active site, as 
are various catalytically active water molecules, for active catalysis to occur, (Nikkola et 
al., 1994). Two deep clefts in the opposing surfaces of the TK molecule are thus formed, 
with TPP/Mg2+ containing active sites sitting at the bottom. Substrates can then enter 
these clefts where they will form multiple interactions with the various amino acid 
residues lining the cleft wall. This multiplicity of interactions lends TK its specificity. 
The various interactions formed in this way allow catalysis of the ketol-transfer reaction 
to occur.
Comparison of the amino acid sequences of TK from various species reveals a high 
degree of similarity. For example amino acid sequences of TK from E. coli and 
Saccharomyces cerevisiae show 46% identity in a pairwise alignment. An alignment 
carried out with 17 different TK sequences revealed 54 invariant residues, suggesting the 
importance of these residues in TK folding or function, (Singleton et al., 1996). Atomic 
resolution crystal structures of TK binding TPP and substrate have revealed many of 
these key conserved residues to be located within the active site, (Fiedler et a l , 2002).
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Figure 1.7. Thiamine pyrophosphate.
Thiazole ring numbered 1 to 5. Pyrimidine ring numbered 1 ’ to 6’.
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Figure 1.8. Mechanism of action of TPP in transketolase-catalysed reaction. 
(Kluger, 1992).
C2 of thiazolium ring attacks and binds ketone group of ketose substrate, liberating 
carbon dioxide, and generating dihydroxyethyl-TPP, which then attacks and binds 
aldehyde group o f aldose substrate, regenerating thiazolium ring, and liberating the 
enzyme reaction products.
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The interactions some of these active site residues form with TPP and the substrate have 
also been elucidated by site-directed mutagenesis, (Wikner et al., 1994;Querol et al., 
2001b).
1 .0 5 .4  M ec h a n ism
The key feature of the catalytic mechanism of TK is thiamine pyrophosphate, (TPP), the 
structure of which is shown in Figure 1.7. As shown in Figure 1.8, (Kluger, 1992), the 
reactive C2 atom of the thiazolium ring is able to form an ylide carbanion capable of 
attacking the carbonyl group o f a ketose sugar substrate. This cleaves the ketose in two, 
liberating the aldose product or CO2 , and leaving the removed two-carbon keto unit 
bound to TPP,forming another nucleophile, of a,p-dihydroxyethyl-TPP. In the second 
half of the reaction, this reactive unit then adds across the carbonyl group o f the aldose 
sugar substrate by nucleophilic attack, thus completing the ketol-transfer reaction.
The essential first step in the catalytic mechanism is the formation of the carbanion at the 
C2 atom of the thiazolium ring, by deprotonation of that position. With no local amino 
acid side chains basic enough or in the right position to effect proton abstraction, it has 
been found instead that deprotonation is carried out by a 4'-imino group on the 
pyrimidine ring. The mechanism for this is shown in Figure 1.9, (Lindqvist et al., 1992). 
The enzyme residues Glutamate-418 and Histidine-481 are in turn responsible for 
stabilizing this 4f-imino group. Site-directed mutagenesis of the protein, or modification 
of TPP at the N 1’ or exo N1 atom, have proved the importance of these interactions,
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GLU418* GLU418*
H,C
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Figure 1.9. Suggested mechanism for deprotonation of TPP at C-2. (Lindqvist etal. , 
1992).
Stabilisation of 4 ’-imino group of pyrimidine ring by Glutamate-418 and Histidine-481, 
and subsequent stabilisation of charge at C2 position of thiazolium ring.
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(Meshalkina et al., 1991;Wikner et al., 1994;Wikner et al., 1997). Various other 
interactions between TPP and the enzyme, either direct, or indirect, via Mg2+ or water 
molecules, are then responsible for holding the molecule of TPP in what is known as the 
V-conformation. This conformation brings the 4'-imino group of the pyrimidine ring in 
close contact with the C2 atom of the thiazolium ring, enabling creation of the vital TPP 
carbanion.
The cleft walls leading towards this activated cofactor are formed by flexible loop 
regions of the TK protein, which bind and orient the substrates, bringing the correct parts 
of the substrates into contact at the right time. Firstly the substrate ketose is brought in 
contact with the TPP ylide, as in Figure 1.8. The inferred pattern of hydrogen bonds 
formed between this substrate and the enzyme active site are critical in ensuring that only 
sugars with the D-z/jreo-configuration at the C3 and C4 carbon atoms are delivered to the 
active site at this step - critical in ensuring the stereospecificity o f the product. 
Deprotonated TPP then couples with this ketol donor to form a zwitterion, which then 
spontaneously cleaves liberating the aldose product, or CO2 , and leaving the ketol group 
bound to TPP as the a  carbanion, a,(3-dihydroxyethyl-TPP, or its resonance isomer 
enamine. (Schneider and Lindqvist, 1998;Fiedler et al., 2001 ;Fiedler et al., 2002).
Then, as in Figure 1.8, the enzyme brings the substrate aldose into contact with this 
enamine, allowing nucleophilic attack o f the aldose carbonyl group. In this way ketol 
transfer to the aldose is effected, and the bond to the thiazole ring of TPP spontaneously 
cleaves, liberating the ketose product and regenerating the TPP. In this final stage the
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enzyme plays another crucial role in determining the stereospecificity of the reaction. By 
specifically delivering the Re-face as opposed to the Si-face of the aldehyde to the 
reaction centre, the enzyme ensures only the D-ketose product is formed. This 
stereospecificity is again determined by the pattern of hydrogen bonds formed by the 
substrate at the active site, and also the space available for groups on the substrate, such 
as the hydroxyl residues, to fit sterically into the active site.
1 .0 5 .5  F lex ib ility  o f  T r a n sk e to la s e
Unlike many enzymes transketolase can be seen to have evolved to exhibit activity 
towards two separate physiological reactions, (de la Haba et ah, 1952;Horecker et al., 
1952). Transketolase is required to catalyse ketol transfer from xylulose-5-phosphate to 
either ribose-5-phosphate or erythrose-4-phosphate - as well as the reverse reactions, 
catalysing ketol transfer from sedoheptulose-7-phosphate or fructose-6-phosphate to 
glyceraldehyde-3-phosphate. These particular evolutionary requirements mean that 
transketolase has evolved to accept substrates of varying chain lengths, from 3 to 7 
carbon atoms in length. This makes transketolase an unusually flexible biosynthetic 
enzyme, which as we shall find out, makes it particularly useful as a biocatalyst.
1.06 Transketolase as Biocatalyst
Transketolase, as we have seen, is capable in vivo of catalysing chain length extension of 
a 3-, 4- or 5-carbon backbone, by a 2-carbon atom ketol group. Most interestingly, from 
the synthetic chemist's point of view, is the stereospecificity of the reaction catalysed by
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TK, which has been the more focused upon aspect in previous studies. (Effenberger et 
al., 1992). While many conventional synthetic techniques have been developed as 
carbon-carbon bond forming reactions, stereospecific carbon-carbon bond formation has 
proven much more difficult. Accordingly the transketolase reaction has therefore been 
developed as a potentially useful alternative method for carbon-carbon bond formation. 
(Bolte et al., 1987;Kobori et al., 1992;Morris et al., 1996). Transketolase has since been 
applied in the asymmetric chemoenzymatic synthesis of a variety of biologically active 
molecules, from the flavour molecule, furaneol, (Takayama et al., 1997), to a new 
glycosidase inhibitor, a novel A-hydroxypyrrolidine, (Humphrey et al., 2000).
1 .06 .1  D e v e lo p m e n t a s  B io c a ta ly s t
There could be said to be three main stages in developing an enzyme as a biocatalyst, 
each addressing a different problem in its use in organic synthesis. These are firstly to 
develop a simple, cheap method of producing large amounts of enzyme at low cost; 
secondly to define the environmental conditions which permit enzyme activity; thirdly to 
define the range of substrates upon which the enzyme may act.
TK was initially isolated from sources such as spinach and yeast - sources that produce 
reasonable quantities o f transketolase, and can be grown to high volumes. Recombinant 
DNA technology has recently enabled overexpression in E. coli and production at even 
higher quantities, (Draths and Frost, 1990). It has been shown that using overproducing
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strains, E. coli TK can be easily and cheaply supplied in quantities surpassing one million 
units of activity from 1000 L bioreactors, (Lilly et al., 1996).
There have been many enzymological studies carried out on transketolase from various 
sources, including E. coli, such that the kinetic properties, and the optimal conditions for 
the enzyme have, as mentioned, been reasonably tightly defined. (Sprenger et a l,  1995). 
The Michaelis constants, Km, have been measured for various substrates, as described 
earlier, as have the Specific Activity. The optimal pH has been measured as 8 - 8.5, and 
the optimal temperature, 30 °C. D-Arabinose-5-phosphate , L-Erythrulose and EDTA 
have all been measured as inhibitors.
In terms of the ketol-donor in the transketolase reaction, it has long been known that 
various phosphorylated and non-phosphorylated sugars o f various lengths have the 
capacity to act as the ketol-donor in a reversible TK-catalysed reaction. The most 
significant discovery however has been that hydroxypyruvate can act as the ketol-donor, 
(Racker et al., 1953). Once the ketol unit has been transferred from hydroxypyruvate, all 
that is left is free carbon dioxide, which is liberated. This effectively renders the reaction 
irreversible, increasing the usefulness o f the reaction for process engineers, as it in turn 
increases the possible product yield.
In terms of the ketol acceptor, it has also long been known that transketolase has a low 
specificity for the aldehydic substrate, and that it is capable of accepting various 
phosphorylated and non-phosphorylated D-a-hydroxy-aldehydes as ketol-acceptors,
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(Racker et al., 1953). More recently it has also been shown that simple a-unsubstituted 
aldehydes, such as propionaldehyde, can also be utilised as ketol-acceptors, although at 
significantly much lower rates, (Demuynck et al., 1991;Hobbs et al., 1993). Relative 
rates of some reactions are shown in Table 1.1. These figures show that while the 
substrate range o f transketolase is relatively broad for an enzyme, it is still very limited as 
a catalyst, particularly as the molecule gets longer and bulkier. Whilst trace levels of 
turnover of some aromatic aldehydes have been shown with TK from yeast or spinach, 
(Corbett and Chipko, 1977;Corbett and Corbett, 1986), the rate is so low as not to be very 
catalytically useful, and no turnover of aromatics has been shown with E. coli TK, 
(Hobbs et al., 1993).
1 .0 6 .2  A p p lic a t io n s  a s  B io c a ta ly s t
TK can be obtained in reasonable quantities relatively cheaply, and can act at a 
reasonable rate in undemanding conditions. These qualities are the minimum necessary 
for a useful catalyst. The relaxed specificity of TK for the aldehydic substrate, and its 
high stereospecificity in the Carbon-Carbon Bond Forming step, make this enzyme an 
extremely useful biocatalyst in asymmetric synthesis.
Since the discovery of the synthetic utility of transketolase as a biocatalyst, various 
commercial applications have been developed. Initially applications were limited to the 
production of various ketose and aldose sugars, (Srere et al., 1958). However, 
transketolase is not limited to phosphorylated substrates, which means the non-
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Substrate Kre, Substrate K e l
OH T
O
Glycolaldehyde
100%
OH
H O \ ^ X / H
O
DL-Glyceraldehyde
37%
OH
h o  y  | |
OH 0  
D-Erythrose
89% 0
Propionaldehyde
20%
OH OH
OH OH 
D-Glucose
14%
OH OH
OH OH °  
D-Mannose
3%
Table 1.1. Relative rates, (Fre]), for transketolase reaction with a selection of 
aldehyde acceptors.
Relative rates, Frei, given as percentage of rate with glycolaldehyde. All data from 
(Hobbs eta l., 1993).
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phosphorylated sugar can be synthesised directly without a dephosphorylation step, 
(Villafranca and Axelrod, 1971). The enzyme has also been used in the synthesis of 
certain deoxy-sugars, (Demuynck et al., 1991). Other commercial applications include 
the production of the beetle pheromone, (+)-exo-brevicomin, (Myles et a l , 1991); the 
valuable aromatic, furaneol, (Takayama et al., 1997); and the azo-sugar 1,4-imino-D- 
arabinitol, (Ziegler et al., 1988). In these syntheses, TK has removed the need for 
complex multi-step reactions, involving the introduction and removal of various 
protective groups.
In addition TK has been used for various commercially useful chiral resolutions, 
(Effenberger et al., 1992). Various a-hydroxyaldehydes are commercially useful as 
starting materials in chemical syntheses, and chiral resolution of the starting material can 
provide the correct enantiomer for synthesis. TK has been used to remove the undesired 
R-enantiomer of several racemic a-hydroxyaldehydes.
1 .0 6 .3  L im ita tion s a s  B io c a ta ly s t
As described in 1.06.1, TK is an easy-to-produce enzyme, which is relatively fast, and 
has a relatively broad substrate range for an enzyme. This has led to its use for the 
various applications described in 1.06.2. However, the enzyme still has its limitations, 
preventing its further use as a biocatalyst.
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While many improvements have already been made in terms of production and 
purification of TK in large quantities cheaply, further work in this area may look at how 
to surface immobilize the enzyme for even more efficient use.
In terms o f the environmental conditions in which TK operates, these are fairly standard 
enzyme conditions, but not always the optimal conditions for use in organic synthesis 
processes. In comparison to many industrial chemical processes, TK works at low 
temperatures, at neutral pH, and on low substrate concentrations in an aqueous solvent. 
In industrial processes environmental conditions are often optimised to increase rate of 
reaction for a chemically catalysed process. This often means high temperature, 
(although this is limited by the thermolability of the reactants and catalysts being used); 
extreme pH - in the case of acid / base catalysis; and organic solvents, (organic reactants 
will often exhibit higher solubility in organic solvents, allowing for higher reactant 
concentration and therefore higher rate of reaction). None of these conditions would 
permit activity of TK or many other enzymes. High temperatures, extremes of pH, and 
organic solvents disrupt correct protein folding, causing enzyme denaturation. Also, high 
reactant concentrations have a reduced effect when using biocatalysis, as enzymes are 
limited by VmaLX. The result of this is that biocatalytic steps tend not to mesh well with 
conventional chemical steps in synthetic processes. The use of enzyme-acceptable 
environmental conditions often reduces the effectiveness o f conventionally chemically 
catalysed steps, while the dilution o f reactants in proportionally large volumes of water 
requires a large input of energy later in the process to evaporate off this water. All these 
problems hinder the broader uptake o f biocatalysts in organic synthesis, although several
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enzymes have been identified which do function in organic solvents and in other 
conditions more acceptable to conventional chemistry.
In terms of substrate range for which the process engineer can consider TK a useful 
catalyst, this is, as we have said, relatively broad for an enzyme. However there are key 
omissions in its substrate range. To begin with, as previously mentioned, TK is unable to 
accept as ketol-acceptors, larger, bulkier aromatic aldehydes. For example, benzaldehyde 
would be a useful substrate, as this would be turned over by TK stereospecifically, to 
produce the correct enantiomeric form of a precursor in synthesis of the biologically 
active epinephrine and ephedrine group of compounds. Also TK limits itself to acting 
upon those aldehydes of the D-enantiomeric form at the C-2 position. Whilst this is 
useful for enantiomeric resolution o f racemates, it also prohibits utilisation of TK as a 
catalyst where the starting material is an aldehyde of the L-enantiomeric form at the C-2 
position, which could be useful for some pharmaceuticals and other biologically active 
molecules, particularly some inhibitors. Finally, significantly, TK is limited to using as a 
keto-donor those ketones with a hydroxyl group at the C-l position, such as fructose, 
sedoheptulose, or indeed hydroxypyruvate. This means any TK products are necessarily 
terminally hydroxylated, as the hydroxyl group is transferred in the 2-carbon ketol group. 
It would be desirable to use other ketol-donors where other terminal functional groups are 
desired. In addition, hydroxypyruvate is a reasonably expensive starting material. If  a 
terminal hydroxyl group were not necessary it would be desirable to use cheaper pyruvate 
as the keto donor rather than hydroxypyruvate, producing instead a 1-deoxy-ketone
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product rather than a 1 -hydroxy-ketone product. Unfortunately TK has been shown not 
to accept pyruvate as a keto-donor, (Usmanov and Kochetov, 1983).
1 .0 6 .4  Im p ro v em en ts  o f  T r a n sk e to la se  th ro u g h  M u ta g e n e s is
Various studies of transketolase have used site-directed mutagenesis to alter different 
amino acid residues in the E. coli or yeast TK structure. Generally however these have 
been limited to using this technique to probe the nature of various interactions made 
between these residues and the substrates of the TK reaction. (Wikner et al., 
1995;Nilsson et al., 1998;Querol et al., 2001b)
A small number of studies however have taken this information, and attempted to 
engineer improvements into TK. Mutant TKs have been generated with broadened 
substrate specificity enabling TK to turnover not just longer chain aldehyde ketol- 
acceptors, but also aromatic aldehydes such as pyridinecarboxaldehydes, and even 
L-enantiomer aldehydes, (Bacon, 2001). These mutants provide the synthetic chemist 
with useful, new catalysts for consideration in designing synthetic pathways. However, 
despite much effort, no success has been achieved thus far on altering TK such that it 
might accept different ketol-acceptors, such as, most significantly, pyruvate. This leads 
one to consider enzymes related to TK for use as biocatalysts.
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1.07 l-Deoxy-D-XyIuIose-5-Phosphate Synthase (DOX-P Synthase)
A TK-related enzyme, l-Deoxy-D-xylulose-5-phosphate Synthase, (DOX-P Synthase), 
was recently discovered in E. coli. It has been cloned, characterised, and shown to carry 
out the first step in a mevalonate-independent synthesis of the isoprenoid precursor, 
isopentenyl diphosphate, (IPP). (Sprenger et al., 1997). In the mevalonate pathway, IPP 
is synthesised from the starting material acetyl-CoA. In this mevalonate-independent 
pathway, the first step, catalysed by DOX-P Synthase, is a transketolase-type addition o f  
pyruvate and D-glyceraldehyde. Thus, this enzyme carries out the crucial reaction that 
TK does not.
1.07.1  C ellu lar F u n ction
Isoprenoids form the most diverse class o f biomolecules in nature. The class includes 
terpenes, such as limonine and menthol; quinones; carotenoids; sterols, such as 
cholesterol; steroid hormones, such as cortisol; and natural rubbers. All of these various 
biological products are polymers of a branched 5-carbon unit, known as isoprene. These 
isoprene units are in turn created by the isoprene monomer, isopentenyl pyrophosphate, 
IPP, and its isomer, dimethylallyl pyrophosphate, DMAPP, as shown in Figure 1.10. 
(Bloch, 1965).
The main biosynthetic route to production of this important precursor, IPP, in plants and 
animals has long been established as producing IPP from acetyl-CoA, via the 6-carbon 
intermediate mevalonate. This pathway is shown in Figure 1.11.
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C-5
CH.
C-10
OPP
CH.
isopentenyl-pyrophosphate
CH. OPP
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geranyl-pyrophosphate
C-15 C-30
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dimethyl al ly 1 -pyrophosphate
terpenes steroids quinones
Figure 1.10. Isoprenoids are created from isopentenyl phosphate, IPP.
The two 5-carbon isomers, isopentenyl pyrophosphate and dimethylallyl pyrophosphate, 
combine in a condensation reaction, to form the 10-carbon monoterpene, geranyl 
pyrophosphate. Further combinations of condensation reactions, and subsequent 
processing reactions, produce the wide variety of isoprenoid compounds seen in nature.
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3 X H,c— COOH
COOH
acetate 3-hydroxy-3-methylglutaryl- mevalonate IPP
coenzyme A
Figure 1.11. The mevalonate pathway to the production of IPP.
Three molecules of acetate combine to form 3-hydroxy-3-methylglutaryl-coenzyme A, 
(HMG-CoA), which is then reduced to form mevalonate, the precursor to IPP, the 
building block of isoprenoids.
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Figure 1.12. The mevalonate-independent pathway to the production of IPP.
Pyruvate and glyceraldehyde-3-phosphate combine to form l-deoxy-D-xylulose-5- 
phosphate, which is then reduced to form 2-C-methyl-D-erythritol-4-phosphate, the 
alternative precursor to IPP, building block of the isoprenoids.
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It was recently demonstrated however that certain eubacteria and algal species produce 
IPP in a mevalonate-independent manner. Various studies later demonstrated that this 
pathway used the alternative starting materials, pyruvate and glyceraldehdye-3- 
phosphate, proceeding via a 2-C-methyl-erythritol-4-phosphate intermediate (Rohmer et 
al., 1993;Rohmer et al., 1996;Schwender et al., 1996). This intermediate has not been 
found to have any alternative use, and gives this biosynthetic pathway its name, the 
methylerythritol-phosphate (MEP) pathway. The reaction steps, intermediates and 
enzymes involved in this pathway have been elucidated through analysis o f mutants and 
radiolabelling studies. The pathway is shown in Figure 1.12.
The first step in this mevalonate-independent MEP pathway is to produce the 5-carbon 
backbone. This is created from pyruvate and glyceraldehyde-3-phosphate in a 
transketolase-type reaction, catalysed by the enzyme, DOX-P Synthase. The gene for 
this enzyme in E. coli, dxs, has been cloned and characterized, (Sprenger et al., 1997). A 
second enzyme, l-Deoxyxylulose-5-Phosphate Reducto-isomerase, encoded by the gene, 
dxr, then reduces l-deoxyxylulose-5-phosphate and carries out an a-ketol rearrangement, 
to yield the key intermediate, methylerythritol-phosphate, (Takahashi et al., 1998). This 
step catalyses the synthesis of the 5-Carbon branched chain backbone of isoprene. Three 
subsequent steps then activate this molecule using CTP, creating methylerythritol-2,4- 
cyclodiphosphate, via 4-diphosphocytidyl-methylerythritol and 4-diphosphocytidyl- 
methylerythritol-2-phosphate. Two further enzymes then catalyse the creation of IPP and 
its isomer, DMAPP, from this activated methylerythritol-2,4-cyclodiphosphate, via the 
intermediate, (£)-4-hydroxy-2-methylbut-2-enyl-diphosphate, (HMBPP).
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1 .0 7 .2  S tructura l S im ilarity  to  T r a n sk e to la se
The gene for DOX-P Synthase, dxs, has been cloned and sequenced, (Sprenger et al., 
1997). This shows DOX-P Synthase to be a very similar enzyme to TK. The dxs gene is 
1860 base pairs in length, encoding 620 amino acids, whilst the tkt gene for TK is 1989 
base pairs in length, encoding 663 amino acids. The two sequences have nucleotide 
identity o f 50%, and amino acid similarity of 44%. Sequence analysis shows TK to be 
split into three domains - an N-terminal domain; a pyrimidine-binding domain; and a 
C-terminal domain. Sequence analysis o f DOX-P Synthase shows it also can be split into 
those three domains, whilst BLAST analysis matches each of these three domains most 
closely with their respective domains in TK, (Figure 1.13). This reveals DOX-P 
Synthase to have a pyrimidine-binding domain, as does TK. This domain in TK is 
involved in the binding of the pyrimidine part of the enzyme cofactor, TPP. One can 
postulate therefore that DOX-P Synthase also utilises the cofactor, TPP.
The gene, dxs, was discovered through overexpression in E. coli. Subsequent PAGE 
analysis showed the DOX-P Synthase protein to have a subunit molecular weight of 67 
kDa. Gel filtration analysis showed that in native conditions, this protein forms a 
homodimer, just as TK does. (The molecular weight of TK is 144 kDa, with a subunit 
molecular weight of 72 kDa). Whilst X-ray crystallographic studies have elucidated 
atomic resolution information on the structure of TK, at the commencement of these 
studies no further information existed on the structure of DOX-P Synthase, but one might 
postulate a resemblance to the structure of TK. (The recently published crystal structure 
of E. coli DOX-P Synthase, (Xiang et al., 2007), is addressed in the Discussion).
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Figure 1.13. Domain structure of DOX-P Synthase and TK.
Both enzymes share the same domain structure, with a TK-N-terminal-like domain of 
250 -  300 residues in length; a central TK-pyrimidine-binding-like-domain of ~100 
residues in length; and a TK-C-terminal-like domain of ~50 residues in length.
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1 .0 7 .3  E n zym atic  D ata
Extraction of the DOX-P Synthase enzyme in native conditions has been used to replicate 
the DOX-P Synthase reaction in vitro. This has been done to demonstrate catalysis of the 
native reaction, using glyceraldehyde-3-phosphate and pyruvate as substrates. 
(Kuzuyama et al., 2000). This has established a KM value for for pyruvate of 0.1 mM, 
and for glyceraldehyde-3-phosphate of 0.24 mM. This compares to values found for TK 
of 18 mM for hydroxypyruvate, and 2.1 mM for glyceraldehyde-3-phosphate. A specific 
activity of 4.3 pmol.min^.mg'1 for DOX-P Synthase with its native substrates has been 
recorded, as compared to a specific activity for TK of 50 pmol.min‘1.mg‘I. These studies 
also demonstrated that like TK, DOX-P Synthase also requires TPP and Mg2+ as 
cofactors. The differences in enzymological constants for the two enzymes may reflect 
the different uses to which they have evolved. TK, with its higher KM and higher specific 
activity, and role linking metabolic pathways, can react quicker to changes in substrate 
concentration in its environment. DOX-P Synthase with its lower Km and lower specific 
activity can maintain a steady flow of l-deoxyxylulose-5-phosphate through the MEP 
pathway to isoprenoid biosynthesis, irrespective of substrate concentrations.
Various methods have been used to assay this reaction. Most commonly, an excess of 
DOX-P reducto-isomerase has been used to turn over the product 1 -deoxy-D-xylulose-5- 
phosphate, (Altincicek et al., 2000). This reaction oxidises NADPH, a reaction which 
can be followed spectrophotometrically. This assay is not ideal due to the difficulty of 
procuring DOX-P reducto-isomerase, and its incompatibility with non-native substrates.
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As a result other methods have been developed, including fluorometric assays, (Querol 
et a l,  2001a), and HPLC-based assays, (Schurmann et a l, 2002). These assays will need 
to be developed further for different substrates and systems.
1 .0 7 .4  S u b str a te  R a n g e
Whilst several studies have demonstrated the DOX-P Synthase catalysed turnover of 
pyruvate and glyceraldehyde-3-phosphate, (or glyceraldehyde), there has been very little 
study of alternative non-native substrates with the enzyme. The only information on 
alternative acceptors to glyceraldehyde in the substrate range of DOX-P Synthase is that 
of erythrose, erythrose-4-phosphate and glycolaldehyde can act as keto-acceptors in the 
reaction, (Schurmann et a l,  2002). Erythrose and glycolaldehyde respectively are simply 
one carbon unit longer or shorter than glyceraldehyde.
1.08 DOX-P Synthase as Biocatalyst
Transketolase has proved itself a very useful enzyme as a biocatalyst. DOX-P Synthase, 
appears to be a very similar enzyme catalysing a similar reaction, but one which TK itself 
is incapable o f catalysing. This suggests DOX-P Synthase could similarly prove a useful 
addition to the synthetic chemist's arsenal of useful biocatalysts. To prepare the enzyme 
for this role it needs to be more fully characterised as a biocatalyst.
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1.08.1  A p p lic a tio n s  a s  B io c a ta ly s t
DOX-P Synthase has the capability to fill as many roles as TK. Applications could range 
from chiral resolutions of deoxysugars to the production of intermediates in the synthesis 
o f bioactive molecules and pharmaceuticals. For example, if  benzaldehyde could be 
employed as a keto-acceptor, DOX-P Synthase could be used as a useful catalyst in the 
production of ephedrines or epinephrines, via a chemically difficult stereospecific 
transketolase-type reaction. DOX-P Synthase would in fact be more appropriate than TK 
for the production of ephedrine, as there is no unnecessary terminal hydroxyl group 
which might need to be removed. How this might be done is shown in Figure 1.14. In 
such ways, DOX-P Synthase opens up biocatalysis to more routes than would be open 
with just TK.
1 .0 8 .2  D e v e lo p m e n t a s  B io c a ta ly s t
For DOX-P Synthase to be more widely useful to the chemical engineer designing a 
synthetic process, the enzyme needs to be developed further as a biocatalyst. To produce 
DOX-P Synthase at high levels it needs to be cloned into a high-expression vector, and 
expressed in a high-growth expression strain of E. coli or a similar host. Enzyme 
production can then be optimised through using the most effective expression vectors, 
and maximising host cell growth and cellular enzyme production by manipulating the 
growth conditions. The extraction method for DOX-P Synthase then needs to be 
optimised to reduce loss of enzyme, or loss of enzyme activity in the process. And to 
measure this, an assay system will need to be developed, capable of measuring the
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Figure 1.14. A suggested pathway for creation of ephedrine, involving a putative 
DOX-P Synthase catalysed step.
A DOX-P Synthase catalysed addition of a 2-carbon ketone unit from pyruvate on to 
benzaldehyde would produce a putative precursor to ephedrine. Transaminase and 
methylase steps could complete the pathway.
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activity of the extracted biocatalyst.
Then, the optimal conditions for DOX-P Synthase activity will need to be more 
extensively described, so that the synthetic chemist is best able to predict the utility of the 
biocatalyst in various conditions, as may prove necessary in an industrial process. This 
will include assaying activity at various temperatures, pH, or cofactor concentrations,
Beyond this, the utility of DOX-P Synthase with various non-native substrates will also 
need to be described. It is known that the enzyme can turn over glyceraldehyde, 
glycolaldehyde or erythrose as keto-acceptors. However, the synthetic chemist will also 
want to know whether the enzyme might turnover a non-hydroxylated substrate such as 
propionaldehyde; a longer chain substrate, such as glucose; or an aromatic substrate, such 
as benzaldehyde.
1 .0 8 .3  L im ita tion s a s  B io c a ta ly s t
In describing the utility of DOX-P Synthase as a biocatalyst, limitations of the enzyme 
will also become apparent. For example, from previous studies it is already known that 
DOX-P Synthase has a lower specific activity than TK. Describing DOX-P Synthase 
further will demonstrate further differences with TK. From the information already 
known about the enzyme, and from information to be discovered, reasons as to the 
limitations of DOX-P Synthase, and to its differences to TK, will then be speculated 
upon.
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1 .0 8 .4  Im p ro v em en ts  th ro u g h  M u ta g e n e s is
In the same way as mutagenesis of TK has been carried out to improve its utility as a 
biocatalyst, mutagenesis of DOX-P Synthase will then also be conducted. This will aim 
to reduce the limitations of the enzyme as may be observed. For example, with TK it was 
speculated that a long isoleucine side-chain protruding into the active site cleft was 
inhibiting the entrance of bulkier aromatic substrates into the catalytic site, (Bacon, 
2001). Where possible, similar hypotheses as to the limitations of DOX-P Synthase will 
be made, then tested by mutagenesis. Where successful this will lead to improvements to 
the enzyme's utility as a biocatalyst.
1.09 Project Aims
In summary therefore the aims of this project are to:
1. Develop DOX-P Synthase expression and extraction method.
2. Improve DOX-P Synthase production.
3. Develop DOX-P Synthase assay method.
4. Describe more fully the optimal conditions for DOX-P Synthase activity.
5. Describe more fully the substrate range of DOX-P Synthase.
6. Mutate DOX-P Synthase in order to improve its utility as a biocatalyst.
7. Describe the effects and success of these mutations.
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2 Materials & Methods
2.01 Suppliers
2 .01 .1  M ateria ls
Dehydrated Bacto™ Tryptone and Bacto™ Yeast and Bacto™ Agar were purchased 
from Difco, BD Biosciences, (Oxford, UK). Dehydrated Nutrient Broth 2 was purchased 
from Oxoid, (Basingstoke, UK).
Ampicillin, agarose, trifluoroacetic acid for HPLC, and all other fine chemicals, (except 
where stated), used to make buffers and reagents were purchased from Sigma-Aldrich, 
(Gillingham, UK).
DNA restriction enzymes, DNA ligase, shrimp alkaline phosphatase, polynucleotide 
kinase enzyme, and their buffers, DNA gel molecular weight markers, and reducing 
agent, DTT, were purchased from New England BioLabs, (Hitchin, UK). Pfu DNA 
polymerase and dNTPs were purchased from Stratagene, (Amsterdam, Netherlands). Taq 
DNA polymerase was purchased from Qiagen, (Crawley, UK).
Oligonucleotides were purchased from Operon, (Cologne, Germany).
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TOPO- TA cloning System was purchased from Invitrogen, (Paisley, UK), including 
vector pCR 2.1 TOPO, (pUC ori fl ori KanR AmpR T7 promoter Piac lacZa). Vector 
pET21a(+), (pBR322 ori fl ori AmpR T7 promoter lacl), purchased from Novagen, 
(Nottingham, UK).
QIAprep miniprep kits and QIAquick gel extraction kits were purchased from Qiagen, 
(Crawley, UK).
Acrylamide and buffers for SDS-PAGE were purchased from National Diagnostics, 
(Atlanta, Georgia, USA). N,N,N',N',-tetramethylethylenediamine (TEMED) and 
ammonium persulphate were purchased from Sigma-Aldrich, (Crawley, UK). Molecular 
weight markers for SDS-PAGE were purchased from New England Biolabs, (Hitchin, 
UK).
BugBuster non-ionic detergent for cell lysis, and Benzonase nuclease for DNA digestion 
were purchased from Novagen, (Nottingham, UK).
Coomassie Plus Protein Assay was purchased from Pierce, (Rockford, Illinois, US).
Whatman LK6D Silica Gel 60A thin layer chromatography plate purchased from 
Whatman, (Brentford, UK).
C M Chudziak 62
Production. Characterisation and Modification of DOX-P Synthase as a Biocatalvst
All substrates used in enzyme catalysed reaction purchased from Sigma-Aldrich, 
(Gillingham, UK). Product, 1-deoxyxylulose, purchased from Echelon Biosciences, (Salt 
Lake City, Utah, US).
2 .0 1 .2  M icro b io lo g ica l S tra in s
2 .01 .2 .1  E. coli TO P10
One-Shot chemically competent E. coli TOP 10, genotype F" mcrA A(mrr-hsdRX\S- 
mcrBC) <j)80/acZAM15 AlacXIA recAl aroD\2>9 A(aro-leu)1691 gal\J galK rpsL (StrR) 
endA\ nupG, purchased from Invitrogen, (Paisley, UK), with TOPO-TA cloning system.
2 .0 1 .2 .2  E.coli DH5ct
E. coli DH5a, genotype F" <|)80/acZAM15 A(lacZYA-argF) U169 recAX endAX hsdRXl 
(rk', mk+) phoA  supE44 X  th f 1 gyrA96 relA 1, purchased from Invitrogen, (Paisley, UK).
2 .0 1 .2 .3  E. coli BL21 (DE3)
E. coli BL21 (DE3), genotype B F" dcm ompT hsdS (rs’ me ) gal A.(DE3), purchased from 
Stratagene, (Amsterdam, Netherlands).
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2 .0 1 .2 .4  E. coli JM 107 pQ R 183
E. coli JM107 pQR183 was obtained from Dr. John Ward, (Department of Biochemistry 
& Molecular Biology, UCL).
JM107 genotype: end A ' gyrA96 thi hsdRXl supE44 relA\ X  A(lac-pro AB) F* traD36 
proAB laclq /acZAM13.
Plasmid pQRl 83 was created by the insertion of a 5 kb fragment of E. coli genomic DNA 
containing the tkt gene and promoter, inserted downstream of the lac promoter in pUC18, 
genotype ori AmpR lacZ’, (French and Ward, 1995).
2 .0 1 .3  E q u ip m en t
Multitron orbital incubator, from HT-Infors (Bottmingen, Switzerland), was used for 
growing E. coli cultures.
Mini Sub-Cell GT, from Bio-Rad, (Hemel Hempstead, UK), was used for agarose gel 
electrophoresis.
Mini Protean 3, from Bio-Rad, (Hemel Hempstead, UK), was used for SDS-PAGE.
AccuSpin Micro microcentrifuge from Fisher Scientific, (Loughborough, UK), was used 
for routine microcentrifugation. Centrifuge 5417R from Eppendorf, (Cambridge, UK), 
was used for refrigerated microcentrifugation. Centrifuge 541 OR from Eppendorf was 
used for refrigerated centrifugation of larger samples. Optima L-100 XP Ultracentrifuge,
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Beckman Coulter, (High Wycombe, UK), was used for ultracentrifugation in genomic 
DNA preparation.
Digilab U-1800 Spectrophotometer from Hitachi, (Wokingham, UK), was used for 
spectrophotometry. Biowave C08000 Cell Density Meter from WPA, (Cambridge, UK), 
was used for measurements of optical density at 600 nm.
A Dionex, (Camberley, UK) HPLC system was employed for Reversed Phase HPLC 
analysis, controlled by Chromeleon 6.0 software. The system comprised of a TC-100 
column oven, and a UVD170U UV detector module, followed by a PC 10 pneumatic 
controller post column NaOH addition unit and an ED50 electrochemical detector 
module. The system was integrated with an LC Packings Famos WellPlate Micro 
Autosampler. The HPLC column used was an Aminex 87H from BioRad, (Hemel 
Hempstead, UK).
A Thermomixer comfort MTP from Eppendorf, (Cambridge, UK), was used for reaction 
incubations.
A Soniprep 150 from MSE, (London, UK), was used for sonication.
A SevenEasy pH meter from Mettler Toledo, (Leicester, UK), was used for pH 
measurement.
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A GeneGenius Bio Imaging System from Syngene, (Cambridge, UK), was used for gel 
imaging.
A TC-512 from Techne, (Stone, UK), was used for thermal cycling.
A water purification system from ELGA, (Marlow, UK), was used for provision of 
deionised water.
2 .0 1 .4  S o ftw a re
2 .01 .4 .1  BLAST
BLAST database search tool, (http://www.ncbi.nlm.nih.gov/BLAST/), (Altschul et al., 
1990;Madden et al., 1996), was used to search for similar genes to the E. coli tkt gene.
2 .0 1 .4 .2  T reeV iew
TreeView, (http://taxonomy.zoology.gla.ac.uk/rod/treeview.html), (Page, 1996), was 
used to create phylogenetic trees.
2 .0 1 .4 .3  C lusta lW
ClustalW, (http://www.ebi.ac.uk/clustalw/), (Chenna et al., 2003), was used to create 
multiple sequence alignments.
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2 .0 1 .4 .4  G e n e S n a p
GeneSnap from Syngene, (Cambridge, UK), was used to take UV and optical photo 
images o f agarose and polyacrylamide gels.
2 .0 1 .4 .5  G e n e T o o ls
GeneTools from Syngene, (Cambridge, UK), was used to analyse gel images by optical 
densitometry.
2 .0 1 .4 .6  C h ro m eleo n  6 .0
Chromeleon 6.0 from Dionex, (Camberley, UK), was used to control the HPLC system, 
and to analyse HPLC traces, measure retention time, peak area, and correlate peak area 
with concentration.
2.02 Materials
2 .02 .1  M icro b io lo g ica l grow th  m ed ia
Solid media was prepared by supplementing liquid media with 2% agar (w/v) prior to
autoclaving. All media were allowed to cool to below 40 °C before any addition of
thermolabile ampicillin to 100 pg.mL'1.
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2 .02 .1 .1  Luria B ertan i (LB) m ed iu m
Bacto™ Tryptone 10 g
Bacto™ Yeast Extract 5 g
NaCl 10 g, per litre deionised water.
2 .0 2 .1 .2  N utrient B roth  2  (N B 2) m ed iu m
Oxoid™ NB2 25 g, per litre deionised water.
2 .0 2 .2  DNA se p a r a tio n
2 .02 .2 .1  TE buffer
Tris.HCl 10 mM, pH 7.5
EDTA 1 mM
TE buffer was used for storage of DNA samples.
2 .0 2 .2 .2  A g a r o s e  g e l e le c tr o p h o r e s is  buffer
10X TBE buffer:
Tris base 54 g
Orthoboric acid 27.5 g
0.5M EDTA, pH 8.0 20 mL, per litre deionised water.
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Used as IX TBE buffer.
2 .0 2 .2 .3  A g a r o s e  g e l
Agarose 1 g
Ethidium bromide 1 pi of 10 jig.mL"1 stock, per 100 mL IX TBE buffer.
2 .0 2 .2 .4  6X G el L oad in g  B u ffer T yp e
Bromophenol Blue 0.25%
Xylene Cyanol FF 0.25%
Ficoll Type 400 15%, in water.
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2.02.2.5 Molecular weight marker
1 kb DNA ladder, NEB:
Mass (ng) Kilobases 
42 10.0 -
42 8.0 -
2.02.3 Protein separation
2.02.3.1 Polyacrylamide gel
12.5% Stacking gel:
30% (w/v) acrylamide 3.275 mL
Tris.HCl, pH 8.8 1.86 mL
Deionised water 2.725 mL
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10% ammonium persulphate 15 pL 
TEMED 15 pL
7.5% Separating gel:
30% (w/v) acrylamide 0.5 mL
Tris.HCl, pH 8.8 0.75 mL
Deionised water 1.7 mL
10% ammonium persulphate 20 pL 
TEMED 20 pL
2 .0 2 .3 .2  SD S-P A G E  R u n n in g  buffer
Tris base 3.03 g
Glycine 14.42 g
Sodium dodecyl sulphate 1 g, per litre deionised water.
2 .0 2 .3 .3  3X S D S  S a m p le  b u ffer
Tris.HCl lOOmM, pH 6.
SDS (electrophoresis grade) 4% (w/v) 
Bromophenol Blue 0.2% (w/v)
Glycerol 20% (v/v)
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DTT 200 mM
2.02.3.4 Molecular weight marker
Broad Range Protein Marker, NEB:
kDa 
. —  212
— —  158 
—  116 
■W — 97.2
M  — 66.4
*■*—  —  55.6
■ w  — 42.7 
« « • *  —  34.6
m *  — 20.0 
—  14.3
2.02.4 DOX-P Synthase reaction (and extraction) buffers
Reaction buffer was also used as the extraction buffer except where stated.
2.02.4.1 Standard reaction buffer
3.4
2.3
Tris.HCl 50 mM
MgCl2.6H20 9 mM
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Thiamine pyrophosphate, TPP 1 mM
Dithiothreitol, DTT 1 mM
Phenylmethylsulphonylfluoride, PMSF 0.1 mM
Made up in deionised water, to pH 7.0.
2 .0 2 .4 .2  A ltern ative  rea c tio n  b u ffers
Three pH buffers used:
Tris.HCl 50 mM, pH 7.0 / 7.5 / 8.0 / 8.5
MOPS 50 mM, pH 6.5 / 7.0 / 7.5
Bis-Tris.HCl 50 mM, pH 6.0 / 6.5 / 7.0
Cofactor concentration varied:
MgCl2.6H20 0 mM / 9 mM / 30 mM
Thiamine pyrophosphate 0 mM / 1 mM / 2.5 mM
2 .0 2 .5  250X  X T T I T rim ethyl-PM S R ea c tio n  S to c k
XTT 50 mg.mL'1 in DMSO
Trimethyl-PMS 1.25 mg.mL'1 in water.
XTT: 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide. 
PMS: Phenazine methosulphate.
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2 .0 2 .6  HPLC s o lu t io n s
2 .02 .6 .1  M obile p h a s e
0.05% TFA:
Trifluoroacetic acid 0.5 mL, per litre HPLC grade water.
0.1% TFA:
Trifluoroacetic acid 1 mL, per litre HPLC grade water.
0.2% TFA:
Trifluoroacetic acid 2 mL, per litre HPLC grade water.
2 .0 2 .6 .2  S a m p le  m o b ile  p h a se
Samples were diluted 1:1 with double concentration mobile phase, (e.g. in 0.2% TFA if 
0.1% TFA to be used as mobile phase).
2 .0 2 .6 .3  S o d iu m  h y d ro x id e  so lu t io n
0.5 M solution of sodium hydroxide in water was made using 50% NaOH, (Sigma).
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2.03 Methods
2 .03 .1  M icro b io lo g ica l te c h n iq u e
Standard sterile technique was maintained throughout. Media, buffers and reagents were 
sterilized by autoclaving at 121 °C for 20 minutes. Thermolabile solutions were 
sterilized by filtration through 0.22 pm filters. Agar plates were poured with an attendant 
flame, to create an updraught.
2 .0 3 .2  C ulturing m e th o d o lo g y
Overnight cultures of E. coli strains were grown from inoculation of 5 mL nutrient broth 
or Luria-Bertani broth with a single colony obtained by streaking out glycerol stocks, 
(50% v/v glycerol stored at -80 °C) on nutrient agar plates. Cultures were grown 
overnight for 16 h at 37 °C, with orbital shaking at 200 rpm. Growth selection was 
achieved, where required, by use o f 100 pg.mL'1 ampicillin in agar or broth.
Large-scale cultures of E. coli strains were grown from inoculation of 150 mL Luria- 
Bertani broth, in 1L conical flasks, with sufficient overnight culture to give OD6oo of 
~0.15. Large-scale cultures were grown at 37 °C, except where stated, and with orbital 
shaking at 200 rpm. Growth selection was achieved, where required, by use of 100 
pg.mL'1 ampicillin in broth. Induction was achieved by addition of IPTG to 1 mM at the 
start of log phase of growth.
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2 .0 3 .3  G en era l m o lec u la r  b io lo g y
2 .03 .3 .1  G e n o m ic  DNA p rep aration
E. coli DH5a genomic DNA was prepared from pelleted 10 mL cultures of E. coli 
DH5a. Cells were lysed by lysozyme digestion and with SDS. Lysate was treated with 
pronase and RNase. DNA was precipitated by NaCl ethanol precipitation. DNA was 
then separated from protein by caesium chloride gradient ultracentrifugation with 
ethidium bromide at 45,000 rpm for 24 h. DNA band was removed by pipette. Ethidium 
bromide was extracted with isopropanol, then DNA precipitated with ethanol and 
resuspended in TE buffer.
2 .0 3 .3 .2  PCR prim er d e s ig n
PCR primers were designed to be uniquely homologous to the desired stretch o f DNA 
sequence, with the addition of a 5’ tail of adenine and thymine residues. A melting 
temperature of ~65 °C was sought, with a more strongly binding 3' tail of cytosine and 
guanine residues. PCR primers were diluted in water to 50 pM.
2 .0 3 .3 .3  PCR a m p lifica tion  o f  d x s
Taq DNA polymerase, (NEB), was used according to the manufacturer's instructions, to 
amplify dxs gene from 1 pL genomic DNA preparation. 1 pL of each oligonucleotide 
primer, (diluted to 50 pM), was used. Melting temperature of 65 °C was used, for 25 
cycles, with an extension time for 1.8 kb of 1 min 48 sec.
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2 .0 3 .3 .4  R estr ic tio n  d ig e s t
Restriction digests were carried out for 2 h at 37 °C in the recommended NEB restriction 
buffer, according to the enzyme used, as per manufacturer's instructions, and at an 
appropriate scale, (10 pL for diagnostic digests, 40 pL for preparative digests).
2 .0 3 .3 .5  L ig a tio n s
Ligations were carried out with T4 DNA ligase with T4 DNA ligase buffer, as per 
manufacturer's instructions, and at 4 °C for 16 h.
2 .0 3 .3 .6  DNA p h o sp h o ry la tio n  an d  d e p h o sp h o r y la t io n  r e a c t io n s
DNA phosphorylation was carried out by PolyNucleotide Kinase, PNK, (NEB), as per 
manufacturer's instructions.
DNA dephosphorylation was carried out by Shrimp Alkaline Phosphatase, SAP, (NEB), 
as per manufacturer's instructions.
2 .0 3 .3 .7  TOPO C lo n in g
TOPO cloning was used for vector capture of linear PCR products created using Taq 
DNA polymerase. PCR products were separated by agarose gel electrophoresis, and 
DNA of correct size excised using QLAquick gel extraction kit.
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7pL extracted PCR product was then incorporated into pCR2.1 using TOPO TA cloning 
kit, (Invitrogen), as per manufacturer's instructions. Ligation into pCR2.1 was catalysed 
by covalently attached topoisomerase.
Newly ligated vector was transformed into One Shot chemically competent E. coli TOP 
10 cells, provided with TOPO TA cloning kit, by chemical transformation, as per 
manufacturer's instructions.
2 .0 3 .3 .8  P ro d u c in g  c h e m ic a lly  c o m p e te n t  c e l ls
Competent cells were made from cultures grown from 2 mL inoculum of overnight 
culture, in 200 mL nutrient broth in a 1 L conical flask. Cultures were grown at 37 °C 
and 200 rpm to an OD600 of ~0.6. Cultures were separated into 50 mL aliquots, then 
placed on ice to halt growth for 10 min. Cells were then harvested by centrifugation at 
4 °C. Cells were resuspended in 5 mL 100 mM CaCL, stored on ice for 45 min, then re­
pelleted by centrifugation at 4 °C. Cells were then resuspended in 100 mM CaCl2 with 
15% v/v glycerol, separated into 50 pL aliquots, and stored at -80 °C
2 .0 3 .3 .9  C h em ica l tra n sform ation
Aliquots of chemically competent cells were placed on ice for 5 min. 1 pL DNA 
minipreparation was added and then kept on ice a further 5 min. Transformation was 
then carried out with 45 sec heat shock at 42 °C, followed by addition of 250 pL nutrient
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broth and recovery for 45 min at 37 °C. Cell suspension was then spread on ampicillin- 
containing nutrient broth agar plates to select for transformants.
2 .0 3 .3 .1 0  Q iaP rep  DNA m in ip reparation
DNA minipreparations were carried out using QIAprep spin miniprep kit, (Qiagen), as 
per manufacturer's instructions.
2 .0 3 .3 .1 1  A g a r o se  g e l e le c tr o p h o r e s is
Analytical and preparative electrophoresis of plasmid DNA, DNA restriction fragments 
and PCR products was performed on 1% horizontal (ethidium bromide-containing) 
agarose gels using Mini Sub-Cell GT, (Bio-Rad), at 100V. Samples were diluted with 
6X loading buffer. 12 pL was loaded on the gel for diagnostic DNA separations. 48 pL 
was loaded for preparative DNA separations. 6 pL DNA ladder was used, containing 0.5 
pg DNA. Ethidium bromide in the agarose gel enabled DNA visualisation on a UV 
transilluminator. UV photo images were taken using GeneSnap, (Syngene).
2 .0 3 .3 .1 2  Q iaQ uick  g e l ex tra c tio n
DNA fragments of different size were separated using agarose gel electrophoresis, then 
extracted from the agarose gel using QiaQuick spin extraction kit, (Qiagen), as per 
manufacturer's instructions.
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2 .0 3 .4  P la sm id  c o n s tr u c tio n
2 .03 .4 .1  pC C 15
E. coli dxs gene was PCR amplified from genomic DNA of E. coli DH5a using Taq 
DNA polymerase, (Qiagen), leaving a 3' poly-adenine tail, necessary for TOPO cloning. 
PCR product of correct size, 1.8 kb, was separated from other DNA present by agarose 
gel electrophoresis, then extracted using QiaQuick gel extraction kit, (Qiagen). PCR 
product was then inserted into pCR 2.1 to create pCC15, using TOPO TA cloning kit, 
(Invitrogen).
2 .0 3 .4 .2  pC C 16
Plasmids, pCC15 and pET21a, (Novagen), were both cut by restriction digest with 
enzymes Ndel and Xhol, (NEB). Insert from pCC16, (1.8 kb), and vector body of pCR 
2.1, (5.4 kb), were then separated and extracted by agarose gel electrophoresis and using 
QiaQuick gel extraction kit, (Qiagen). Insert was phosphorylated using PolyNucleotide 
Kinase, (NEB), and pET21a vector body phosphorylated using Shrimp Alkaline 
Phosphatase, (NEB). PNK and SAP were then heat denatured and ligation involving dxs 
insert and pET21a vector body set up using T4 DNA ligase, (NEB), to create pCC16. 
Ligation was then transformed into chemically competent E. coli DH5a by chemical 
transformation.
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2 .0 3 .5  DNA s e q u e n c in g
Sequencing was performed by the DNA Sequencing Facility at the Wolfson Institute for 
Biochemical Research.
2 .0 3 .6  M easu rin g  cu ltu re grow th
2 .03 .6 .1  OD 600 m e a su r e m e n t
1 mL samples were removed at timepoints during culture growth in order to measure 
increase in cell density. Cell density was measured as optical density at 600 nm, OD6oo- 
OD600 was measured in 1 mL cuvette in Biowave C08000 Cell Density Meter, (WPA). 
If OD600 was greater than 0.6, the culture was diluted 1 in 10 in growth media for more 
accurate measurement of OD6oo-
2 .0 3 .6 .2  W et c e ll w e ig h t  m e a su r e m e n t
1 mL samples were centrifuged at 15000 rpm in accuSpin Micro microcentrifuge, (Fisher
Scientific), in a tube of known mass. Supernatant was removed by pipette, leaving wet
pellet in tube. Mass of tube was re-measured to calculate wet cell weight in 1 mL 
culture.
2 .0 3 .6 .3  O D 6oo v s  W et c e ll w e ig h t
OD600 was plotted against wet cell weight per mL culture for untransformed E. coli BL21 
and E. coli BL21 pCC16 showing a linear relationship.
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Figure 2.1. OD600 vs Wet cell weight.
O D 6oo an d  w et cell w eight m easured  at tim e  o f  induction  (after 2 h  grow th); 3 h post 
induction; and  24 h p o st induction.
2.03.6.4 Measuring plasmid carriage during cell growth
100 pL aliquots of a series of 10-fold dilutions of 1 mL samples of culture, down to a
o <
dilution of 10', were spread both on nutrient agar plates containing 100 pg.ml 
ampicillin and non-selective nutrient agar plates. After 16 h incubation at 37 °C, number 
of colonies was counted on each plate, to measure viable cells, as colony forming units, 
(cfu). The number of cfu on the ampicillin plates showed the number of viable cells per 
mL culture which were ampicillin resistant, and therefore carrying the plasmid, pCC16. 
The number of cfu on the non-selective plates showed the total number of viable cells per 
mL culture. The proportion of the first value to the second could be expressed as a 
percentage, describing the percentage of viable cells in the culture at that time, which 
were carrying the pCC16 plasmid.
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2 .0 3 .7  DOX-P S y n th a s e  ex tra c tio n
2 .03 .7 .1  P reparation  o f  p rotein  fr a c tio n s  for  initial SD S-P A G E
10 mL culture samples were taken at timepoints, then centrifuged at 4 °C at 5000 rpm in 
5804R refrigerated centrifuge, (Eppendorf). Supernatant was retained as the extracellular 
fraction. Whole cell pellet was retained as the whole cell fraction. A second whole cell 
pellet was retained and resuspended in 1 mL 0.9% NaCl(aq). This cell suspension was 
lysed by sonication. 6 cycles of 10 sec pulses with 10 sec intervals were carried out, 
using a Soniprep 150 sonicator, (MSE). Lysed cell suspension was re-centrifuged at 4 °C 
at 5000 rpm in 5817R refrigerated centrifuge, (Eppendorf). Supernatant was retained as 
the soluble cell fraction. Pellet was retained as the insoluble cell fraction.
2 .0 3 .7 .2  P reparation  o f  DOX-P S y n th a se  c larified  ex tra c t
Final protocol:
10 mL culture samples were taken at timepoints and centrifuged at 4 °C at 5000 rpm in 
5804R refrigerated centrifuge, (Eppendorf). Supernatant was discarded. Whole cell 
pellet was retained as whole cell fraction. A second whole cell pellet was retained and 
resuspended in 1 mL 0.9% NaCl(aq). This cell suspension was re-centrifuged at 4 °C at 
5000 rpm in 5417R refrigerated centrifuge, (Eppendorf). Supernatant was discarded. 
Pellet was resuspended in 0.9 mL reaction buffer containing 1 mg.mL'1 lysozyme. This 
was incubated at 37 °C for 20 min with shaking. 100 pL 10X BugBuster and 1 pL 
Benzonase, (both Novagen), was added. Cell suspension was incubated, on a rotating 
platform, at room temperature for 30 min. Lysed cell suspension was re-centrifuged at
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4 °C at 5000 rpm in 5417R refrigerated centrifuge, (Eppendorf). Supernatant was 
retained as soluble cell fraction. Pellet was retained as insoluble cell fraction.
Protamine sulphate protocol:
After lysozyme digestion, 100 pL 10X BugBuster was added, but with 50 pL 100 mM 
protamine sulphate instead of Benzonase. Protocol then continued as above.
Sonication protocol:
After resuspension of NaCl washed pellet in 1 mL reaction buffer, the cell suspension 
was lysed by sonication. 6 cycles of 10 sec pulses with 10 sec intervals were carried out, 
using a Soniprep 150 sonicator, (MSE). Lysed cell suspension was re-centrifuged at 4 °C 
at 5000 rpm in 5417R refrigerated centrifuge, (Eppendorf). Supernatant was retained as 
soluble cell fraction. Pellet was retained as insoluble cell fraction.
2 .0 3 .8  SD S-P A G E
2.03 .8 .1  S a m p le  preparation
Whole cell pellet and insoluble cell fraction pellet was resuspended in 100 pL SDS 
sample buffer per mL culture at OD600 of 1.0 from which pellet was generated, i.e. in3 
mL SDS sample buffer for pellet generated from 10 mL culture at OD6oo of 3.0. 
Resuspension of insoluble cell fraction pellet required heating for 10 min at 95 °C.
Soluble cell fraction supernatant was diluted 1 -in-3 in SDS sample buffer.
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All samples, including molecular weight marker, were heated for 5 min at 95 °C before 
use.
2 .0 3 .8 .2  P rotein  sep a ra tio n
Polyacrylamide gels were submerged in Mini Protean 3 electrophoresis tank, (BioRad), 
filled with SDS-PAGE running buffer for vertical electrophoresis. 15 pL of whole cell 
and insoluble cell fraction samples were added per well. Equivalent volume of soluble 
cell fraction samples were added per well, e.g. 15 pL if  OD600 is 3.0. (If OD600 is 3.0, 
whole cell and insoluble cell fraction pellets were resuspended in 3 mL SDS sample 
buffer, of which 15 pL was added to the gel well. This is equivalent to 5 pL of 1 mL 
soluble cell fraction supernatant, or 15 pL when diluted to 3 mL in SDS sample buffer). 
7 pL NEB Broad Range Protein Marker was loaded in molecular weight marker well.
2 .0 3 .9  C o o m a s s ie  P lu s  P rotein  A s s a y
Coomassie Plus Protein Assay, (Pierce), was used as per manufacturer's instructions. 
Protein standard BSA diluted in DOX-P Synthase extraction buffer, (with or without 
BugBuster). Absorbance at 595 nm, A595 was measured in Digilab U-1800 
Spectrophotometer, (Hitachi).
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Protein Concentration (ug/mL)
Figure 2.2. Concentration of standard protein Bovine Serum Albumin, (BSA), in DOX-P 
Synthase extraction buffer, plotted against net absorbance of A595. (Net absorbance 
represents subtraction of baseline absorbance at 0 ug/mL BSA).
2.03.10 Setting up DOX-P Synthase catalysed reaction
0.95 mL reaction buffer was set up in 1 mL reaction tubes, to which 50 pL clarified 
DOX-P Synthase extract was added. Reaction buffer contained 1.05X required substrate 
concentration, achieving IX required concentration upon dilution by extract addition.
Concentration of ketone acceptor:
20 mM DL-glyceraldehyde, or for alternative acceptors, 10 mM glycolaldehyde /
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D -ery th ro se  /  p ro p io n a ld e h y d e  /  D -g lucose  /  D -m an n o se  / b en z a ld eh y d e  / 3 -p y rid in e- 
c a rb o x a ld eh y d e  /  4 -p y rid in eca rb o x a ld eh y d e .
Concentration o f ketone donor:
10 mM sodium pyruvate, or for alternative donors, 10 mM sodium hydroxypyruvate.
The reaction tubes were then incubated in a Thermomixer comfort MTP, with shaking at 
300 rpm for 30 sec in every 5 min. The tubes were incubated at 37 °C, except where 
stated otherwise. 150 pL samples were taken at time points.
2 .03 .10 .1  DOX-P S y n th a s e  p re-in cu b ation
To measure the effect of DOX-P Synthase pre-incubation, 50 pL extract was diluted in 
0.5 mL reaction buffer in 1.5 mL tubes. As with reaction tubes, these incubation tubes 
were then incubated at 37 °C in a Thermomixer comfort MTP, with shaking at 300 rpm 
for 30 sec in every 5 min. After the incubation period 0.5 mL reaction buffer containing 
2X substrate concentration was added, and subsequent reaction followed as before.
2 .0 3 .1 0 .2  DOX-P S y n th a s e  s to r a g e
To measure effect of storage on activity, clarified DOX-P Synthase extract, as prepared 
in 2.03.7.2, was stored for 7 days at either 25 °C, 4 °C, or -20 °C. After the storage 
period, activity was assessed as before.
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2 .03 .11  TLC a s s a y
Whatman LK6D Silica Gel 60A thin layer chromatography plate was equilibrated for 24 
h with propanol / ethyl acetate / water (6:1:3) in TLC tank at room temperature. 20 pL of 
samples to be analysed were spotted per lane. TLC plate was developed with propanol / 
ethyl acetate / water (6:1:3) for 3 h at room temperature.
After development TLC plate was dried then stained with aerosol of anisaldehyde / 
sulphuric acid. Stain prepared was 15 g p-anisaldehyde dissolved in 250 mL ethanol with 
5 mL 98% sulphuric acid. After staining plate was dried until spots appeared.
2 .0 3 .1 2  XTT a s s a y
DOX-P Synthase reaction was set up as described in 2.03.10. After 15 h incubation, 96 
pL samples were removed to 96-well plate and 4 pL of 250X XTT / trimethyl-PMS stock 
was added, to final concentration of 0.2 mg.mL'1 XTT and 5 pg.mL'1 trimethyl-PMS.
2 .0 3 .1 3  HPLC a s s a y
2 .0 3 .1 3 .1  HPLC se p a r a tio n
HPLC analysis was carried out using an Aminex 87H column at 60 °C, mobile phase
0.1% v/v trifluoroacetic acid, (TFA), and a flow rate of 0.6 mL.min'1. UV detection was 
via a UVD170U UV detector, at 210 nm. Electrochemical detection was via an ED50
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electrochemical detector, set to a standard triple potential, following adjustment of pH to 
above 12 by post column addition of NaOH.
150 pL samples were taken at time points, as stated, and activity quenched by dilution 
with 150 pL 0.2 % TFA. Samples were injected into HPLC system by Famos WellPlate 
Microwell Autosampler. HPLC system was controlled by Chromeleon 6.0 software, 
which was also used to analyse HPLC traces, measure retention time, peak area, and 
correlate peak area with concentration.
2.03.13.2 Peak area vs substrate concentration
Substrates at standard concentrations were analysed in all cases. Peak area was plotted 
against substrate concentration as below, so that concentration could be calculated from 
peak area for timepoint samples.
1.
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_  700 ----------
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I  600 ----------(J£  500 -----
400
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Figure 2.3. HPLC peak area versus concentration of l.DL-Glyceraldehyde; 2. 
Pyruvate; 3. 1-Deoxyxylulose.
Triplicates of DL-glyceraldehyde, pyruvate and 1-deoxyxylulose made up to standard 
concentrations in DOX-P Synthase reaction buffer. Area of peak seen in HPLC-ECD 
trace for DL-glyceraldehyde and 1 -deoxyxylulose plotted against concentration. Area of 
peak seen in HPLC-UV trace for pyruvate plotted against concentration. Relationship 
between peak area and concentration was linear, and used to calculate concentration from 
peak area. Peak area measurements made by Chromeleon 6.0 software, (Dionex).
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2 .0 3 .1 4  S ite -d ir ec ted  m u ta g e n e s is
The site-directed mutagenesis protocol used was based on that of the QuikChange Site- 
Directed Mutagenesis Kit of Stratagene, (Amsterdam, Netherlands).
Step 1 - Plasmid preparation:
Plasmid, pCC16, was prepared by QIAprep minipreparation.
Step 2 - Temperature Cycling
Polymerase Chain Reaction was set up with Pfu DNA polymerase, (Stratagene), as per 
manufacturer’s instructions, using 2 pL pCC16 plasmid template DNA, andl pL of each 
oligonucleotide primer, (diluted to 50 pM). Cycling parameters:
Segment Cycles Temperature Time
1 1 95 °C 30 sec
2 16 95 °C 30 sec
60 °C 1 min
68 °C 7 min 12 sec
3 1 68 °C 20 min
Step 3 - Digestion
After temperature cycling, the reactions were placed on ice for 2 min to cool to <37 °C. 
2 pL Dpnl restriction enzyme was added directly to the amplification reaction, which 
were then incubated at 37 °C for 1 h to digest (methylated) template DNA.
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Step 4 - Ligation
6 pL T4 ligase buffer and 2 pL T4 DNA ligase were added, and reactions were then 
incubated at 4 °C for 16 h to anneal nicked ends.
Step 5 - Transformation
DNA was then chemically transformed into chemically competent E. coli BL21 (DE3).
2 .03 .14 .1  M u ta g e n e s is  p rim ers
Primers were designed to be uniquely homologous to the desired stretch of DNA 
sequence, with nucleotide substitutions for introduction of desired mutations. A melting 
temperature of -60  °C was sought. Oligonucleotides were diluted in water to 50 pM.
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3 Expression and Analysis of 1-Deoxy-D-xylulose 5-phosphate 
Synthase
3.01 Introduction
The range of industrial chemical processes to which one could apply the use of enzyme 
catalysis, in biotransformations, is necessarily limited by our knowledge of the range of 
enzymes available in nature. Transketolase, (TK), catalysed carbon chain elongation, 
through the addition of a ketol group, from a ketose sugar, such as hydroxypyruvate, to 
an aldehyde, has proven a useful biotransformation applicable to several chemical 
processes. As with all enzymes however, it is inevitably limited in the range of reactions 
it can catalyse. Specifically it fails to catalyse the addition of a 2-carbon ketone group 
from pyruvate instead of hydroxypyruvate, (Meshalkina et al., 1995). However, this 
reaction is so chemically similar to that catalysed by transketolase, that it was decided to 
carry out a search of related transketolase-like enzymes, to look for other enzymes, which 
might catalyse this reaction. This chapter describes that search, followed by the cloning, 
expression and extraction of the identified enzyme, l-Deoxy-D-Xylulose-5-Phosphate 
Synthase.
3.02 Identification of 1-Deoxy-D-xylulose 5-phosphate Synthase
The DNA sequence of the E. coli Transketolase, tkt, gene, (Sprenger, 1993), was used to 
search the BLAST database, (http://www.ncbi.nlm.nih.gov/BLAST/), (Altschul et a l,
C.M Chudziak 93
Production. Characterisation and Modification o f DOX-P Synthase as a Biocatalyst
1990;Madden et al., 1996). Amongst other genes, this search identified the dxs gene 
from E. coli. This gene encodes the enzyme 1 -Deoxy-D-Xylulose-5-Phosphate Synthase, 
(DOX-P Synthase), which catalyses a transketolase-type reaction, transferring a ketone 
group from pyruvate to glyceraldehyde, and producing 1 -deoxy-D-xylulose, (Sprenger et 
al., 1997).
The sequences of a selection of the genes found using the database search were then 
entered into the computer program TreeView, (http://taxonomy.zoology.gla.ac.uk/ 
rod/treeview.html), (Page, 1996), to create a phylogenetic tree with all the collated 
sequences. This tree can be seen in Figure 3.1. The collected sequences of TK-like 
genes clearly cluster into three distinct groups. The first of these comprises transketolase 
genes, and also dihydroxyacetone synthase genes, from various bacterial sources; the 
second group comprises DOX-P Synthase genes from various bacterial sources; and the 
third is more diverse, comprising of genes for various 2-oxo-acid dehydrogenases from 
various bacterial sources. All three groups of genes encode TPP-dependent enzymes. 
The close relation between each of the three groups can be seen in the presence of some 
genes named transketolase within the DOX-P Synthase grouping.
As described previously in the Introduction, a subsequent literature review on DOX-P 
Synthase revealed it to be an enzyme of interest to this particular area of study, and 
capable of catalysing the reaction being looked for. It was then decided to clone, express 
and analyse DOX-P Synthase, in relation to ongoing studies into the applications of 
transketolase as a biocatalyst.
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T.elongatus-DXS 
B.subtiis-DXS 
B.anthracis-DXS
Atumefaciens
T.maritima-TK-1
T.elongatus-TK
P.marinus-TK
H.influenzae-DXS
Styphi murium-DXS 
” E.coB-DXS
P.aerugriosa-DXS 
Neuropaea-TK 
M.capsulatus-DXS
E.coB-TK-2 
E.coB-TK-1 
SiypNmarium-TK-1
H.hfluenzae-TK-1 M.capsulati^-TK
P.aeruginosa-TK Myc .JC1 -Dihydroxyacetone synthase
S. awerm itilis -3- Methyl-2-oxobutyrate Dehydrogenas e
S. ai«e us-2- Oxois oval erate dehydrogenase 
Ent faecal is-Pyrovate dehydrogense 
B.subtitils-Pyruvate dehydrogenase
K pneumoniae-Acetoin DCPIP oxidoneductase 
Clost.magnum-Acetoin Dehydrogenase
Figure 3.1. Phylogenetic tree of TPP containing enzymes from various species, 
showing three clusters of related genes.
List compiled by BLAST search with E. coli tkt DNA sequence. Phylogenetic tree 
compiled using TreeView. (Transketolases denoted as TK; DOX-P Synthases denoted as 
DXS).
C.M Chudziak 95
Production. Characterisation and Modification of DOX-P Synthase as a Biocatalvst
3.03 Cloning of dxs from Genomic DNA
To clone the dxs gene, PCR primers were designed and procured, (2.03.3.2), 
complementary to the start and end of the dxs DNA sequence in the E. coli genome 
database, and samples o f E. coli DH5a genomic DNA prepared, (2.03.3.1). The PCR 
primers are shown in Figure 3.2. A PCR amplification of the dxs gene was then carried 
out as described in 2.03.3.3. The PCR product mix was then analysed by agarose gel 
electrophoresis, (2.03.3.11), and a UV photograph of the gel can be seen in Figure 3.3. 
There has been clear, strong amplification showing production of a band on the gel, 
which would correspond to 1.8 kb, when compared to the DNA size marker run 
alongside, (2.02.2.5). A band of 1.8 kb would correspond to the size of the dxs gene, as 
amplified. (It can also be seen that there has been some non-specific amplification of 
smaller fragments of DNA. However, this has not prevented strong amplification of dxs 
and production of a clear, concentrated dxs band).
TOPO-TA cloning (Invitrogen) of the PCR product mix was then carried out to clone the 
amplified dxs gene into the PCR capture vector, pCR2.1, as described in 2.03.4.1. The 
vector pCR2.1 is a high copy number, non-expression plasmid, used for amplifying 
medium-length sequences of DNA created in PCR reactions. A plasmid map of pCR2.1 
is shown in Figure 3.4. The PCR amplified dxs gene was cloned into pCR2.1 to create 
pCC15.
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5'-terminal primer:
5 ' ATATCATATGAGTTTTGATATTGCCAAATACCCG3'
3-terminal primer:
5 ' ATATGAGCTCTTATGCCAGCCAGGCC3'
Figure 3.2. PCR primers used to amplify dxs gene.
Italics indicate non-complementary nucleotides; bold indicates restriction enzyme site.
2 kb 1S  kbp 1 kbp 500 bp
1 
2
A m plified dxs
Figure 3.3. UV agarose gel image showing PCR amplification of dxs from a 
preparation of genomic DNA from E. coli DH5a.
1. 0.5 pg 1 kb DNA Ladder, (NEB); 2. 10 pL of product of dxs PCR amplification.
m m  i
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lacZa AT G 
M13 Reverse Primer I
Hind III Kpn I Sac I BamH I Spe I
I I I I I
CAG GAA ACA GCT ATG AC C ATG ATT ACG CCA AGC TTG GTA CCG AGC TCG GAT CCA CTA 
GTC CTT TGT CGA TAC TG G TAC TAA TGC GGT TCG AAC CAT GGC TCG AGC CTA GGT GAT
BstX I E coR I  
I I
GTA ACG GCC GCC AGT GTG CTG GAA TTC GGC 
CAT TGC CGG CGG TCA CAC GAC CTT AAG CCG
Ava I 
PaeR7 I 
BstX I Not I Xho I
I I I
£coR I I
A GCC GAA TTC TGC 
T CGG CTT AAG ACG
EcoRVI
AGA TAT 
TCT ATA
CCA TCA CAC TGG CGG CCG CTC GAG CAT GCA TCT 
GGT AGT GTG ACC GCC GGC GAG CTC GTA CGT AGA
Nsi I Xba I Apa II I I
AGA GGG CCC AAT TCG 
TCT CCC GGG TTA AGC
CCC TAT 
GGG ATA
T7 Promoter M13 Forward (-20) Primer 
CTG GCC GTC GTT TTA ClAA CGT CGT GAC TGG GAA AAC 
GAC CGG CAG CAA AAT G TT GCA GCA CTG ACC CTT TTG
AGT GAG TCG TAT JA C AAT TCA 
TCA CTC AGC ATA AT GTTA AGT
pCR®2.1
3.9 kb
Comments for pCR®2.1 
3929 nucleotides
LacZagene: bases t -545
M13 Reverse priming site: bases 205-221
T7 promoter: bases 362-381
M13 (-20) Forward priming site: bases 389-404
f1 origin: bases 546-983
Kanamycin resistance ORF: bases 1317-2111
Ampicillin resistance ORF: bases 2129-2989
pUC origin: bases 3134-3807
Figure 3.4. Plasmid map of pCR2.1. (Invitrogen).
PCR product inserted into multiple cloning site in lacZ gene by covalently attached 
topoisomerase.
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3.04 Cloning dxs into an Expression Plasmid
It was decided to use plasmid pET21a, (Novagen), as the dxs expression vector. Plasmid 
pET21a was chosen as it has a high copy number, has a strong T7 promoter, gives IPTG 
inducible expression, and can be selected for by ampicillin resistance. A plasmid map of 
pET21a is shown in Figure 3.5. The 1.8 kb fragment from pCC15 was cloned into 
pET21a between Ndel and Xhol sites as described in 2.03.4.2. A restriction map of the 
resulting plasmid, pCC16, can be seen in Figure 3.6. After transforming the ligation 
mixture into E. coli DH5a, correct ligation was shown by a diagnostic Ndel / Xhol 
restriction digest as described in 2.03.3.4. This digest was analysed by agarose gel 
electrophoresis and a UV photograph of this gel is shown in Figure 3.7.
3.05 Sequencing of the dxs Expression Plasmid
To ensure that the original PCR amplified the correct piece o f DNA, the 1.8 kb sequence 
inserted into pET21a then needed to be fully sequenced in triplicate. The start and end of 
the dxs gene could be sequenced making use of the T7 promoter and T7 terminator 
sequences within the pET21a vector. Six further sequencing primers were designed to 
give full coverage of the insert. A full list o f the sequencing primers used can be seen in 
Figure 3.8. The full sequence of the 1.8 kb insert can be seen in Figure 3.9. The 
sequenced insert was 100 % similar to the dxs gene sequence in the E. coli genome 
database. There were a few silent differences in redundant bases, which would not affect 
the encoded amino acid sequences. Such minor differences might arise because the
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Dra 111(5201)
Ava 1(158)
Xho 1(158)
Not 1(166)
Eag 1(166)
Hind 111(173) 
Sal 1(179}
S ac 1(190} 
EcoR 1(192} 
BamH 1(198}
Nhe 1(231)
Nde {(238)
Xba 1(276)
Bgl 11(342)
SgrA 1(383)
Sph 1(539)
EcoN 1(599) 
PflM [(646) 
ApaB 1(748)
Sea  1(4538) 
Pvu 1(4428) 
P st 1(4303)
Bsa 1(4119 
Eam1105 1(4058)-
AlwN 1(3581)
Sty 1(57) 
Bpu1102 l(80)
pE T -21 a (+ )
(5443bp)
Mlu 1(1064) 
Bel 1(1078)
BstE 11(1245) 
Bmg 1(1273) 
Apa 1(1275)
f /B ssHII(1475) 
eoR V(1514) 
Hpa 1(1570)
PshA 1(1909)
BspLU11 1(3165)
S ap  1(3049)
B st1107 1(2936) 
Tth111 1(2910)
PpuM 1(2171) 
Psp5 11(2171) 
Bpu10 1(2271)
BspG 1(2691)
Figure 3.5. Plasmid map of pET21a. (Novagen).
PCR product inserted between Ndel and Xhol sites of expression region, flanked by the 
T7 promoter and terminator sequences, and controlled by the lac operator.
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STOP
X h o l
f1 origin
dxs
p C C 16  
7230 bp
T7
ori
lacl
Nde I
Figure 3.6. pCC16 cloning map. (pET21a-dxs).
PCR amplified dxs sequence cloned into Ndel / Xhol restriction sites of pET21a.
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Figure 3.7. UV agarose gel image showing insertion of dxs PCR product into Ndel / 
Xhol sites of pET21a.
1. 0.5 pg 1 kb DNA Ladder, (NEB); 2. 1 hour Ndel / Xhol digest o f 5 pL pCC16 
minipreparation.
T7 promoter primer:
5 ' T A A T A C G A C T C A C T A T A G G G 3'
Dxs500 reverse primer:
5 ' C C A G C A T A T C A G G A C G G A T A T C G C 3'
Dxs500 forward primer:
5 ' G C G A T A T C C G T C C T G A T A T G C T G G 3'
Dxs 1000 reverse primer:
5 ' C G C C A T C A G C T T G T T G T C T T T C G C 3'
Dxs 1000 forward primer:
5 ' G C G A A A G A C A A C A A G C T G A T G G C G 3'
Dxs 1500 reverse primer:
5 ' G G A T C G C C A G T T T C T C G C C A C G 3'
Dxs 1500 forward primer:
5 ' C G T G G C G A G A A A C T G G C G A T C C 3'
T7 terminator primer:
5 ' G C T A G T T A T T G C T C A G C G G 3'
Figure 3.8. pCC16 Sequencing primers.
(E.g. Dxs500 reverse primer is used to sequence backwards from the 500 position in the 
dxs sequence. Primer sequences were identified from the known sequence o f dxs).
6 kbp 5 kbp 2 kbp
1 
2
pET21 a Vector Dxs Insert
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A T G A G T T T T G
C C A G G A G TT A
AA C T G C G C C G
GCCTC CG GG C
C A A C A C C C C G
C G C A T A A A A T
AAAG G CG G TC
A T T A A G C G T C
C G G TT G C TG C
GGCGATGGCG
GGG CG ATATC
C G A T T T C C G A
T CC G G TAAG C
TG G CG TGC CC
A A G G C A TG G T
A TC GG CC CG G
G AACATG CG C
A AG G TCG TG G
G T G C C T A A A T
T T TG C C G A G C
C G AA A G A C A A
G G CATG G TCG
A A T TG C C G A G
G G TA C A A A C C
GATCA GG TG C
CA T C G A C C G C
C T T T T G A T C T
CCG AG CG ATG
TAA C G A TG G C
TG G AACTG AC
CGTCGTGGCG
AGCG G CG AAA
T T G TG A A A C C
GAAGCGCTGG
CGGCGTGAAC
A C A T T G G C C T
CG CGCCGAAC
CTG G C TG G C A
A T A T T G C C A A
C G A C T G T TG C
C T A T T T A C T C
TGGGCACGGT
T T T G A C C A A T
TT TG A C C G G A
TG C A C C C G TT
G G G C A TT C A T
CG AA A A A G A A
CG A TT A C C G C
C G T C C T G A T A
A A A T G TC G G C
T T T A C T C T T C
C C A A T T A A A G
A G TG CCTG G C
TG G ACG G TCA
G ACCTGA AAG
TT A TG A A C C G
T T G A T C C C T C
T A T T C A A A A A
C AAG CTG ATG
A G T T T T C A C G
CAACACGCGG
C A T TG TC G C G
TG C A TG A C G T
GCGGGCATTG
C T C T T A C C T G
A A A A C G A A TG
CCGTCAGCGG
G CCG CTG G AA
AG AAACTG G C
G TCG CCG AA T
G C T T G A T G A A
T C A C C G TA G A
G AAG TG CTG A
G CCG G ACTTC
TC G G C C TC G A
TAA
A T A C C C G A C C
CGAAAGAGAG
G ACAG CG TG A
C G A ACTG ACC
T G A T T T G G G A
C G CCG CG ACA
CCCGTGGCGC
C A A C C T C C A T
G G C A A A A A T C
A G G CATG G CG
T G C TG G TG A T
G C G C TC A A C A
A C T G C G C G A A
A G C T G C T C A A
A C G T T G T T T G
CG A TG T G C TG
GC C C G C A G T T
GCAG AAAAA G
C A G C G G TT G T
T C T T T G G C G A
G C G A TT A C T C
T A A A T T C C C G
T G A C C T T T G C
A T T T A C T C C A
G G C G A TT C A A
T T G G T G C T G A
C G C TG C A TA C
T CG CC AG ATG
TG C G C TA C C C
A A A C T A C C A A
G A T C C T T A A C
CGCTG AA CG C
G C G T T A A T T C
A G AAAAC GC C
TG G C C C A TC G
T T T A T T C C G C
TG C C G C TG G T
CTG G CAC TG G
T T T A C C G A A A
G C C G TT C C A G
GTGGCGCTGC
TG TG GG G CAT
A A A T C G G C A C
GGCGAAAGCG
CAG TG CC GG A
G CCG CACCG T
T T TG A A G C G A
T C T C A A C G A C
A C C A T C TG G C
GGCGGGAAAA
A CG C A C C G A A
AAGAGCTGGG
G G G C T T A T C A
C C T G C A TA T C
A C C C G A TC A C
T T G C C G A A A A
C TG G TTG TG C
CGGCGATGCG
G A TC G C T A C T
TGCGGGTCTG
C T T T C C T G C A
A A G C T TC C G G
CG G TCAA ACC
CGGAAATGGT
C TC T A T A C C G
GCGTGGCAAC
TTGGCAAAGG
TT T G G T A C C C
CACG CTG GTC
TGGAAATGGC
ATTA TG G G C G
T A A A C C A G T A
AA G G A A C T C A
ATG G AAG CC A
T C G A C TC C A C
C TC TG CG ACG
CG G G CACTTC
A C T A T G T C T A
C A G G C TT A TC
C A T C C G TC A G
A A T A TG A C G T
A T T G G T A T T G
C T G T G T C A T T
TG AATCACG C
A A T G A A A TG T
A C A G C T G C T T
A A G T T T T C T C
G A A C A T A T T A
C T T T A A C T A C
C C A C G C T A A A
A TG A C C A A A A
T T TC C A C G C C
GTAGCGGCGG
GAAACGGCAG
C G AAG G TTCC
TCGACGTGGC
GCG ATTG G TG
A C G C G C C T A T
T C C TG T T C G C
CATCAGGGTG
C A T TA TG A C C
G C T A T C A C T A
GCGGTCGGCG
C A T TG TG A A G
TG ATG CCAG A
G A TA T G C G TT
C GCCAGCCAT
GCGCAGGCAG
CCCG TGC TG A
GGAAGAAATG
A AATCAAG G C
Figure 3.9. Sequence of pCC16 insert.
Start and stop codons shown in red. Dxs 500, Dxs 1000 and Dxs 1500 sequencing primer 
binding sites shown in blue.
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published DNA sequence in the genome databases are from E. coli strain MG 1655, 
whilst the DNA used for PCR of the dxs gene was isolated from E. coli strain DH5a.
3.06 Creation of a dxs Expression Strain
E. coli BL21 (DE3) (2.01.2.3) was used as the expression host strain, as it can be grown 
to high densities, and can be used for IPTG induction of expression. The dxs expression 
plasmid pCC16 was transformed into the host strain by chemical transformation 
(2.03.3.9). A sample of the plasmid DNA was prepared from the expression strain by 
QiaPrep, (Qiagen), as described in 2.03.3.10, and the plasmid verified as pCC16 by dual 
Ndel / Xhol restriction digestion, (2.03.3.4), and analysis by agarose gel electrophoresis, 
as before.
3.07 Growth and Induction of dxs Expression Strain
Large-scale cultures of the expression strain were grown in batches of 150 mL LB broth, 
in 1 L conical flasks, (to give maximal aeration), and growth monitored. Cell growth was 
measured as increase in cell density, measured as the optical density at 600 nm, (OD600), 
with OD600 beginning at 0.15, upon inoculation with overnight culture. (OD600 was 
monitored by sampling the cultures at time intervals, and taking OD600 readings using a 
spectrophotometer, (2.03.6.1). This is calibrated against wet cell weight in 2.03.6.3, 
showing a linear relationship, verifying OD600 to be a good measure of cell growth). 
Figure 3.10 then shows a growth curve for a 150 mL culture of the expression strain, 
plotted against time. The cultures can both be seen to be entering exponential phase after
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Figure 3.10. Culture growth in shaking 1 L conical flasks at 37 °C.
150 mL LB broth in 1 L conical flask inoculated with overnight culture o f E. coli BL21 
or E. coli BL21 pCC16 to OD6oo o f approximately 0.15. Incubated in orbital shaker at 
37 °C for 26 h. One set E. coli BL21 pCC16 induced with 1 mM IPTG at 2h. 1 mL 
samples taken at time intervals and OD6oo measured. Growth monitored as OD6oo over 
time. Time intervals: 0; 0.5; 1; 2; 3; 4; 5; 6; 7; 8; 9; 10; 11; 12; 13; 14; 26 h. Observed to 
enter exponential growth phase at approximately 2 h; observed to exit exponential growth 
phase at approximately 5 h.
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alongside a growth curve for the untransformed host strain E. coli BL21, with cell density 
0.5 h, at an OD600 of about 0.2, and leaving this phase after 5 h, at an OD600 o f between 
3.0 and 3.5. Growth from this point slows, until stationary phase is reached at around 12 
h, at an OD600 of between 4.0 and 5.0. In the third culture whose growth curve is seen in 
Figure 3.10, the IPTG induced culture, IPTG is added at 2 h, at the start of log phase. 
Again exponential growth ends at around 5 h, with stable stationary phase reached around 
12 h. Neither presence of the plasmid, pCC16, nor IPTG induction, is shown to 
significantly affect growth rate compared to untransformed BL21 (DE3), all rapidly 
entering exponential growth after just 0.5 h, and then leaving exponential phase after 5 h, 
at an OD600 of between 3 and 3.5.
Plasmid stability over the course o f the culture growth was assessed by sampling the 
cultures at time intervals, and transferring the sampled culture to either non-selective or 
ampicillin containing agar plates, as described in 2.03.6.4. Plasmid stability was assessed 
as percentage of ampicillin resistant cfu.m L1 per total cfu.mL'1. A graph of plasmid 
retention over time is shown in Figure 3.11. IPTG induction is shown to significantly 
decrease plasmid pCC 16 stability beyond 3 h post induction, retention falling as low as 
25% at 24 h post induction. This shows a significant loss of plasmid beyond 3 h post 
induction, and possible causes and solutions are discussed later in the Discussion.
3.08 Protein Expression from the dxs Expression Strain
With dxs cloned into an expression system of E. coli BL21 and pET21a, the next stage
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Figure 3.11. Plasmid stability on IPTG induction.
150 mL cultures of E. col BL21 pCC16 grown for 24 h in orbital shaker at 37 °C, with or 
without addition of IPTG to 1 mM after 2 h. 1 mL samples taken at time intervals after 
induction, (0 h; 3 h; 6 h; 12 h; 24 h), and cfu measured on ampicillin media, then 
expressed as percentage of cfu measured on non-selective media.
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was to attempt to extract some protein. E. coli BL21 pCC16 was then grown in two 
150 mL cultures, alongside two controls of untransformed E. coli BL21, with one of each 
culture induced with IPTG at 2 h. At 3 h post induction, two samples from each of the 
four cultures were taken, and diluted with further liquid media where necessary to a 
standard OD600 of 3.0, to represent equivalent cell densities.
Fractions were then extracted from each of these four cultures, to represent the 
extracellular protein and the intracellular protein, and of this, the soluble and insoluble 
protein, (2.03.7.1). One of the 10 mL samples, from each culture, was then pelleted in a 
centrifuge, with the supernatant representing the extracellular fraction, and the pellet 
representing the whole cell fraction. The pellets from the second set of samples were 
then resuspended in 0.9% NaCl solution, and then sonicated to break open the cells. 
These were then pelleted in a centrifuge again, with the supernatant representing the 
soluble cell fraction, and the pellet the insoluble cell fraction.
Thus four sets of extract from each culture were produced: 1. The extracellular protein 
extract from the culture; 2. the whole intracellular protein extract from the culture; 3. the 
soluble intracellular protein fraction from the culture; and 4. the insoluble intracellular 
protein fraction.
The four sets of protein extracts were then suitably diluted in SDS loading buffer, 
(2.03.8.1), and analysed by SDS-PAGE, (2.03.8.2). With the whole cell fraction, a 
heavy, distinct protein band is seen from the induced culture that is not observed with the
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Figure 3.12. PAGE gel image showing dxs expression by E. coli BL21 pCC16 upon 
IPTG induction.
150 mL cultures of E. coli BL21 pCC16 grown in orbital shaker at 37 °C, with addition 
o f IPTG to 1 mM at 2 h. 10 mL samples taken at 5 h, after dilution to OD600 o f 3.0, then 
centrifuged. Pellets resuspended in 3 mL SDS sample buffer to make whole cell extract. 
Analysed by SDS-PAGE. Photo shown. Lanes: 1. 15 pL whole cell extract from 
induced untransformed E. coli BL21; 2. 15 pL whole cell extract from uninduced E. coli 
BL21 pCC16; 3. 15 pL whole cell extract from IPTG induced E. coli BL21 pCC16; 4. 7 
pL NEB Broad Range Protein Marker.
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uninduced culture, or from the induced untransformed host strain BL21 (DE3). The 
protein in the band is approximately 68 kDa in size, from reference to the molecular 
weight marker, the size we would expect of expressed DOX-P Synthase. This is shown 
in Figure 3.12. We can conclude therefore that DOX-P Synthase is being produced by 
E. coli BL21 pCC16 upon IPTG induction.
Four fractions from the induced sample are then shown in Figure 3.13. Of these, a heavy 
DOX-P Synthase band can be seen in the whole cell fraction, representing a significant 
fraction of the whole cell protein. The DOX-P Synthase band for the soluble cell fraction 
is similarly large, suggesting a large proportion of the expressed DOX-P Synthase in the 
whole cell fraction was in the soluble form. A smaller, yet significant, band is seen in the 
insoluble fraction, suggesting a significant proportion of the expressed DOX-P Synthase 
protein was forming into insoluble inclusion bodies. As expected, no significant band 
was seen in the extracellular fraction, DOX-P Synthase being an intracellular protein. 
(Results not shown).
3.09 Extraction of Active DOX-P Synthase Enzyme and Optimisation of
Extraction Conditions
With a method for producing significant levels of DOX-P Synthase confirmed, the next 
stage is to develop and improve the extraction of this enzyme, in an active form, from the 
cell culture. Based upon extraction methods used in other work with TK, (Hobbs et al., 
1993), and iteration following subsequently described HPLC analysis of the enzyme
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Figure 3.13. PAGE gel image showing dxs expression in the soluble protein fraction.
150 mL cultures o f E. coli BL21 and E. coli BL21 pCC16 grown in orbital shaker at 37 
°C, with or without, addition o f IPTG to 1 mM at 2 h. 10 mL samples taken at 5 h, after 
dilution to OD60o of 3.0, then centrifuged, and pellets resuspended in 3 mL SDS sample 
buffer to make whole cell extract. 10 mL samples taken at 5 h after dilution to OD6oo o f 
3.0, centrifuged, pellets resuspended in 0.9% NaCl(aq), sonicated and then centrifuged 
again. Supernatant diluted l-in-3 in SDS sample buffer to make soluble cell fraction. 
Pellet resuspended in 3 mL SDS sample buffer to make insoluble cell fraction. Analysed 
by SDS-PAGE. Photo shown. Lanes: 1. 15 pL whole cell extract; 2. 15 pL soluble cell 
fraction; 3. 15 pL insoluble cell fraction; 4. 7 pL NEB Broad Range Protein Marker.
C.M Chudziak 111
Production. Characterisation and Modification of DOX-P Synthase as a Biocatalvst 
activity, the extraction method described in 2.03.7.2 was developed.
As the DOX-P Synthase enzyme was shown to be intracellularly expressed, the 
extraction protocol commenced with harvesting the cell matter by centrifugation. The 
resultant cell pellet was then washed first with osmotically neutral 0.9 % NaCl, then with 
the chosen reaction buffer. At this point, after this washing stage, it was found later that 
the cell pellet could be stored at -80 °C for at least 1 week with no effect on catalytic 
activity.
The reaction buffer used was chosen based on buffers used in previous work, (Hobbs et 
al., 1993). A Tris.HCl based buffer (2.02.4.1) was selected, rather than a phosphate 
buffer, as phosphate has previously been shown to be inhibitory to transketolase, (Mitra 
and Woodley, 1996), as have, more recently, phosphonates and diphosphates been shown 
to be inhibitory to the next enzyme in the MEP pathway, the 1 -deoxyxylulose accepting 
enzyme, 1-Deoxy-D-xylulose-5-Phosphate Reductase, (DxpR), (Cheng and Oldfield, 
2004). This reaction buffer was equilibrated to pH 7.0, as suggested in previous studies 
o f DOX-P Synthase, (Kuzuyama et al., 2000). As with TK, the reaction buffer would 
need to provide TPP and a source of Mg2+, as these are cofactors of DOX-P Synthase. 
1 mM TPP and 9 mM Mg2+ were used, (Hobbs et al., 1993). 0.1 mM PMSF was added 
to inhibit any protease activity in the extract; and 1 mM DTT to inhibit oxidative 
denaturation of the enzyme.
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The next stage of the extraction process was then to break open these cells to extract the 
DOX-P Synthase. Initially, sonication was used to lyse the cells. However there was 
cause for concern that in the small volume of extract being used, sonication was not 
lysing the cells to a consistent level. SDS-PAGE analysis of multiple extracts confirmed 
this. (Results not shown). The detergent, BugBuster (Novagen) was then tried as the cell 
lysis agent, along with lysozyme. BugBuster consists of a type of non-ionic detergent, 
which acts to lyse the bacterial cells. SDS-PAGE analysis revealed an efficient 
consistent level of lysis. BugBuster seemed not to adversely affect enzyme activity, as 
subsequent removal of the detergent, by passing the extract through a desalting column, 
did not increase activity.
The extraction method, as described so far, left a large amount of DNA in the extract, 
which was stringy, and affected the consistency of the extract. This crucially affected 
ability to pipette the extract. The next stage of the extraction process therefore needed to 
address this problem. Protamine sulphate was initially added after the BugBuster, to salt 
out the DNA from the extract. This could then be centrifuged down and removed as a 
pellet. This was shown to be an efficient method of DNA removal. However the use of 
the nuclease, Benzonase, (Novagen), was shown to be a far simpler, and just as efficient, 
method to remove the stringiness. Benzonase digests the DNA to single, or small 
stretches of, nucleotides, thus removing the stringiness, and improving the consistency of 
the extract.
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Of the extract thus created, active enzyme would only be present in the soluble fraction. 
Any enzyme present in the insoluble fraction would be aggregated as inclusion bodies, 
and inactive. The insoluble fraction is therefore removed by centrifugation as the pellet. 
The supernatant from this step, a clarified extract, will then be the final active DOX-P 
Synthase extract for testing catalytic activity.
In an enzymological study, the next step in the extraction process might be to purify the 
protein further, for example by ammonium sulphate precipitation. However we aimed to 
keep extraction simple if possible. A purified protein might well be more active than a 
clarified extract, but the increase in activity might not outweigh the difficulty and 
expense. First, the activity of the simple clarified extract will be ascertained, which will 
show whether further purification might be necessary.
3.10 Assay of DOX-P Synthase Activity
Previous studies have described various methods of assaying DOX-P Synthase activity. 
An assay of DOX-P Synthase activity using radiological methods has previously been 
described, (Hahn et al., 2001). However, for the purposes of this thesis such methods 
were discarded as being impractical.
Elsewhere, it has been described that subsequent reduction of the product 1-deoxy-D- 
xylulose 5-phosphate, (DxP), by the enzyme 1-Deoxy-D-xylulose 5-Phosphate Reductase 
(DxpR) can be used to follow DxP production, (Altincicek et al., 2000). In this case,
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reduction of DxP by DxpR as it is produced, oxidises NADH to NAD+, a transformation 
which can be followed simply by spectrophotometry. As the studies described in this 
thesis, however, aim to produce alternative products to DxP, this would not be a suitable 
assay.
It has also been described how the enzyme may be assayed by the subsequent reaction of 
the product, DxP, with 3,5-diaminobenzoic acid, to produce a fluorescent indicator, 
(Querol et al., 2001a). In this way the reaction may be followed by spectrophotometry. 
However, this assay would not be ideal for use with non-phosphorylated 
1 -deoxyxylulose, (Dx), or other non-phosphorylated products, or products which are not 
1-deoxysugars, as produced in this thesis.
The unsuitability of these methods that have previously been used, is due to the fact that 
these methods were used in studies that were solely looking at the native DOX-P 
Synthase reaction. As this thesis describes the use of DOX-P Synthase for non-native 
biotransformations, other assay methods had to be developed. The one method described 
in previous studies which may be of use, is to follow the reaction by high performance 
liquid chromatography, (HPLC), (Schurmann et al., 2002). As HPLC is the method used 
previously to assay transketolase-catalysed biotransformations, (Mitra et al., 1996), this 
thesis therefore describes work concentrating on developing this assay method. Other 
methods of assaying DOX-P Synthase using thin layer chromatography, (TLC), or 
through reaction with reducing dyes are also briefly described. First, though, in order to 
measure rate of reaction, a reaction needed to be set up.
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3.11 Setting Up a DOX-P Synthase Catalysed Reaction
In an industrial process, the enzyme catalysed step would take place in a large bioreactor 
vessel. In this study the reaction volume will be 1 mL, and the substrates, DL- 
glyceraldehyde and pyruvate, will be present at 20 mM and 10 mM respectively. (Since 
the racemic form of glyceraldehyde was being used, double the glyceraldehyde 
concentration was used compared to pyruvate. It was assumed that since L- 
glyceraldehyde is not a substrate for transketolase, L-glyceraldehyde would not to be a 
substrate of DOX-P Synthase either, (Hobbs et a l, 1993)). Alternative substrates will 
also be used where discussed. In addition, as in the extraction medium, the cofactors, 
TPP and Mg2+, as well as PMSF and DTT, will also be present. 50 pL of catalytic extract 
will be used.
3.12 TLC Analysis of DOX-P Synthase Reaction
For TLC analysis, DL-glyceraldehyde and pyruvate, or glycolaldehyde and pyruvate, 
were used as substrates. The reaction was incubated for 4 h at 37 °C, then upon 
termination of the reaction by heat shock, the reaction mixture was analysed by TLC 
along with a negative control, and samples of the substrates. This process is described in 
2.03.11. The TLC plate was developed with propanol /ethyl acetate /water (6:1:3) and 
stained with anisaldehyde / sulphuric acid, and a photograph of the TLC plate taken, see 
Figure 3.14. In the DL-glyceraldehyde / pyruvate plus DOX-P Synthase track, (8), a light 
blue-green band of approximate Rf value 0.60 was seen immediately adjacent to a brown 
band of Rf value 0.65 representing glyceraldehyde. The light blue-green band is
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Figure 3.14. TLC image showing the DOX-P Synthase catalysed production of 1- 
deoxyxviulose.
Soluble cell fraction extracted from untransformed E. coli BL21 and E. coli BL21 
pCC16. Reaction mix: 10 mM glycolaldehyde / 10 mM pyruvate, or 20 mM DL- 
glyceraldehyde / 10 mM pyruvate in 50 mM Tris.HCl(aq) buffer with 9 mM MgCB, 1 mM 
TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell fraction added in 1 mL reaction 
mix. Incubated for 4 h at 37 °C. 20 pL samples added to each lane on W hatman LK6D 
Silica Gel 60A thin layer chromatography plate. Developed with propanol/ethyl 
acetate/water (6:1:3) and stained with anisaldehyde/sulphuric acid. Lanes: 1. Soluble 
extract o f untransformed E. coli BL21; 2. Soluble extract o f E. coli BL21 pCC16; 3. 
Reaction mix o f  glycolaldehyde / pyruvate; 4. Reaction mix o f glycolaldehyde / pyruvate 
incubated with soluble extract o f untransformed E. coli BL21; 5. Reaction mix o f 
glycolaldehyde / pyruvate incubated with soluble extract o f E. coli BL21 pCC16; 6. 
Reaction mix o f DL-glyceraldehyde / pyruvate; 7. Reaction mix o f DL-glyceraldehyde / 
pyruvate incubated with soluble extract o f untransformed E. coli BL21; 8. Reaction mix 
o f DL-glyceraldehyde / pyruvate incubated with soluble extract o f E. coli BL21 pCC16.
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reported elsewhere to represent 1-deoxyxylulose, (Lois et ah, 1998). This band is not 
seen in the negative control reaction. The TLC analysis shows that DOX-P Synthase 
enzyme activity has been expressed in the extract. However TLC analysis is clearly 
insufficient for provision o f quantitative data on the reaction. No reaction was observed 
between glycolaldehyde and pyruvate.
3.13 Colorimetric Analysis of DOX-P Synthase Reaction
The option of following the reaction spectrophotometrically was also studied. 
Absorption spectra were created of the substrates and products of the DOX-P Synthase 
reaction. However, all these showed absorption peaks of less than 190 nm. Therefore, it 
would not be possible to follow the course of the DOX-P Synthase reaction by simple 
spectrophotometry. However, it was found that the colour reagent, 2,3-Bis(2-methoxy-4- 
nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide, (XTT), as shown in Figure 3.15, 
could react with some substrates and products differentially. This reagent specifically 
reduces secondary alcohols, liberating an orange-red dye, (Pauli et a l , 1988). This could 
then be added at the end of the DOX-P Synthase reaction. It was shown to reduce 
hydroxylated substrates, such as the ketol-accepting aldehyde, glyceraldehyde, producing 
the orange-red dye with an absorption peak at 460 nm, as seen in Figure 3.16. 
Hydroxylated products, such as 1 -deoxyxylulose, would also be expected to react with 
XTT. XTT was shown not to reduce the non-hydroxylated substrate pyruvate, as seen in 
Figure 3.17. Other non-hydroxylated substrates, such as propionaldehyde would also not 
be expected to react with XTT.
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Figure 3.15. Structure of XTT.
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Figure 3.16. Absorption spectrum of XTT red/orange dye.
XTT / trimethyl-PMS reagent added to 1 mL cuvette of 20 mM DL-glyceraldehyde 
solution in 50 mM TrisHCl(aq) buffer pH7.0 / 9mM MgCl2 / 1 mM TPP / 0.1 mM PMSF. 
After 5 min, absorption spectra generated by scanning spectrophotometer.
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Figure 3.17. Absorption spectrum in absence of XTT colour reaction.
XTT / trimethyl-PMS reagent added to 1 mL cuvette of 10 mM pyruvate solution in 50 
mM TrisHCl(aq) buffer pH7.0 / 9mM MgCl2 / 1 mM TPP / 0.1 mM PMSF. After 5 min, 
absorption spectra generated by scanning spectrophotometer.
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Since the product o f the DOX-P Synthase reaction would be hydroxylated, whether or not 
the substrates were hydroxylated, as shown in Figure 3.18, it was thought that the product 
should always react with TPP to produce the orange-red dye. Therefore it was thought 
that a reaction could be set up using non-hydroxylated substrates, which if reaction 
occurred would produce a hydroxylated product. The course of this reaction could then 
be followed by spectrophotometry o f samples taken at various timepoints. Such reactions 
were set up, as described in 2.03.12, with pyruvate as the ketone donor, with a variety of 
ketone acceptors, (hydroxylated and non-hydroxylated), or none. The reactions were set 
up in a microwell plate, and to one set was added DOX-P Synthase extract, to one set was 
added negative control extract from untransformed E. coli BL21, and to one set water, as 
a further negative control. After a 15 h incubation, the colour reagent, XTT, was added, 
and the reactions analysed by spectrophotometry.
A photograph of the reaction plate is shown in Figure 3.19, and the measurements of 
optical density at 460 nm, OD460, are shown in Table 3.1. It can be seen that pyruvate 
with the unhydroxylated ketone acceptors, propionaldehyde, acetaldehyde and acetoin, 
alone with no extract, do not undergo the XTT colour reaction. It can also be seen that 
neither the DOX-P Synthase extract, nor the BL21 extract, in absence of any ketone 
acceptor substrate underwent the colour reaction. Interestingly, combining these non- 
hydroxylated ketone acceptor substrates, the donor pyruvate, and the catalytic extract, 
created a product which did undergo the colour reaction. However, it can also be seen 
that the colour reaction is observed with just the BL21 extract.
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Figure 3.18. Chemical reaction pathway showing function of DxpS on either 
hydroxylated or non-hydroxylated substrates, to produce a hydroxylated product.
Pyruvate and (hydroxylated) glyceraldehyde combine to form (hydroxylated) 1 - 
deoxyxylulose. Pyruvate and (non-hydroxylated) propionaldehyde combine to form 
(hydroxylated) 3-hydroxypentanal.
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Figure 3.19. 96-well plate photo showing differential reactivity with the colour 
reagent XTT.
Wells contain 200 pL reaction mixture of 10 mM pyruvate and: 1. 20 mM DL- 
glyceraldehyde; 2. 10 mM glycolaldehyde; 3. 10 mM acetaldehyde; 4. 10 mM 
propionaldehyde; 5. 10 mM acetoin; 6. water. Incubated for 15 h with 10 pL: A. water; 
B. soluble extract of untransformed E. coli BL21; C. soluble extract of E. coli BL21 
pCC16. XTT reagent added at end of incubation. Photo taken after 5 min.
1 2 3 4 5 6
A 0.1062 0.1431 0.0579 0.0561 0.0563 0.0496
B 0.4575 0.5173 0.6986 0.6951 0.7905 0.2835
C 0.9377 1.0262 1.0719 1.3379 1.2117 0.1527
Table 3.1. OD460 measurements from 96-well plate, showing differential reactivity 
with the colour reagent XTT.
Wells contained 200 pL reaction mixture of 10 mM pyruvate and: 1. 20 mM DL- 
glyceraldehyde; 2. 10 mM glycolaldehyde; 3. 10 mM acetaldehyde; 4. 10 mM 
propionaldehyde; 5. 10 mM acetoin; 6. water. Incubated for 15 h with 10 pL: A. water; 
B. soluble extract of untransformed E. coli BL21; C. soluble extract of E. coli BL21 
pCC16. XTT reagent added at end of incubation. After 5 min, OD46o measurements 
taken using 96-well plate spectrophotometer.
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With the negative control giving a positive result it was decided not to pursue this course 
of inquiry any further. However, further value in this assay may be found, possibly if the 
biocatalyst was purified further.
3.14 HPLC Analysis of DOX-P Synthase Reaction
One method for HPLC analysis of the DOX-P Synthase has previously been described 
based upon a system using a solvent of 6 mM H2 SO4 with a Bio-Rad HP87X-H column, 
and detection by uv and refractive index, (Kuzuyama et al., 2000;Schurmann et a l , 
2002). However in this study an alternative system was developed based upon the TK 
reaction assay, (Ingram, 2006), using trifluoroacetic acid, (TFA), as a solvent with a Bio- 
Rad Aminex-87H column, and detection by uv, and electrochemical detection, (ECD).
The method described in 2.03.13.1 was proposed, taking 150 pL samples of the reaction 
mix at timepoints, and analysing by HPLC, using uv detection at 210 nm, and 
electrochemical detection, (ECD).
First, the components of the DOX-P Synthase reaction which could be expected to be 
present at significant concentrations, the substrates, DL-glyceraldehyde and pyruvate; the 
cofactor, TPP; and the possible product, 1 -deoxy-D-xylulose, were individually analysed 
using this HPLC assay, when diluted in reaction buffer. HPLC traces are shown in 
Figures 3.20.i-iv. Peaks for the substrate, DL-glyceraldehyde, at 11.6 min; the cofactor, 
TPP, at 13.6 min; and the product, 1-deoxy-D-xylulose, at 12.2 min, could all be clearly
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seen in the ECD traces. The peak for the second substrate, pyruvate, was weaker on the 
ECD trace, at 10.2 min, but could also be seen, more clearly, in the UV trace, at 9.7 min. 
Area of each peak was shown to be proportional to concentration, allowing the 
calculation of concentration change as a change in peak area. This is shown in 2.03.13.2.
DOX-P Synthase was then assayed in a reaction with DL-glyceraldehyde and pyruvate as 
described before, and in 2.03.10. A sample of the reaction mixture was taken after 15 h, 
and analysed as described. A simultaneous reaction was set up using extract from the 
untransformed host strain E. coli BL21, as a negative control, sampled and analysed. The 
ECD traces from both these reactions are shown in Figures 3.21.i-ii. The substrates, 
pyruvate and DL-glyceraldehyde, and the cofactor, TPP, can all be seen in both traces at 
10.2 min, 11.6 min and 13.6 min respectively, as previously seen in Figures 3.20.i-iii. 
Another peak can also clearly be seen, but only in the HPLC trace of the DOX-P 
Synthase reaction. This peak appears at 12.2 min, corresponding to that of the product, 
1-deoxyxylulose, as seen in Figure 3.20.iv. This peak was not present in the negative 
control reaction, confirming catalysis of the production of 1 -deoxyxylulose by the DOX- 
P Synthase extract.
It has therefore been confirmed that an active DOX-P Synthase extract has been 
produced, and it has also been shown that HPLC can be used for an efficient assay of 
substrate turnover. Next, optimisation of this assay method will be discussed.
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Figure 3.20.i. HPLC-ECD trace showing substrates, pyruvate and glyceraldehyde.
20 mM DL-glyceraldehyde / 10 mM pyruvate solution made up in 50 mM TrisHCl(aq) 
buffer pH7.0 / 9mM MgCl2 / 1 mM DTT / 0.1 mM PMSF. Diluted 1:1 with 0.2% TFA. 
Analysed by HPLC using Aminex 87H column at 60°C, mobile phase 0.1% TFA, flow 
rate 0.6 mL.min'1. Electrochemical detection with Dionex ED40 electrochemical 
detector module. Pyruvate retention time 10.2 min; glyceraldehyde retention time 11.6 
min.
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Figure 3.20.11. HPLC-UV trace showing substrates, pyruvate and glyceraldehyde.
20 mM DL-glyceraldehyde / 10 mM pyruvate solution made up in 50 mM TrisHCl(aq) 
buffer pH7.0 / 9mM MgCl2 / 1 mM DTT / 0.1 mM PMSF. Diluted 1:1 with 0.2% TFA. 
Analysed by HPLC using Aminex 87H column at 60°C, mobile phase 0.1% TFA, flow 
rate 0.6 mL.min'1. UV detection at 210 nm with Dionex AD20 UV detector module. 
Pyruvate retention time 9.7 min; glyceraldehyde retention time 11.0 min.
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Figure 3.20.iii. HPLC-ECD trace showing cofactor, TPP.
10 mM TPP solution made up in 50 mM TrisHCl(aq) buffer pH7.0 / 9mM MgCl2 / 1 mM 
DTT / 0.1 mM PMSF. Diluted 1:1 with 0.2% TFA. Analysed by HPLC using Aminex 
87H column at 60°C, mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. Electrochemical 
detection with Dionex ED40 electrochemical detector module. TPP retention time 13.6 
min.
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Figure 3.20.iv. HPLC-ECD trace showing product, 1-deoxyxylulose.
1 mM 1-deoxyxylulose solution made up in 50 mM TrisHCl(aq) buffer pH7.0 / 9mM 
MgCl2 / 1 mM DTT / 0.1 mM PMSF. Diluted 1:1 with 0.2% TFA. Analysed by HPLC 
using Aminex 87H column at 60°C, mobile phase 0.1% TFA, flow rate 0.6 mL.min"1. 
Electrochemical detection with Dionex ED40 electrochemical detector module. 1- 
deoxyxylulose retention time 12.2 min.
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Figure 3.2l.i. HPLC trace showing no product formation upon incubation with E. 
coli BL21 extract.
Soluble cell fraction extracted from untransformed E. coli BL21. Reaction mix: 10 mM 
glycolaldehyde / 10 mM pyruvate, or 20 mM DL-glyceraldehyde / 10 mM pyruvate in 50 
mM Tris.HCl(aq) buffer with 9 mM MgCl2, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 
50 pL soluble cell fraction added in 1 mL reaction mix. Incubated for 15 h at 37 °C. 150 
pL sample taken after 15 h. Diluted 1:1 with 0.2% TFA. Analysed by HPLC using 
Aminex 87H column at 60°C, mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. 
Electrochemical detection with Dionex ED40 electrochemical detector module. Pyruvate 
peak 10.2 min; glyceraldehyde 11.6 min; TPP peak 13.6 min.
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Figure 3.21.ii. HPLC trace showing 1-deoxyxylulose product formation upon 
incubation with E. coli BL21 pCC16 extract.
Soluble cell fraction extracted from E. coli BL21 pCC16. Reaction mix: 10 mM 
glycolaldehyde /1 0  mM pyruvate, or 20 mM DL-glyceraldehyde /1 0  mM pyruvate in 50 
mM Tris.HCl(aq) buffer with 9 mM MgCL, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 
50 pL soluble cell fraction added in 1 mL reaction mix. Incubated for 15 h at 37 °C. 150 
pL sample taken after 15 h. Diluted 1:1 with 0.2% TFA. Analysed by HPLC using 
Aminex 87H column at 60°C, mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. 
Electrochemical detection with Dionex ED40 electrochemical detector module. Pyruvate 
peak 10.2 min; glyceraldehyde 11.6 min; 1-deoxyxylulose peak 12.2 min; TPP peak 13.6 
min.
C.M Chudziak 130
Production. Characterisation and Modification of DOX-P Synthase as a Biocatalvst
3.15 Optimisation of HPLC Analysis
Since the peaks representing the substrate, glyceraldehyde, and the product, 1 -deoxy-D- 
xylulose appear quite close on the ECD trace, it was decided to see if the peaks could be 
made more distinct by altering the properties of the mobile phase. The stationary phase 
in the HPLC column being used, Aminex 87H, is a complex multipolar resin designed for 
analysis of carbohydrates and organic acids, which places limits on the types of solvent 
which can be effectively used. However samples taken from the above positive reactions 
were passed through the column using varying concentrations of TFA as the mobile 
phase. Reducing TFA concentration to 0.05 % was seen to slightly broaden the peaks. 
Increasing TFA concentration to 0.2 % was seen to slightly sharpen the peaks. However, 
the effect is minimal, so for consistency, in the rest of this thesis, 0.1 % TFA is used for 
HPLC analysis.
3.16 Calculation and Optimisation of Protein Concentration
Once it had been ascertained that active enzyme was being produced, it was decided to 
aim towards increasing the activity of the extract being used, by targeting increasing the 
concentration of active soluble protein in the extract. Two courses were followed in this 
respect. Firstly, by looking at how we might optimise the growth conditions of the DOX- 
P Synthase producing culture, to enable production of more soluble protein. And 
secondly, by looking at how we might optimise the time of harvest that enables the 
greatest soluble protein concentration.
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3.17 Optimisation of Growth Conditions
The DOX-P Synthase producing strain was grown in 150 mL cultures as described 
before, and in 2.03.2, with three environmental conditions varied. These conditions were 
the growth temperature; concentration of the inducing agent, IPTG; and the growth 
media. Varying these conditions can have a significant effect on percentage protein 
solubility, reducing the proportion of expressed protein that forms into inclusion bodies 
of insoluble inactive protein, and therefore also increasing proportion of soluble protein. 
Firstly, lower temperatures can reduce the rate of protein synthesis, thus relieving the 
burden on the protein synthesis machinery, and allowing more time for proteins to fold 
properly. Secondly, lower IPTG concentrations can reduce the level of protein 
overexpression, thus also relieving the general burden on the protein synthesis 
machinery, allowing more time for proteins to fold properly. Thirdly, uptake of the 
compatible solute, glycyl betaine, by the cell has been shown to encourage correct protein 
folding and therefore reduce the proportion of protein forming insoluble inclusion bodies, 
and increase the proportion expressed as soluble protein, (Blackwell and Horgan, 1991). 
Glycyl betaine is taken up by the cells when present in the media with the sugar alcohol, 
sorbitol.
The cultures were grown at four different temperatures, (37 °C, 32 °C, 28 °C and 25 °C); 
using two concentrations of the inducing agent, IPTG, (1 mM and 0.1 mM); and with or 
without the addition of betaine and sorbitol to the media. Effect on growth alone is 
shown in Figure 3.22. As can be seen, growth of the cultures was not significantly 
affected by varying the concentration of IPTG, or addition of betaine or sorbitol.
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Reducing temperature, however, can be seen to have significantly slowed growth. By 
reducing temperature to 25 °C, it can even be seen that the culture begins to leave 
exponential growth phase at a significantly lower cell density.
Samples were taken from the cultures when they reached the end of exponential growth, 
as determined in Figure 3.22, and clarified extract produced from each culture, (2.03.7.2). 
These were then analysed by SDS-PAGE (2.03.8.2), and the gel images taken were 
subsequently analysed by optical densitometry, as described in 2.01.4.5, to calculate 
percentage of protein represented by DOX-P Synthase. This data is shown in Table 3.2. 
About 10% total protein is represented as DOX-P Synthase at 37 °C, and the analysis 
clearly shows that reducing the concentration of IPTG does not significantly affect DOX- 
P Synthase concentration. It is possible that the T7 promoter of pCC16 is such a strong 
promoter that reduction below even 0.1 mM IPTG would be necessary to have a 
significant effect on protein production. Similarly addition of betaine and sorbitol was 
shown to have no effect on protein production. In this case it is likely that the fraction of 
overexpressed protein which is soluble is already large enough, such that presence of 
betaine cannot have a significant effect on protein folding and therefore solubility.
Reducing temperature to 25 °C is however seen to increase the density of the DOX-P 
Synthase protein band, or percentage of DOX-P Synthase per total protein production. 
This increase is of about 3 to 4%, representing a small but significant increase. However 
the increase is viewed here not to compensate for the reduction in OD6oo, (and therefore
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Figure 3.22.i. Culture growth in shaking 1 L conical flasks at 37 °C.
150 mL LB broth, with or without glycyl betaine and sorbitol (2.5 mM and 1 mM), in 1 L 
conical flask - inoculated with overnight culture of E. coli BL21 pCC16 to O D 60o of 
approximately 0.15. Incubated in orbital shaker at 37 °C for 5 h. Induced with 1 mM or 
0.1 mM IPTG at 2 h. 1 mL samples taken at 1-hour time intervals and O D 6oo measured. 
Growth monitored as O D 6oo over time. By 5 h, observed to begin leaving exponential 
growth phase, at OD600 of 3.0 to 4.0. Cells harvested at this point.
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Figure 3.22.ii. Culture growth in shaking 1 L conical flasks at 32 °C.
150 mL LB broth, with or without glycyl betaine and sorbitol (2.5 mM and 1 mM), in 1 L 
conical flask - inoculated with overnight culture of E. coli BL21 pCC16 to O D 6oo of 
approximately 0.15. Incubated in orbital shaker at 37 °C for 6 h. Induced with 1 mM or 
0.1 mM IPTG at 2.5 h. 1 mL samples taken at time intervals and O D 6oo measured. (Time 
intervals: Oh; 1 h; 2 h; 2.5 h; 3.5 h; 4.5 h; 6 h). Growth monitored as O D 6oo over time. 
By 6 h, observed to begin leaving exponential growth phase, at O D 60o of 3.0 to 4.0. Cells 
harvested at this point.
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Figure 3.22.iii. Culture growth in shaking 1 L conical flasks at 28 °C.
150 mL LB broth, with or without glycyl betaine and sorbitol (2.5 mM and 1 mM), in 1 L 
conical flask - inoculated with overnight culture of E. coli BL21 pCC16 to OD600 o f 
approximately 0.15. Incubated in orbital shaker at 37 °C for 8 h. Induced with 1 mM or 
0.1 mM IPTG at 3 h. 1 mL samples taken at time intervals and O D 6oo measured. (Time 
intervals: Oh; 1 h; 2 h; 3 h; 4.5 h; 5.5 h; 7 h; 8 h). Growth monitored as O D 60o over time. 
By 8 h, observed to begin leaving exponential growth phase, at O D 6oo o f 3.0 to 4.0. Cells 
harvested at this point.
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Figure 3.22.iv. Culture growth in shaking 1 L conical flasks at 25 °C.
150 mL LB broth, with or without glycyl betaine and sorbitol (2.5 mM and 1 mM), in 1 L 
conical flask - inoculated with overnight culture of E. coli BL21 pCC16 to O D 60o of 
approximately 0.15. Incubated in orbital shaker at 37 °C for 9 h. Induced with 1 mM or 
0.1 mM IPTG at 4 h. 1 mL samples taken at time intervals and OD600 measured. (Time 
intervals: Oh; 2 h; 4 h; 6 h; 8 h; 9 h). Growth monitored as OD600 over time. By 9 h, 
observed to begin leaving exponential growth phase, at O D 60o of 2.5 to 3.0. Cells 
harvested at this point.
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total protein quantity), or for the increased time required to reach stationary phase. The 
conditions therefore, that were chosen for DOX-P Synthase production for the rest of 
these studies, are a temperature of 37 °C; with no added betaine or sorbitol; and 1 mM 
IPTG for induction.
3.18 Optimisation of Harvest Time
Protein harvesting has currently been done at end-log phase, at 3 h after induction. Effect 
on protein concentration of harvesting at either this time point, or at stationary point, 24 h 
after induction, will be examined here, as will harvesting at time of induction. Effect on 
total protein concentration, and specifically on DOX-P Synthase concentration, will be 
measured, by Bradford-type assay, and SDS-PAGE densitometry respectively.
The DOX-P Synthase producing strain was grown in 150 mL cultures, as described in 
2.03.2. Samples were then taken at the time of induction, denoted as 0 h; at 3 h after 
induction, when the culture was leaving exponential growth phase; and at 24 h after 
induction, when culture growth had stabilised in stationary phase. Total protein 
concentration was then quantified, using the Coomassie Plus protein assay, (Pierce), as 
described in 2.03.9. DOX-P Synthase concentration was then quantified by first 
analysing whole cell, soluble and insoluble fractions of these samples by SDS-PAGE, 
then by analysing the gels by optical densitometry to indicate percentage of total protein 
represented by DOX-P Synthase in each fraction.
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T /C [IPTG1 / mM Betaine / 
Sorbitol
% DOX-P 
Synthase
37 1.0 Present 9.9
37 1.0 Absent 9.8
37 0.1 Present 9.4
37 0.1 Absent 10.2
32 1.0 Present 9.6
32 1.0 Absent 10.2
32 0.1 Present 9.4
32 0.1 Absent 9.3
28 1.0 Present 11.2
28 1.0 Absent 10.4
28 0.1 Present 10.8
28 0.1 Absent 10.6
25 1.0 Present 13.8
25 1.0 Absent 13.4
25 0.1 Present 13.9
25 0.1 Absent 12.9
Table 3.2. DOX-P Synthase production as percentage of total protein production.
150 mL LB broth, with or without glycyl betaine and sorbitol (2.5 mM and 1 mM), in 1 L 
conical flask - inoculated with overnight culture of E. coli BL21 pCC16 to OD60o of 
approximately 0.15. Incubated in orbital shaker at 37 °C; 32 °C; 28 °C; or 25 °C. 
Induced with 1 mM or 0.1 mM IPTG when entering exponential growth phase, at 2 h; 2.5 
h; 3 h; or 4 h, respectively. 10 mL samples taken as cultures began to exit exponential 
growth phase, at 5 h; 6 h; 8 h or 9 h, respectively. Soluble cell fraction extracted from 
samples. Analysed by SDS-PAGE. Photo image analysed by Syngene Gene Tools, and 
density of DOX-P Synthase band calculated as percentage of density of all protein bands 
present.
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Table 3.3 shows the cell density at sampling, measured as OD600; total protein 
concentration, measured by Coomassie Plus protein assay; and DOX-P Synthase density, 
measured as a percentage of total protein by PAGE band densitometry. Total extract 
DOX-P Synthase concentration at each of the three timepoints was then calculated, as the 
product of total protein concentration and the percentage DOX-P Synthase.
The table shows that protein concentration, and total DOX-P Synthase concentration per 
mL extract, is greatest at 24 h post induction, with DOX-P Synthase concentration 
reaching almost 200 pg.mL'1. However, DOX-P Synthase concentration in the extract, 
relative to other protein, is low, at only 4%. At 3 h post induction, a lower DOX-P 
Synthase concentration per mL extract is reached, of 140 pg.m L1, but concentration 
relative to other protein is greater, at almost 10%. This may be occurring due to the loss 
of pCC16 plasmid stability beyond 3 h post induction, as observed in 3.07, or it may be 
caused by the increase in concentration of other proteins, the expression of which may be 
induced more slowly than DOX-P Synthase.
The result of this observation is therefore that DOX-P Synthase extract is purest at 3 h 
post induction. It was decided therefore to use the 3 h extract as the biocatalyst, noting it 
contained a DOX-P Synthase concentration of 140 pg.mL'1. As a result, from now on 
DOX-P Synthase will be harvested at 3 h post induction, when protein quantity is 
reasonably high, and whilst purity is higher. At this point in culture growth an OD600 of 
just over 3.0 is observed. The sample harvested at OD600 is therefore standardised to 3.0
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Sample t / h (from 
induction)
o d 600 Extract [Protein]
pg/ml
% Density 
of DOX-P 
Synthase
[DOX-P
Synthase]
ug/ml
BL21 0 0.905 Whole cell 802 N/ A N/ A
Soluble 685 N/ A N/ A
Insoluble 44 N/ A N/ A
3 3.17 Whole cell 2257 N/ A N/ A
Soluble 1658 N/ A N /A
Insoluble 418 N/ A N/ A
24 4.81 Whole cell 4960 N/ A N/ A
Soluble 3586 N /A N /A
Insoluble 769 N/ A N /A
BL21 pCC16 0 0.851 Whole cell 309 1.1 3.4
Soluble 201 1.2 2.4
Insoluble 27 1.3 0.4
3 3.05 Whole cell 2022 10.4 210.3
Soluble 1438 9.8 140.9
Insoluble 270 19.9 53.8
24 4.68 Whole cell 5742 5.2 298.6
Soluble 4779 4.1 195.9
Insoluble 741 6.2 45.9
Table 3.3. Cell density, total protein production and DOX-P Synthase production at 
0 h, 3 h and 24 h post-induction.
150 mL LB broth in 1 L conical flask - inoculated with overnight culture of 
untransformed E. coli BL21, or E. coli BL21 pCC16 to OD600 of approximately 0.15. 
Incubated in orbital shaker at 37 °C, and induced with 1 mM IPTG at 2 h. 10 mL 
samples taken at time of induction, 0 h; 3 h after induction; and 24 h after induction. Cell 
density also measured at these timepoints, as OD6oo. Whole cell fraction, soluble cell 
fraction, and insoluble cell fraction extracted from 10 mL samples. Analysed by 
Coomassie Plus Protein Assay to give total protein concentration values. Analysed by 
SDS-PAGE, and gel photo image analysed by gel band densitometry using Syngene 
Gene Tools, to calculate percentage of protein represented by DOX-P Synthase. DOX-P 
Synthase concentration then calculated, as the product of these two values.
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by dilution, (as a proxy to ensuring standard enzyme concentration), then active catalytic 
extract prepared as previously described.
It has also been shown in Table 3.2 that around 25% of the expressed DOX-P Synthase 
protein is still being lost in the insoluble fraction. It is seen that this can be reduced to 
less than 20% if harvested 24 h after induction, although again this is at the cost of losing 
extract purity. Also, as described before, the proportion of soluble protein could be 
increased by reducing growth temperature to 25 °C, although this would in turn be at the 
cost of reduced cell density and extended growing time, as discussed. In addition, 
unfortunately, it was also found that use of lower IPTG concentration and glycyl betaine 
did not increase protein solubility. Therefore it was decided to proceed despite the 
significant loss of protein in the insoluble fraction. Other methods which might reduce 
this loss will be discussed again later in the Discussion.
3.19 Timecourse and Characterisation of DOX-P Synthase Reaction
Having developed and improved the methods of production, extraction, and of analysis, 
the rate of reaction catalysed by this extract will now be determined, and from this the 
catalytic activity of the extract. As before, extract was added to reaction mixtures of 
DL-glyceraldehyde and pyruvate, and change in HPLC peak area, and thence substrate 
concentration, monitored by HPLC, this time to allow determination of rate of substrate 
turnover. (To enable this, substrate and product concentration was plotted against peak 
area, revealing a linear relationship, as shown in 2.03.13.2).
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DOX-P Synthase reaction mixture was set up in triplicates. A starting concentration of 
10 mM pyruvate and 20 mM DL-glyceraldehyde was used, close to the maximal 
glyceraldehyde solubility in water. Either DOX-P Synthase extract; negative control 
untransformed BL21 extract; or simply water, as a further negative control, was then 
added to the reaction mixtures. Change in substrate concentration was then followed, by 
analysing samples taken at timepoints, (0 h, 1 h, 4 h and 24 h), by HPLC, as described in 
2.03.13.1.
Figure 3.23 shows the timecourse of substrate concentration over time, upon addition of 
either water, or negative control untransformed BL21 extract, and Figure 3.24 shows the 
timecourse of substrate concentration over time upon addition of DOX-P Synthase 
catalytic extract. With the negative controls it can be clearly seen that there is little 
change in concentration of either substrate in 6 h. Initial rates of turnover of 0.00 mM.h'1 
for both substrates were observed with water, and of 0.00 m M .h1 [pyruvate] and 0.02 
m M .h1 [DL-glyceraldehyde] with untransformed BL21 extract. However, with the active 
catalytic DOX-P Synthase extract an initial rate of turnover of 0.64 mM.h"1 [pyruvate] 
and 0.62 mM.h'1 [DL-glyceraldehyde] can be seen. Subtracting the background rate of 
substrate turnover, the enzyme can be said to catalyse turnover at an initial rate of 0.64 
mM.h"1 [pyruvate] and 0.60 mM.h"1 [DL-glyceraldehyde].
This rate of reaction was verified by looking at rate of 1-deoxyxylulose production. 
Change in concentration of the two substrates and the product are shown in Figure 3.25.
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An initial rate of production of 0.66 mM.h'1 [1-deoxyxylulose] was observed, which 
matches closely the rate of substrate loss, confirming that this was due to turnover into 
product.
As rate of reaction is proportional to enzyme concentration, this DOX-P Synthase activity 
is dependent both on the amount of extract added, and the amount of soluble DOX-P 
Synthase present in the extract. The catalytic activity of the expressing strain can 
therefore be expressed in these terms, as a specific activity of the extract, to be compared 
with that of purified enzyme. Taking the figure of 0.64 m M .h1, for pyruvate, an activity 
for the added extract can be calculated by multiplying by the reaction volume of 1 mL. 
This gives an extract activity, for the volume of extract added, of 0.64 pmol.h'1 or 0.0107 
pmol.min'1. By dividing by that volume of extract added, 50 pL, a specific activity of the 
extract can be given, as 0.213 pmol.min^.mL1. And since the mass of enzyme present 
per mL extract has also been estimated, at 140 pg.m L1, an apparent specific activity of 
DOX-P Synthase can also be calculated, as 1.5 pmol.min’.mg"1. (Note, this measure of 
DOX-P Synthase activity is only an apparent specific activity, and cannot be compared 
with the reported absolute specific activities of other enzymes, which are recorded with 
purified enzyme).
The reported absolute specific activity of DOX-P Synthase from recombinant E. coli is 
4.3 pmol.min ’.m g1, (Schiirmann et al., 2002). The extract therefore possesses just over 
one third the activity of the purified protein. The difference is likely to result from
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♦ [Glyceraldehyde]; incubated with water
■ [Pyruvate]; incubated with water
♦ [Glyceraldehyde]; incubated with BL21
♦ [Pyruvate]; incubated with BL21
Figure 3.23. Graph of substrate concentration against time, showing no substrate 
turnover upon incubation with water or E. coli BL21 extract.
Soluble cell fraction extracted from untransformed E. coli BL21. Reaction mix: 20 mM 
DL-glyceraldehyde / 10 mM pyruvate in 50 mM Tris.HCl(aq) buffer, pH 7.0, with 9 mM 
MgCb, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL water or soluble cell fraction 
added in 1 mL reaction mix. Incubated for 24 h at 37 °C. 150 pL samples taken at 0 h; 
1 h; 4 h; and 24 h. Diluted 1:1 with 0.2% TFA. Analysed by HPLC using Aminex 87H 
column at 60°C, mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. UV detection with 
Dionex AD20 UV detector module; electrochemical detection with Dionex ED40 
electrochemical detector module. Peak areas at 9.7 min on UV trace (pyruvate); and 11.6 
min on ECD trace (glyceraldehyde) integrated and converted to substrate concentrations 
using Chromeleon 6.0 HPLC software, (Dionex).
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♦ [Glyceraldehyde] 
■ [Pyruvate]_____
Figure 3.24. G raph of substrate concentration against time, showing substrate 
turnover occurs upon incubation with E. coli BL21 pCC16 extract.
Soluble cell fraction extracted from E. coli BL21 pCC16. Reaction mix: 20 mM DL - 
glyceraldehyde / 10 mM pyruvate in 50 mM Tris.HCl(aq) buffer, pH 7.0, with 9 mM 
MgCb, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell fraction added in 
1 mL reaction mix. Incubated for 24 h at 37 °C. 150 pL samples taken at 0 h; 1 h; 2 h; 4 
h; 6 h; and 24 h. Diluted 1:1 with 0.2% TFA. Analysed by HPLC using Aminex 87H 
column at 60°C, mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. UV detection with 
Dionex AD20 UV detector module; electrochemical detection with Dionex ED40 
electrochemical detector module. Peak areas at 9.7 min on UV trace (pyruvate); and 11.6 
min on ECD trace (glyceraldehyde) integrated and converted to substrate concentrations, 
(calibrated against peak areas generated at standard concentrations), using Chromeleon 
6.0 HPLC software, (Dionex).
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Figure 3.25. Graph of substrate concentration against time, showing substrate 
turnover and product creation occurs upon incubation with E. coli BL21 pCC16 
extract.
Soluble cell fraction extracted from E. coli BL21 pCC16. Reaction mix: 20 mM DL - 
glyceraldehyde / 10 mM pyruvate in 50 mM Tris.HCl(aq) buffer, pH 7.0, with 9 mM 
MgCh, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell fraction added in 
1 mL reaction mix. Incubated for 24 h at 37 °C. 150 pL samples taken at 0 h; 1 h; 2 h; 4 
h; 6 h; and 24 h. Diluted 1:1 with 0.2% TFA. Analysed by HPLC using Aminex 87H 
column at 60°C, mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. UV detection with 
Dionex AD20 UV detector module; electrochemical detection with Dionex ED40 
electrochemical detector module. Peak areas at 9.7 min on UV trace (pyruvate); 11.6 min 
on ECD trace (glyceraldehyde); and 12.2 min on ECD trace (1-deoxyxylulose) integrated 
and converted to substrate concentrations, (calibrated against peak areas generated at 
standard concentrations), using Chromeleon 6.0 HPLC software, (Dionex).
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substrate and cofactor sequestration, posed by the other proteins, (or lipids), in the 
extract, or even perhaps some non-specific inhibition. However, the fact that substantial 
activity remains could be taken to vindicate the decision against pursuing further extract 
purification. As will be observed below, the clarified extract is still capable of substantial 
substrate biotransformation.
Whilst the specific activity of the extract may not be particularly high, 32 % turnover of 
pyruvate, and 18% turnover of glyceraldehyde is still seen to occur in 6 h when active 
extract is added. And after 24 h, 100 % turnover of pyruvate was observed. Whilst the 
calculated initial rates of reaction show DOX-P Synthase to only catalyse a 
comparatively slow reaction, this high percentage turnover of substrate which is 
eventually reached, reveals how useful this extract could prove to be as a biocatalyst.
3.20 Discussion
To conclude this chapter, it can be said that an active DOX-P Synthase extract has 
successfully been produced. This extract contains 140 pg DOX-P Synthase enzyme per 
mL extract, and is capable of acting as a biocatalyst for the production of 
1-deoxyxylulose with a specific activity of 0.213 pmol.min‘I.mL'1, (implying an apparent 
specific activity for DOX-P Synthase of 1.5 pmol.min^.mg1).
To begin with, a method of production was developed. A pET21 expression system was 
used, with transcription driven from the powerful T7 promoter for high expression in
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liquid culture. Variations in growth conditions were tested, and a growth temperature of 
37 °C, and induction with 1 mM IPTG chosen, as offering high protein production, and in 
a short period of time. Harvesting extract at 3 h post induction, at the exit of exponential 
phase, rather than at 24 h, in stationary phase, was also chosen, for greater protein purity.
The extraction method was also developed. Sonication and use of protamine sulphate 
was used initially, but for simplicity of extraction, it was found that the non-ionic 
detergent, BugBuster, and the nuclease, Benzonase, could be used more effectively.
The analysis method was then also developed. After testing TLC and colorimetric 
assays, an assay based on the HPLC method used for TK was developed, using an 
Aminex-87H column, 0.1% TFA and UV and ECD detection.
It was then shown, as mentioned, that, using this analysis method, and these production 
and extraction methods, a DOX-P Synthase extract could be produced containing 140 
pg.mL'1 enzyme, and this extract was shown to be capable of catalysing the synthesis of 
1-deoxyxylulose from glyceraldehyde and pyruvate. The initial rate of this catalysed 
reaction was then determined. The initial rate of pyruvate turnover, upon addition of a 
50 pL extract to a 1 mL solution of 20 mM DL-glyceraldehyde / 10 mM pyruvate 
solution, was determined as 0.64 mM.h'1. In 24 h, the pyruvate was turned over 
completely. This showed the DOX-P Synthase extract could be a useful biocatalyst. The 
specific activity of this extract was then calculated as 0.213 pmol.min^.mL1, and with 
mass of DOX-P Synthase enzyme present per mL extract estimated at 140 pg.mL'1, an
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apparent specific activity for the DOX-P Synthase enzyme could then be estimated, at 1.5 
pmol.min'1.p.g'1. This compares to the reported absolute specific activity for DOX-P 
Synthase of 4.3 pmol.min'1. pg '1, which suggests some degree of substrate or cofactor 
sequestration, or enzyme inhibition, by impurities in the extract, but not so much as to 
make further purification a necessity.
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4 Characterisation of Activity and Substrate Specificity of 
l-Deoxy-D-Xylulose-5-Phosphate Synthase
4.01 Introduction
In the previous chapter, the DOX-P Synthase enzyme was identified, cloned and 
produced in E. coli, and extracted for use as a biocatalyst. The DOX-P Synthase extract 
was then proven to be efficient at catalysing the transformation of pyruvate and 
glyceraldehyde into 1 -deoxy-D-xylulose, and the rate of this reaction was measured. In 
this chapter, the extract is further characterised in order to optimise the conditions for use 
of the biocatalyst. The substrate range of the enzyme is then analysed in order to 
describe the utility of the extract as a biocatalyst.
4.02 Optimisation of Reaction Conditions for DOX-P Synthase- 
Catalysed Reaction
For use as a biocatalyst, the reaction conditions need to be optimised for maximal rate. 
The conditions in the reaction to be optimised in this study cover a range of factors which 
may play an effect on rate: reaction buffer; buffer pH; temperature; and cofactor 
concentration.
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4.03 Optimisation of Buffer and pH for Reaction
DOX-P Synthase extract, produced and used as described, has been shown to catalyse the 
transfer of a 2-carbon ketol group from pyruvate to glyceraldehyde to produce 1-deoxy- 
D-xylulose, at an initial rate for pyruvate turnover of 0.64 mM.1T1, or at an apparent 
specific activity of 1.5 pmol.min^.mg"1, in the reaction conditions described, in a 
Tris.HCl buffer at pH 7.0. It was then decided to assess the suitability of the buffer and 
ascertain the optimal pH, by repeating the reaction using three different buffers, at six 
different pH. The buffers used were Bis-Tris.HCl buffer, at pH 6.0, 6.5 and 7.0; 3- 
morpholinopropanesulfonic acid, (MOPS) buffer, at pH 6.5, 7.0 and 7.5; and Tris.HCl 
buffer at pH 7.0, 7.5, 8.0 and 8.5. (Note, phosphate buffer was not used as it has been 
found to be inhibitory with transketolase, (Pontremoli et al., 1960). It has been proposed 
that this is caused by inorganic phosphate occupying phosphate-binding sites in the TK 
active site, sites also likely to be present in the DOX-P Synthase active site).
The DOX-P Synthase catalysed reaction was set up in each of the ten buffers, with all the 
other conditions as before, and change in substrate concentration followed by HPLC, as 
before. Change in substrate concentration over time was then plotted to calculate initial 
rate of reaction, as before, and since this used the same volume of extract, 50 pL, at the 
same estimated concentration of enzyme, 140 pg.mL'1, activity of extract could then be 
calculated at the various pH values and in the various buffers. Activity is then plotted 
against the type of buffer and pH in Figure 4.1. This shows DOX-P Synthase with 
slightly reduced activity in Bis-Tris.HCl, and MOPS buffer, compared to its activity in
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Figure 4.1. Apparent specific activity of DOX-P Synthase measured at six PH 
intervals, (6.0; 6.5; 7.0; 7.5; 8.0; 8.5), and in three buffers, (Bis-Tris.HCI; MOPS; 
Tris.HCl).
Soluble cell fraction extracted from E. coli BL21 pCC16. Reaction mix: 20 mM DL - 
glyceraldehyde / 10 mM pyruvate in 50 mM Bis-Tris.HCl(aq) / MOPS(aq) / Tris.HCl(aq) 
buffer, pH as stated, with 9 mM MgCh, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 
50 pL soluble cell fraction, containing 140 pg.mL'1 DOX-P Synthase, added in 1 mL 
reaction mix. Incubated for 24 h at 37 °C. 150 pL samples taken at 0 h; 1 h; 2 h; 4 h; 6 
h; and 24 h. Diluted 1:1 with 0.2% TFA. Analysed by HPLC using Aminex 87H column 
at 60°C, mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. UV detection with Dionex 
AD20 UV detector module; electrochemical detection with Dionex ED40 
electrochemical detector module. Peak areas at 9.7 min on UV trace (pyruvate); 11.6 min 
on ECD trace (glyceraldehyde); and 12.2 min on ECD trace (1-deoxyxylulose), 
integrated and converted to substrate concentrations using Chromeleon 6.0 HPLC 
software, (Dionex). Timecourse of substrate turnover plotted and initial rate of pyruvate 
turnover calculated. From DOX-P Synthase concentration in extract, an apparent specific 
activity for the enzyme was calculated for each set of conditions, as plotted above. 
Reactions were carried out in triplicate.
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Tris.HCl buffer. Figure 4.1 also shows DOX-P Synthase to be active in the pH range, 6.5 
to 8.0, with the pH optimum between 7.0 and 7.5, at an apparent specific activity of 1.48 
pmol.min'I.mg’1. However, apparent specific activity at pH 6.5 has only fallen to 1.26 
pmol.min'1.mg'1, or 85 % of that at 7.0, and at pH 8.0 has only fallen to 1.22 pmol.min' 
1.mg'1, or 82 % of that at pH 7.0. As this is the case, the rest of this thesis will use 
Tris.HCl buffered to pH 7.0 as the reaction buffer for the DOX-P Synthase reaction, but 
the applicability of DOX-P Synthase outside of this pH is noted. This data agrees with 
the previously described pH optimum of 7.5, (Kuzuyama et al., 2000), but also adds extra 
information on the fuller pH range of 6.5 to 8.0 in which useful catalytic activity can be 
found.
4.04 Optimisation of Reaction Temperature
The DOX-P Synthase extract has so far only been characterised at 37 °C. This could be 
expected to be the optimal temperature for enzyme activity, as 37 °C is the optimal 
growth temperature for E. coli, however this assumption need not necessarily be correct. 
Indeed a previous study has observed an optimal temperature of 42 °C, (Kuzuyama et a l, 
2000). In addition, by adjusting the temperature of the reaction, it may prove possible to 
increase product yield, depending on the effect of temperature upon enzyme stability. 
Therefore it was decided to assess the impact of temperature upon enzyme activity and 
also biotransformation yield.
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Figure 4.2a. Apparent specific activity of DOX-P Synthase measured at three 
temperature intervals, (25 °C; 37 °C; 42 °C).
Soluble cell fraction extracted from E. coli BL21 pCC16. Reaction mix: 20 mM DL - 
glyceraldehyde / 10 mM pyruvate in 50 mM Tris.HCl(aq) buffer, pH 7.0, with 9 mM 
MgCh, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell fraction, 
containing 140 pg.mL'1 DOX-P Synthase, added in 1 mL reaction mix. Incubated for 
24 h at stated temperature. 150 pL samples taken at 0 h; 1 h; 2 h; 4 h; 6 h; and 24 h. 
Diluted 1:1 with 0.2% TFA. Analysed by HPLC using Aminex 87H column at 60°C, 
mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. UV detection with Dionex AD20 UV 
detector module; electrochemical detection with Dionex ED40 electrochemical detector 
module. Peak areas at 9.7 min on UV trace (pyruvate); 11.6 min on ECD trace 
(glyceraldehyde); and 12.2 min on ECD trace (1-deoxyxylulose), integrated and 
converted to substrate concentrations using Chromeleon 6.0 HPLC software, (Dionex). 
Timecourse of substrate turnover plotted and initial rate of pyruvate turnover calculated. 
From DOX-P Synthase concentration in extract, an apparent specific activity for the 
enzyme was calculated for each set of conditions, as plotted above. Reactions were 
carried out in triplicate.
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Figure 4.2b. Percentage pyruvate turnover catalysed by DOX-P Synthase after 6 h, 
measured at three temperature intervals, (25 °C; 37 °C; 42 °C).
Soluble cell fraction extracted from E. coli BL21 pCC16. Reaction mix: 20 mM DL - 
glyceraldehyde / 10 mM pyruvate in 50 mM Tris.HCl(aq) buffer, pH 7.0, with 9 mM 
MgCb, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell fraction, 
containing 140 pg.mL'1 DOX-P Synthase, added in 1 mL reaction mix. Incubated for 
24 h at stated temperature. 150 pL samples taken at 0 h; and 6 h. Diluted 1:1 with 0.2% 
TFA. Analysed by HPLC using Aminex 87H column at 60°C, mobile phase 0.1% TFA, 
flow rate 0.6 mL.min'1. UV detection with Dionex AD20 UV detector module; 
electrochemical detection with Dionex ED40 electrochemical detector module. Peak 
areas at 9.7 min on UV trace (pyruvate); 11.6 min on ECD trace (glyceraldehyde); and
12.2 min on ECD trace (1-deoxyxylulose), integrated and converted to substrate 
concentrations using Chromeleon 6.0 HPLC software, (Dionex). Reactions were carried 
out in triplicate.
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To this end, the reaction was set up as before. Of three sets of reactions, one set was 
incubated at 25 °C, another at 37 °C, and the final one at 42 °C. These were then 
incubated for 24 h, and samples taken at time intervals, as previously. Again, initial rates 
and apparent specific activities were calculated, and activity plotted against temperature 
in Figure 4.2a. Activity was observed to be reduced from 1.48 pmol.min^.mg'1 to 0.71 
pmol.min^.mg1, or to 48 %, when temperature was reduced from 37 °C to 25 °C, but it 
also increased to 1.64 pmol.min^.mg'1 or 110 % when temperature increased to 42 °C. 
In agreement with the previous study, optimal temperature for DOX-P Synthase activity 
was observed to be 42 °C. However, as shown in Figure 4.2b, turnover at 6 h is actually 
higher at 37 °C, with 33% turnover rather than 30% at 42 °C. This suggests that the 
increased initial rate of reaction derived from increasing reaction temperature is 
outweighed by decreased enzyme stability over time. This phenomenon is looked at in 
more detail in 4.07. However, as a result of these studies, 37 °C will be taken as the 
optimal temperature for biocatalysis, permitting optimum turnover over an extended 
period of time. As expected from the reduced activity, turnover was shown to be halved 
from 33 % to 18 %, when temperature was decreased from 37 °C to 25 °C.
4.05 Optimisation of Cofactor Concentration
Cofactors are compounds which are required by the enzyme, in order to catalyse reaction, 
as necessary components of the catalytic mechanism. Generally they will sit in the active 
site of the enzyme, playing a role in providing interactions with the substrate that the 
enzyme alone cannot provide. Due to the essential nature of these compounds to enzyme
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activity, it is therefore important to quantify the effect of cofactor concentration on 
enzyme activity. In addition, the expense of some of these compounds means it can 
sometimes be economical to reduce cofactor concentration at the expense of activity.
2 j #
The two cofactors used by DOX-P Synthase, are magnesium ions, Mg provided here in 
the form of MgCl2 , and thiamine pyrophosphate, TPP. Here we will look at the effect on 
rate of reaction, of altering Mg2+ and TPP concentration. Multiple reactions were set up, 
as described previously, and loss of substrate followed by HPLC. These timecourses are 
shown in Figures 4.3a and 4.4a, and then effect of cofactor concentration on apparent 
specific activity shown in Figures 4.3b and 4.4b.
It can be seen that TPP concentration can be reduced from 2.5 mM to 1 mM, with no 
significant effect on activity. This would allow expense to be saved in a DOX-P 
Synthase catalysed process, by reducing TPP usage. It can also be seen that removing all 
TPP from the reaction buffer does not eliminate DOX-P Synthase activity. This is 
because a residual amount of TPP is retained in the active sites of the DOX-P Synthase 
enzyme molecules, when it is harvested from E. coli culture. This is looked at in more 
detail in 4.06.
It can also be seen that increasing Mg2+ concentration from 9 mM to 30 mM increases 
activity from 1.50 pmol.min^.mg"1 to 1.68 pmol.min^.mg'1, an increase of 12%. As 
MgCL is so inexpensive, this would be a cheap way o f increasing rate o f reaction. For 
the rest of this study however, as this finding was only made late in proceedings, a MgCL
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Figure 4.3a. Graph showing pyruvate turnover over time, as catalysed by E. coli 
BL21 pCC16 extract, at three different concentrations of Mg2+, (0 mM; 9 mM; 30 
mM).
Soluble cell fraction extracted from E. coli BL21 pCC16. Reaction mix: 20 mM DL - 
glyceraldehyde / 10 mM pyruvate in 50 mM Tris.HCl(aq) buffer, pH 7.0, with 0 mM / 9 
mM / 30 mM MgCl2, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell 
fraction, containing 140 pg.mL'1 DOX-P Synthase, added in 1 mL reaction mix. 
Incubated for 24 h at stated temperature. 150 pL samples taken at 0 h; 4 h; and 24 h. 
Diluted 1:1 with 0.2% TFA. Analysed by HPLC using Aminex 87H column at 60°C, 
mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. UV detection with Dionex AD20 UV 
detector module; electrochemical detection with Dionex ED40 electrochemical detector 
module. Peak areas at 9.7 min on UV trace (pyruvate); 11.6 min on ECD trace 
(glyceraldehyde); and 12.2 min on ECD trace (1-deoxyxylulose), integrated and 
converted to substrate concentrations using Chromeleon 6.0 HPLC software, (Dionex). 
Reactions were carried out in triplicate.
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Figure 4.3b. Apparent specific activity of DOX-P Synthase measured at at three 
different concentrations of Mg2+, (0 mM; 9 mM; 30 mM).
Soluble cell fraction extracted from E. coli BL21 pCC16. Reaction mix: 20 mM DL - 
glyceraldehyde / 10 mM pyruvate in 50 mM Tris.HCl(aq) buffer, pH 7.0, with 0 mM / 
9 mM / 30 mM MgCh, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell 
fraction, containing 140 pg.mL'1 DOX-P Synthase, added in 1 mL reaction mix. 
Incubated for 24 h at 37 °C. 150 pL samples taken at 0 h; 1 h; 2 h; 4 h; 6 h; and 24 h. 
Diluted 1:1 with 0.2% TFA. Analysed by HPLC using Aminex 87H column at 60°C, 
mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. UV detection with Dionex AD20 UV 
detector module; electrochemical detection with Dionex ED40 electrochemical detector 
module. Peak areas at 9.7 min on UV trace (pyruvate); 11.6 min on ECD trace 
(glyceraldehyde); and 12.2 min on ECD trace (1-deoxyxylulose), integrated and 
converted to substrate concentrations using Chromeleon 6.0 HPLC software, (Dionex). 
Timecourse of substrate turnover plotted in Figure 4.3a, and initial rate of pyruvate 
turnover calculated. From DOX-P Synthase concentration in extract, an apparent specific 
activity for the enzyme was calculated for each set of conditions, as plotted above. 
Reactions were carried out in triplicate.
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Figure 4.4a. Graph showing pyruvate turnover over time, as catalysed by E. coli 
BL21 pCC16 extract, at three different concentrations of TPP, (0 mM; 1 mM; 2.5 
mM).
Soluble cell fraction extracted from E. coli BL21 pCC16. Reaction mix: 20 mM DL - 
glyceraldehyde / 10 mM pyruvate in 50 mM Tris.HCl(aq) buffer, pH 7.0, with 9 mM 
MgCl2, 0 mM /1 mM / 2.5 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell 
fraction, containing 140 pg.mL'1 DOX-P Synthase, added in 1 mL reaction mix. 
Incubated for 24 h at stated temperature. 150 pL samples taken at 0 h; 4 h; and 24 h. 
Diluted 1:1 with 0.2% TFA. Analysed by HPLC using Aminex 87H column at 60°C, 
mobile phase 0.1% TFA, flow rate 0.6 mL.min’1. UV detection with Dionex AD20 UV 
detector module; electrochemical detection with Dionex ED40 electrochemical detector 
module. Peak areas at 9.7 min on UV trace (pyruvate); 11.6 min on ECD trace 
(glyceraldehyde); and 12.2 min on ECD trace (1-deoxyxylulose), integrated and 
converted to substrate concentrations using Chromeleon 6.0 HPLC software, (Dionex). 
Reactions were carried out in triplicate.
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Figure 4.4b. Apparent specific activity of DOX-P Synthase measured at at three 
different concentrations of TPP, (0 mM; 1 mM; 2.5 mM).
Soluble cell fraction extracted from E. coli BL21 pCC16. Reaction mix: 20 mM DL - 
glyceraldehyde / 10 mM pyruvate in 50 mM Tris.HCl(aq) buffer, pH 7.0, with 9 mM 
MgCl2, 0 mM / 1 mM / 2.5 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell 
fraction, containing 140 pg.mL'1 DOX-P Synthase, added in 1 mL reaction mix. 
Incubated for 24 h at 37 °C. 150 pL samples taken at 0 h; 4 h; and 24 h. Diluted 1:1 with 
0.2% TFA. Analysed by HPLC using Aminex 87H column at 60°C, mobile phase 0.1% 
TFA, flow rate 0.6 mL.min1. UV detection with Dionex AD20 UV detector module; 
electrochemical detection with Dionex ED40 electrochemical detector module. Peak 
areas at 9.7 min on UV trace (pyruvate); 11.6 min on ECD trace (glyceraldehyde); and
12.2 min on ECD trace (1-deoxyxylulose), integrated and converted to substrate 
concentrations using Chromeleon 6.0 HPLC software, (Dionex). Timecourse of substrate 
turnover plotted in Figure 4.4a, and initial rate of pyruvate turnover calculated. From 
DOX-P Synthase concentration in extract, an apparent specific activity for the enzyme 
was calculated for each set of conditions, as plotted above. Reactions were carried out in 
triplicate.
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2 1
concentration of 9 mM was used. In addition, again, as for TPP, when Mg 
concentration in the reaction buffer is reduced to 0 mM, residual DOX-P Synthase
 ^I
activity persists. As before this is due to residual Mg trapped in the active sites of 
DOX-P Synthase enzyme molecules when harvested from the E. coli culture. It should 
also be noted that Mg2+ and TPP are both necessary cofactors, and both bind each other 
into the active site, and helping maintain that residual enzyme activity at apparent 
cofactor concentrations of 0 mM.
4.06 Analysis and Discussion of the Ratio of Holo- to Apo-Enzyme
A cofactor-dependent enzyme can exist in two states: as holenzyme; or as apoenzyme. 
The holoenzyme has cofactor bound, and is active as a result. The apoenzyme has no 
cofactor bound, and is therefore inactive. Proportion of enzyme present in the holo- or 
apo- form is dependent on the concentrations of both enzyme and cofactor, and also the 
affinity of the enzyme for the cofactor, described by the dissociation constant.
In the previous set of experiments it was seen that despite absence of TPP from the 
extraction and reaction buffers, some residual DOX-P Synthase activity could be seen. 
As explained previously, this residual activity exists because some of the enzyme in this 
extract has retained TPP, bound in its active site. The extract can be said to have a 
proportion of holoenzyme, and a proportion of apoenzyme. The ratio of holoenzyme to 
apoenzyme in these DOX-P Synthase extracts was then analysed, as described here. If 
proportion of holoenzyme could be maintained high in the absence of TPP, the quantity
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of expensive TPP being used could perhaps then be reduced in any DOX-P Synthase 
catalysed process.
When TPP is present in the extraction buffer or reaction buffer at 1 mM or 2.5 mM, TPP 
concentration is so much higher than enzyme concentration that it can be assumed 
enzyme TPP binding sites are saturated. At a relative molecular mass for DOX-P 
Synthase of 68 kDa, an enzyme concentration of 140 pg.mL'1 can also be described as a 
concentration of 2.06 xlO'3 mM. This is 1,000-fold lower than TPP concentration, so it 
should not be surprising that the drop from 2.5 mM TPP to 1 mM TPP has no effect on 
enzyme activity. It can be assumed that TPP is saturating at these concentrations. In the 
similar enzyme, TK, TPP is observed to be limiting only below a 2-fold concentration, 
(Kochetov, 1982).
However when TPP concentration is dropped to 0 mM in the reaction buffer, there is an 
observable drop in enzyme activity. When 50 pL extract is added to 1 mL reaction buffer 
from which TPP is absent, TPP is then diluted 20-fold. The residual activity is a measure 
of how much enzyme is left present in the holoenzyme or apoenzyme form. This will be 
dependent on the enzyme’s affinity for TPP, its dissociation constant for TPP. If enzyme 
affinity for TPP is sufficiently high the effective 20-fold TPP dilution may not affect 
enzyme activity, permitting TPP to be dropped from the reaction buffer of DOX-P 
Synthase in a biocatalysis process.
C M Chudziak 162
Production. Characterisation and Modification of DOX-P Synthase as a Biocatalvst
Simultaneously we can look at the need for TPP in the extraction buffer. This may be 
found not to be necessary as there could be residual TPP bound into the enzyme active 
site from when the enzyme was originally produced in fermentation. The level of TPP 
present in DOX-P Synthase active sites at the end of fermentation will be dependent both 
on the cellular concentrations of both TPP and enzyme, and the enzyme’s dissociation 
constant for TPP. If cellular concentrations of TPP are higher than cellular DOX-P 
Synthase concentrations to a sufficient degree, (dependent both on DOX-P Synthase 
affinity for TPP, and presence of other TPP-binding ligands), this could permit TPP to 
also be dropped from the extraction buffer used in biocatalyst preparation. If not, perhaps 
TPP present in the reaction buffer may so quickly saturate empty active sites, such that its 
absence in the extraction buffer might not have an effect on activity once the extract is 
diluted in the reaction buffer. This again would be dependent on enzyme affinity for 
TPP.
While the TPP dissociation constant of DOX-P Synthase was not directly measured, the 
effect of removing TPP from reaction and extraction buffers was assessed. The DOX-P 
Synthase extract was made using extraction buffer with either 0 mM or 1 mM TPP. 
These two extracts were then assayed for DOX-P Synthase activity, using reaction buffer 
with either 0 mM or 1 mM TPP, giving four reactions in total. Pyruvate turnover was 
then followed as before, by HPLC, and initial rate of reaction calculated. Whilst these 
experiments would not be capable of producing enzymological constants, they should be 
able to give some simple, but useful, information for the biochemical engineer setting up 
a DOX-P Synthase catalysed process, on the need or otherwise for TPP in either buffer.
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Extraction Reaction Apparent Specific Activity 
(umol/min/mg)
Percentage of 
maximum activity
Percentage 
turnover after 24 h
TPP absent TPP absent 0.49 32.7 23
TPP absent TPP present 1.20 80.0 94
TPP present TPP absent 0.68 45.3 76
TPP present TPP present 1.50 100.0 100
Table 4.1. Apparent specific rate of activity of DOX-P Synthase, and percentage 
substrate turnover in 24 h, when TPP is present or absent in the extraction or 
reaction buffers.
Soluble cell fraction extracted from E. coli BL21 pCC16. Extraction buffer 50 mM 
Tris.HCl(aq) buffer, pH 7.0, with 9 mM MgC^, 0 mM / 1 mM TPP, 1 mM DTT and 
0.1 mM PMSF. Reaction mix: 20 mM DL -glyceraldehyde / 10 mM pyruvate in 50 mM 
Tris.HCl(aq) buffer, pH 7.0, with 9 mM MgCb, 0 mM / 1 mM TPP, 1 mM DTT and 
0.1 mM PMSF. 50 pL soluble cell fraction, containing 140 pg.mL'1 DOX-P Synthase, 
added in 1 mL reaction mix. Incubated for 24 h at 37 °C. 150 pL samples taken at 0 h; 1 
h; 4 h; 6 h; and 24 h. Diluted 1:1 with 0.2% TFA. Analysed by HPLC using Aminex 
87H column at 60°C, mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. UV detection 
with Dionex AD20 UV detector module; electrochemical detection with Dionex ED40 
electrochemical detector module. Peak areas at 9.7 min on UV trace (pyruvate); 11.6 min 
on ECD trace (glyceraldehyde); and 12.2 min on ECD trace (1-deoxyxylulose), 
integrated and converted to substrate concentrations using Chromeleon 6.0 HPLC 
software, (Dionex). Timecourse of substrate turnover plotted, and initial rate of pyruvate 
turnover calculated. From DOX-P Synthase concentration in extract, an apparent specific 
activity for the enzyme was calculated for each set of conditions, as plotted above. 
Reactions were carried out in triplicate. Percentage of maximum activity data represents 
percentages of apparent specific activity of DOX-P Synthase where 1 mM TPP is present 
in both the extraction and reaction buffers. Percentage turnover of pyruvate after 24 h 
also recorded.
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The data here is shown in Table 4.1. When TPP is present in the extraction buffer, 
dilution into reaction buffer with no TPP, can be seen to reduce apparent specific activity 
of DOX-P Synthase from 1.50 pmol.min '.m g'1 to 0.68 pmol.min’.m g1, or to 45 % of 
that at TPP saturation. Thus level of enzyme present as holoenzyme reduces to 45 % of 
the level found when TPP is saturating. When TPP is present in neither extraction buffer 
or reaction buffer, DOX-P Synthase activity can be seen to decrease further, from 1.50 
pmol.min '.m g 1 to 0.49 pmol.min’.mg'1, or to 33 % of original activity. Adding TPP to 
the reaction buffer in this case can only be seen to increase DOX-P Synthase activity 
from 0.49 pmol.min^.mg'1 to 1.20 pmol.min^.mg1, or from 33 % to 80 %. This could 
be due to a deleterious effect on the DOX-P Synthase enzyme through absence of TPP at 
the extraction stage. Apoenzyme may be more susceptible to proteolysis for example. 
Alternatively this could also be due to a time lag in TPP fully reoccupying DOX-P 
Synthase active sites. This would be dictated by the dissociation constant of the enzyme 
for TPP.
Presence or absence of TPP in either the extraction or reaction buffers also has an effect 
on total turnover at 24 h. There is 100 % turnover of pyruvate after 24 h, when TPP is 
present in both the DOX-P Synthase extraction and reaction. Turnover is reduced to 94 
% when TPP is only present in the reaction buffer, and to 76 % when only present in the 
extraction buffer. In total absence of TPP in both extraction and reaction buffers, 
turnover is only 23 %.
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This data all suggests the importance of TPP in both the extraction and reaction buffers. 
In addition, that presence of TPP is more significant in the reaction buffer than in the 
extraction buffer. The data suggests that TPP affinity is not high enough to enable 
removal of TPP from both the extraction and the reaction buffer, without a significant 
cost to DOX-P Synthase activity. However it is notable that significant turnover can still 
occur, albeit at a slower rate, particularly when TPP is still present in the reaction buffer, 
where 94% substrate turnover is achieved. Further work to measure the dissociation 
constant of TPP for DOX-P Synthase would be useful though. This would tell us how far 
TPP concentration could be reduced without a significant loss of activity. This would 
enable the further optimisation of the process conditions.
4.07 Enzyme Stability on Incubation
In constructing a biosynthetic process, there are other characteristics of the biocatalyst 
important for the process engineer to understand, as well as those already described. 
While initial enzyme activity has been measured, as described in 3.19, enzyme activity 
could possibly be decreasing over the full 24 h time period. This can happen as the 
enzyme denatures over time. Whether such loss of activity was occurring needed to be 
measured, as is now described.
As with setting up an enzyme catalysed reaction, the enzyme extract was added to the 
reaction buffer followed by incubation at temperature for various time periods. However 
this time, the reactions were set up in the absence of substrate. At time intervals substrate
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was then added, and the reaction timecourse followed as before. The experimental 
method is described in 2.03.10.1.
As shown in Figure 4.5, activity falls over time. While initial rate remains effectively 
constant from 0 h to 1 h, by 6 h a slight reduction in activity has occurred, dropping from 
1.52 pmol.min^.mg'1 to 1.42 pmol.min ’.m g1, or 93 % of initial activity. However by 
24 h, a more significant drop in activity has occurred, falling to 1.10 pmol.min^.mg'1, or 
72 % of initial activity. (Negative controls with absence of cell extract show substrate 
concentration unchanged by incubation at temperature). This would suggest that to attain 
high rates of reaction over longer periods of time, it may be desirable to supplement the 
reaction mix with additional enzyme periodically.
4.08 Enzyme Stability on Storage or Freezing
While the above reaction looked at the stability of the biocatalyst on incubation, it is also 
important for the bioprocess engineer to look at its stability upon storage. Once the 
biocatalyst has been produced, it is important to be able to store it such that activity is not 
lost, otherwise biocatalyst will have to be made afresh every time it is needed. Such a 
situation would not be ideal, and would mediate against the choice of biological catalysts 
when designing a synthetic process.
Three options are analysed for storage of the biocatalytic extract. These are storage at 
room temperature 25 °C, or at 4 °C or frozen at -20 °C. The extracts were prepared as
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Figure 4.5. Apparent specific rate of activity of DOX-P Synthase after pre­
incubation in reaction buffer at 37 °C.
Soluble cell fraction extracted from E. coli BL21 pCC16. Pre-incubation buffer: 50 mM 
Tris.HCl(aq) buffer, pH 7.0, with 9 mM MgCl2, 1 mM TPP, 1 mM DTT and 0.1 mM 
PMSF. 50 pL soluble cell fraction, containing 140 pg.mL'1 DOX-P Synthase, added in 
0.5 mL pre-incubation buffer. Incubated for time stated at 37 °C. 0.5 mL 2X reaction 
mix then added: 40 mM DL -glyceraldehyde / 20 mM pyruvate in 50 mM Tris.HCl(aq) 
buffer, pH 7.0, with 9 mM MgCl2, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 
Incubated for 24 h at 37 °C. 150 pL samples taken at 0 h; 1 h; 4 h; and 24 h. Diluted 1:1 
with 0.2% TFA. Analysed by HPLC using Aminex 87H column at 60°C, mobile phase 
0.1% TFA, flow rate 0.6 m L.m in1. UV detection with Dionex AD20 UV detector 
module; electrochemical detection with Dionex ED40 electrochemical detector module. 
Peak areas at 9.7 min on UV trace (pyruvate); 11.6 min on ECD trace (glyceraldehyde); 
and 12.2 min on ECD trace (1-deoxyxylulose), integrated and converted to substrate 
concentrations using Chromeleon 6.0 HPLC software, (Dionex). Timecourse of substrate 
turnover plotted, and initial rate o f pyruvate turnover calculated. From DOX-P Synthase 
concentration in extract, an apparent specific activity for the enzyme was calculated for 
each set o f conditions, as plotted above. Reactions were carried out in triplicate.
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previously described in 2.03.7.2. The final extract was then stored for 1 week at 25 °C, 4 
°C or -20 °C. No cryoprotectant such as glycerol was used, so as not to interfere in any 
way with enzyme activity. The activity of the extracts was then assessed as before. The 
results are shown in Figure 4.6, and compared against the activity found with freshly 
prepared biocatalyst.
Figure 4.6 clearly shows that storage at room temperature 25 °C, or even refrigerated at 
4 °C, for 1 week is unsuitable for storage of the biocatalyst. Activity of the extract 
completely disappears in these circumstances. Equally it can be seen that storage at 
-20 °C is in fact suitable for the extract, for at least a week, as in this case no activity 
seems to be lost. That glycerol is not necessary, at least for a 1 -week storage, saves the 
need for further steps in biocatalyst production, although it is possible that a 
cryoprotectant such as glycerol might be needed for longer term storage.
4.09 Activity of DOX-P Synthase Extract Upon Alternative Substrates
In describing the properties of DOX-P Synthase, in order to advertise its utility as a 
useful catalyst for industrial synthetic processes, it is necessary to go beyond the normal 
reaction it catalyses within the cell. Whilst the synthesis of l-deoxy-D-xylulose-5- 
phosphate, or just 1-deoxy-D-xylulose, may indeed be the process a chemical or 
biochemical engineer is looking to design, DOX-P Synthase would be a far more useful 
catalyst if  it could be used to catalyse the formation of similar, but different products. 
For example, if the engineer wants to design a process which involves the formation of
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Figure 4.6. Apparent specific rate of activity of DOX-P Synthase after 1-week 
storage at various temperatures, compared with that of freshly prepared DOX-P 
Synthase extract.
Soluble cell fraction extracted from E. coli BL21 pCC 16. Used immediately for freshly 
prepared extract, or stored for 1 week at temperature stated. Reaction mix: 20 mM 
DL -glyceraldehyde / 10 mM pyruvate in 50 mM Tris.HCl(aq) buffer, pH 7.0, with 9 mM 
MgCl2, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell fraction, 
containing 140 pg.m L1 DOX-P Synthase, added in 1 mL reaction mix. Incubated for 24 
h at 37 °C. 150 pL samples taken at 0 h; 1 h; 4 h; and 24 h. Diluted 1:1 with 0.2% TFA. 
Analysed by HPLC using Aminex 87H column at 60°C, mobile phase 0.1% TFA, flow 
rate 0.6 mL.min'1. UV detection with Dionex AD20 UV detector module; 
electrochemical detection with Dionex ED40 electrochemical detector module. Peak 
areas at 9.7 min on UV trace (pyruvate); 11.6 min on ECD trace (glyceraldehyde); and
12.2 min on ECD trace (1-deoxyxylulose), integrated and converted to substrate 
concentrations using Chromeleon 6.0 HPLC software, (Dionex). Timecourse of substrate 
turnover plotted, and initial rate o f pyruvate turnover calculated. From DOX-P Synthase 
concentration in extract, an apparent specific activity for the enzyme was calculated for 
each set o f conditions, as plotted above. Reactions were carried out in triplicate.
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1-deoxyerythrulose, or xylulose, the analysis carried out so far would not help him or her 
decide whether DOX-P Synthase would be a useful catalyst for their purposes. Current 
studies of substrate range of DOX-P Synthase have been limited. The largest study, 
(Schiirmann et a l, 2002), has shown that along with the phosphorylated and non- 
phosphorylated forms of glyceraldehyde, glycolaldehyde, both the phosphorylated and 
non-phosphorylated forms of erythrose also act as keto-acceptors with DOX-P Synthase. 
It was also shown that along with pyruvate, hydroxypyruvate, a-oxobutyrate, 
acetaldehyde and acetoin could also act as keto-donors. Table 4.2 shows the activities 
observed in this study. While the donor range has been well assessed, it can be seen that 
further information on the acceptor range would be desirable.
For this reason the activity of the DOX-P Synthase extract was then assessed with respect 
to various substrates with slight structural modifications from DL-glyceraldehyde. As 
alternative acceptors, both D- and L-glyceraldehyde are looked at separately; chain- 
shortened glycolaldehyde; unhydroxylated propionaldehyde; chain-lengthened D- 
erythrose, D-glucose and D-mannose; and aromatic benzaldehyde. In addition, following 
the previously described study, two alternative donors to pyruvate are also assessed: 
acetaldehyde and hydroxypyruvate. Use of hydroxypyruvate enables an interesting 
comparison with transketolase. The structures of these alternative substrates are shown 
in Table 4.3, for comparison with the native substrates.
The course of the reactions catalysed by DOX-P Synthase, with the above mentioned 
substrates, were followed, as before, by HPLC. Because rates were frequently very low,
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Acceptor Vre. (%)
D-G lycera ldehyde-3- 100
Phosphate
D-Glyceraldehyde 100
Glycolaldehyde 71
D-Erythrose-4-Phosphate 84
D-Erythrose 17
Donor Vrel (%)
Pyruvate 100
Hydroxypyruvate 7.2
a-Oxobutyrate 1.5
Acetaldehyde 0.7
Acetoin 0.9
Table 4.2. Relative enzyme activity of DOX-P Synthase, Vrei9 as measured by 
Schiirmann, et al. (2002).
100% measured as 4.3 U/mg with D-Glyceraldehyde-3-phosphate and pyruvate.
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Acceptors:_______
i. D-Glyceraldehyde v. D-Erythrose
OHOH
H
OH OH OH
ii. L-Glyceraldehyde vi. D-Glucose
OH OH OH
H H
OH OH OH OH
iii. Glycolaldehyde vii. D-Mannose
OH OH
H H
OH OH OH OH
iv. Propionaldehyde viii. Benzaldehyde
CH
H
Donors:
i. Pyruvate iii. Acetaldehyde
OOC CH CH.
ii. Hydroxypyruvate
OOC
OH
Table 4.3. Structures of alternative substrates.
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Acceptor % Turnover
DL-Glyceraldehyde 50
D-Glyceraldehyde 100
L-Glyceraldehyde 0
Glycolaldehyde 32
Propionaldehyde 0
D-Erythrose 70
D-Glucose 0
D-Mannose 0
Benzaldehyde 0
Donor % Turnover
Pyruvate 100
Hydroxypyruvate 0
Acetaldehyde n/a
Table 4.4. Percentage substrate turnover with DOX-P Synthase extract in 24 h, for 
variety of acceptor and donor substrates.
Soluble cell fraction extracted from E. coli BL21 pCC16. Reaction mix: 10 mM stated 
acceptor substrate, (except 20 mM for DL -glyceraldehyde) /10  mM pyruvate, or 10 mM 
stated donor substrate / 20 mM DL-glyceraldehyde, in 50 mM Tris.HCl(aq) buffer, pH 7.0, 
with 9 mM MgCL, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell 
fraction, containing 140 pg.mL'1 DOX-P Synthase, added in 1 mL reaction mix. 
Incubated for 24 h at 37 °C. 150 pL samples taken at 0 h and 24 h. Diluted 1:1 with 
0.2% TFA. Analysed by HPLC using Aminex 87H column at 60°C, mobile phase 0.1% 
TFA, flow rate 0.6 mL.min"1. UV detection with Dionex AD20 UV detector module; 
electrochemical detection with Dionex ED40 electrochemical detector module. Peak 
areas on UV trace at 8.2 min (hydroxypyruvate); and 9.7 min (pyruvate). Peak areas on 
ECD trace at 9.4 min (glucose); 9.9 min (mannose); 11.1 min (propionaldehyde); 11.2 
min (benzaldehyde); 11.6 min (glyceraldehyde); 11.7 min (erythrose); and 12.2 min (1- 
deoxyxylulose). Integrated and converted to substrate concentrations using Chromeleon 
6.0 HPLC software, (Dionex). Percentage turnover of stated substrate after 24 h 
recorded. Reactions were carried out in triplicate.
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turnover at 24 h was compared for the various reactions. The results for each reaction are 
shown in Table 4.4, with the table showing the amount of substrate turnover, expressed 
as a percentage. (No significant loss of substrate was observed for any of the substrates, 
when water or untransformed E. coli BL21 was added instead of extract). It can be seen 
that, as previously observed by Schurmann, et a l , glycolaldehyde and erythrose act well 
as keto acceptors. However, for all of the additional substrates used, zero enzyme 
activity was observed. It was found not to be possible to follow acetaldehyde turnover 
with this assay. The results are discussed below.
4.10 Discussion of substrate range
D- and L-Glyceraldehyde
As expected, D-glyceraldehyde proves to be the active substrate of DOX-P Synthase, 
rather than L-glyceraldehyde, which proves not to function as a substrate. That activity 
with DL- and D-glyceraldehyde are equal would suggest that L-glyceraldehyde does not 
act as an inhibitor in any way. We can conclude that DOX-P Synthase is stereospecific 
in its choice of D-glyceraldehyde as a substrate, and that L-glyceraldehyde is not an 
inhibitor.
Glycolaldehyde and D-Erythrose
Glycolaldehyde and erythrose represent a modification to the native substrate, 
glyceraldehyde, through respectively shortening or lengthening the carbon chain 
backbone of the substrate molecule by one carbon atom. Relative turnover of these
C M Chudziak 175
Production. Characterisation and Modification of DOX-P Synthase as a Biocatalvst
"modified" substrates were measured at 32 % and 70 % respectively. This is in contrast 
to the relative rate o f  turnover seen in the previous study by Schurmann, et a l, which 
showed a relative rate for the two substrates o f 71 % and 17 % respectively. This 
difference may be attributable to the different measure being used - that of initial rate of 
turnover, as opposed to total turnover after 24 h. However, while these are two different 
measures, one might normally expect a higher rate of turnover, to be translated into 
higher turnover, although it is possible that product inhibition may occur over the 
extended period. Alternatively the difference may be through use of different conditions 
for buffer or cofactor concentration, (not described in the paper). In general qualitative 
terms however, the story is the same - DOX-P Synthase is active for both substrates, but 
at a lower level than with the native substrates.
D-Glucose and D-Mannose
Glucose and Mannose are six-carbon aldose sugars, represnting a further lengthening of 
glyceraldehde from the four-carbon aldose sugar, erythrose, analysed above. D-Glucose 
has the same stereoconformation to substrate D-glyceraldehyde at the Carbon position 
proximate to the aldehyde group, while D-mannose has the same stereoconformation to 
the non-substrate L-glyceraldehyde at the Carbon position proximate to the aldehyde 
group. We might not therefore be surprised if we were to find DOX-P Synthase to 
exhibit differential activity to the two substrates. However, analysis of these two sugars 
as DOX-P Synthase substrates shows DOX-P Synthase to be inactive towards both of 
them. This would suggest that the lengthened backbone may prevent DOX-P Synthase
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from acting on the molecule. Such an effect could occur if the substrates were no longer 
of the correct size to be able to fit into the active site of the DOX-P Synthase enzyme.
Propionaldehyde and Benzaldehyde
Propionaldehyde and benzaldehyde, unlike the substrates analysed above, are not sugars, 
and are not hydroxylated as the other substrates are. Both turn out to be inactive as 
DOX-P Synthase substrates. Benzaldehyde may be completely the wrong shape for the 
DOX-P Synthase enzyme active site, but propionaldehdye is of the same chain length as 
glyceraldehyde. This would suggest the importance of the hydroxyl groups in the 
catalytic process, possibly in terms of binding the active site.
Hydroxypyruvate
Hydroxypyruvate is the 3-hydroxylated form of pyruvate, and is the keto-donor used by 
transketolase. Schiirmann, et al. observed a 7.2 % rate of turnover with DOX-P 
Synthase, using hydroxypyruvate and D-glyceraldehyde-3-phosphate as substrates. In 
this study no reaction with hydroxypyruvate was observed. This is difficult to explain, 
but may be due to using the non-phosphorylated glyceraldehyde as the acceptor substrate 
here, or, as mentioned before, could be due to other possible differences in the reaction 
conditions, such as buffer or cofactor concentration.
Acetaldehyde
Acetaldehyde is the simplest molecule with a 2-carbon keto group which could be 
transferred to the acceptor substrate, glyceraldehyde. Schurmann, et al. observed a 0.7 %
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rate of turnover with DOX-P Synthase, using acetaldhyde with D-glyceraldehyde-3- 
phosphate as substrates. However, acetaldehyde was seen here to create many random 
peaks in the HPLC trace, suggesting that acetaldehyde, as a particularly reactive 
compound, is participating in many, various side reactions, possibly with components of 
the extract. Further purification of the enzyme may help here.
4.11 Comparison of DOX-P Synthase Activity with Transketolase
This characterisation of DOX-P Synthase enables us to compare the enzyme as a 
biocatalyst with transketolase, our starting point. Previous studies of E. coli transketolase 
have shown a pH optimum of 8.5, and an optimal temperature of 30 °C. E. coli DOX-P 
Synthase is shown to differ here, with a pH optimum of 7.0 - 7.5, and an optimal 
temperature of 42 °C.
Rate o f  Reaction with Transketolase
Most importantly, perhaps, DOX-P Synthase seems to be a significantly less active 
enzyme than transketolase. Previous studies of DOX-P Synthase have reported a specific 
activity for E. coli DOX-P Synthase of 4.3 pmol.min'.mg'1, whilst that for E. coli 
transketolase has been recorded at 50.4 pmol.min^.mg"1. Using the biocatalyst as 
prepared in this study, an apparent specific activity of 1.50 pmol.min^.mg’1 was 
observed. This was calculated from an observed rate of turnover with the conditions used 
of 0.64 m M .h1, which will now be compared with a transketolase extract prepared and 
assayed in exactly the same way.
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The transketolase was prepared from the TK expression strain, E. coli JM107 pQR183, 
(2.01.2.4). Cultures were grown up and biocatalyst extract harvested exactly as 
previously described for the DOX-P Synthase expression strain, E. coli BL21 pCC16, 
(2.03.7.2). SDS-PAGE analysis of the extract, using optical densitometry, showed 
transketolase in the JM107 pQR183 extract to be abundant in approximately 3 times 
greater quantity than DOX-P Synthase is in the BL21 pCC16 extract. Initial rate of 
turnover with this extract was then assayed with the comparable substrates, 
glyceraldehyde and hydroxypyruvate, using exactly the same assay method and reaction 
conditions as used for the DOX-P Synthase extract, albeit non-optimal conditions for TK. 
The extract was assayed as a freshly prepared extract, and as a 1/3 dilution representing 
equivalent amount of enzyme present as with DOX-P Synthase. The results are shown in 
Figure 4.7, where initial rate of hydroxypyruvate turnover with TK is compared to initial 
rate of pyruvate turnover with DOX-P Synthase. These showed that in equivalent 
conditions, transketolase extract could catalyse turnover of substrate at 4.74 mM.h'1, or 
approximately 7.5 times the rate at which DOX-P Synthase extract can. Diluted TK 
extract could catalyse turnover of substrate at 1.64 mM.h'1, or approximately 2.5 times 
the rate per unit of protein. To improve the activity of the DOX-P Synthase extract, such 
that it is more like that of the TK extract, firstly the expression system could be improved 
to increase the level of protein production to be comparable with that of TK. For 
example an expression system similar to that with transketolase in E. coli JM107 pQR183 
could be used. (In this system, TK expression is driven from the strong native tkt 
promoter). While this area of research is being approached in other studies, the next
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■ DOX-P Synthase Extract
■ TK Extract
□  Diluted TK Extract
Figure 4.7. Initial rates of reaction observed for DOX-P Synthase extract; 
Transketolase extract; and 1/3 Diluted Transketolase extract.
DOX-P Synthase soluble cell fraction extracted from E. coli BL21 pCC16. TK soluble 
cell fraction extracted from E. coli JM107 pQR183. Diluted extract diluted l-in-3 in 
extraction buffer. Reaction mix: 20 mM DL -glyceraldehyde / 10 mM pyruvate in 50 
mM Tris.HCl(aq) buffer, pH 7.0, with 9 mM MgCl2, 1 mM TPP, 1 mM DTT and 0.1 mM 
PMSF for DOX-P Synthase. Reaction mix: 20 mM DL-glyceraldehyde / 10 mM 
hydroxypyruvate in 50 mM Tris.HCl(aq) buffer, pH 8.0, with 9 mM MgCl2, 1 mM TPP, 1 
mM DTT and 0.1 mM PMSF for TK. 50 pL soluble cell fraction added in 1 mL reaction 
mix. Incubated for 24 h at 37 °C. 150 pL samples taken at 0 h; 1 h; 4 h; 6 h; and 24 h. 
Diluted 1:1 with 0.2% TFA. Analysed by HPLC using Aminex 87H column at 60°C, 
mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. UV detection with Dionex AD20 UV 
detector module; electrochemical detection with Dionex ED40 electrochemical detector 
module. Peak areas at 8.2 min on UV trace (hydroxypyruvate); 9.7 min on UV trace 
(pyruvate); 10.3 min on ECD trace (xylulose); 11.6 min on ECD trace (glyceraldehyde); 
and 12.2 min on ECD trace (1-deoxyxylulose), integrated and converted to substrate 
concentrations using Chromeleon 6.0 HPLC software, (Dionex). Timecourse of substrate 
turnover plotted and initial rate of pyruvate or hydroxypyruvate turnover calculated. 
Reactions carried out in triplicate.
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Chapter of this thesis will look one step further, at methods for increasing the activity 
found per unit of protein, i.e. to improve the activity of the DOX-P Synthase enzyme 
itself. This could also be used to improve the substrate range of DOX-P Synthase to be 
more like that of transketolase.
Substrate Range o f Transketolase
Whilst transketolase carries out a very similar reaction to DOX-P Synthase, studies on the 
substrate specificity of transketolase show it to be able to turn over a much broader 
variety of substrates, (Hobbs et ah, 1993). This is shown in Table 4.5.
This is most likely because transketolase has evolved to catalyse a number of different, 
but similar reactions in the cell, using any of glyceraldehyde-3-phosphate, erythrose-4- 
phosphate or ribose-5-phosphate as ketol acceptors; and any of xylulose-5-phosphate, 
fructose-6-phosphate or sedoheptulose-7-phosphate as ketol donors. To achieve this 
broad natural substrate range must have required a certain flexibility in the ability of the 
enzyme’s active site to bind these substrates. This flexibility in turn may lend itself well 
to accepting other similar substrates. DOX-P Synthase on the other hand seems to have 
evolved solely to use glyceraldehyde-3-phosphate as keto-acceptor, and pyruvate as keto- 
donor. DOX-P Synthase may therefore not have been required to evolve the same 
flexibility as transketolase, in turn leaving it with reduced ability to bind non-natural 
substrates. The next Chapter of this thesis will then also look at methods for increasing 
the substrate range of DOX-P Synthase.
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A ccep to r
S u b stra te
T r a n sk e to la se  Vrei 
(%)
DL-Glyceraldehyde 37
Glycolaldehyde 100
Propionaldehyde 20
D-Erythrose 89
D-Glucose 14
D-Mannose 3
Benzaldehyde 4
Table 4.5. Relative enzyme activity of Transketolase, Frei, towards alternative 
acceptor substrates, as measured by Hobbs, etal. (1993).
Vrei measured as percentage of maximum activity, measured with glycolaldehyde as 
acceptor substrate.
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5 Creation and Characterisation of Modified 1-Deoxy- 
D-Xylulose-5-Phosphate Synthase as a Biocatalyst
5.01 Introduction
At the end of the previous chapter the activity and substrate range of DOX-P Synthase 
were compared with those of the enzyme, transketolase, (TK). DOX-P Synthase 
however, unlike TK, is able to use pyruvate as its keto donor. So DOX-P Synthase does 
still fill a niche in the encyclopaedia of biocatalysts available to that chemical engineer 
designing a process for an industrial synthesis. However, it would be highly desirable if 
DOX-P Synthase also had some more of those characteristics present in transketolase - 
higher rate of activity, and broader substrate range. The reasons for those differences 
between the two enzymes will now be investigated, and attempts made to modify DOX-P 
Synthase to improve its performance to be more in line with that of TK. In the process 
another key difference between the two enzymes will also be investigated: why one 
enzyme utilises pyruvate, and the other hydroxypyruvate.
5.02 Rational Enzyme Redesign
As discussed in 1.05.04, the specificity of TK is controlled by the interactions formed 
between the substrates and the enzyme, as with all enzyme-controlled reactions. X-ray 
crystallography and site-directed mutagenesis have elucidated the nature and importance 
of some of these interactions, (Nikkola et al., 1994;Wikner et al., 1995;Nilsson et a l,
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1997;Schneider et al., 1998;Fiedler et al., 2002). This has enabled subsequent research 
into altering the specificity of TK, by rational site-directed mutagenesis. This has 
enabled the generation of TK mutants capable of accepting larger, aromatic substrate 
aldehydes, or even L-aldoses rather than D-aldoses. (Bacon, 2001).
It is hoped here to rationally alter the similar enzyme DOX-P Synthase to be more like 
TK in some of its attributes - namely higher rate of activity and broader substrate range. 
This could be done by looking for differences in the active sites of both enzymes. 
Unfortunately, until after the completion of this work, (Xiang et al., 2007), no X-ray 
crystal structure of DOX-P Synthase existed, which would have enabled a look at the 
enzyme's active site. Instead the process here will begin with a comparison of the protein 
sequences of the two enzymes. The conclusions will be discussed in the light of the 
recently published crystal structure in the Discussion, Chapter 6 of this thesis.
5.03 Sequence Comparison of Transketolase and DOX-P Synthase
The protein sequence of DOX-P Synthase is known from its DNA sequence. Alignment 
of the E. coli TK and DOX-P Synthase amino acid sequences by ClustalW alignment, 
(Chenna et al., 2003), revealed the two sequences to have 44% similarity of residues. 
This alignment is shown in Figure 5.1. This level of protein sequence identity is usually 
taken to indicate the proteins have similar structure, (Rost, 1999). Given the similarity of 
the reactions catalysed, a similarity of catalytic mechanism might well be expected, and 
hence a similarity of enzyme structure. Moreover the level of similarity increases around
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CLUSTAL W ( 1 . 8 2 )  m u l t i p l e  s e q u e n c e  a l i g n m e n t
COLI-TKT
COLI-DXS
 MSSRKELAN-AIRALSMDAVQKAKSGHPGAPMGMADIAEVLWRDFLKHNPQNPSWAD 5 6
MSFDIAKYPTLALVDSTQELRLLPKESLPKLCDELRRYLLDSVSRSSGHFASGLGTVELT 6 0
COLI-TKT
COLI-DXS
RDRFVLSNGHGSMLIYSLLHLTGYDLPMEELKNFRQLHSKTPGHPEVGYTAGVETTTGPL 1 1 6  
VALHYVYNTPFDQLIWDVGHQAYPHKILTGRRDKIGTIRQKGGLHPFPWRGESEYDVLSV 1 2 0
COLI-TKT
COLI-DXS
GQG- IANAVGMAIAEKTLAAQFNRPGHDIVDHYTYAFMGDGCMMEGISHEVCSLAGTLKL 1 7 5
GHSSTSISAGIGIAVAAEKEGKNRR----------------- TVCVIGDGAITAGMAFEAMNHAGDIRP 1 7 2
* • ★ •★★★ ★•• ★ ★★ ••
COLI-TKT
COLI-DXS
GKLIAFYDDNGISI DGHVEGWFTDDTAMRFEAYGWHVIRD IDG -  HDAASIKRAVEEARAV 2 3 4  
- DMLVILNDNEMSI S --------------------------------------------------------------- ENVGALNNHLAQLLSG 2 0 2
COLI-TKT
COLI-DXS
TDKPSLLMCKTIIGFGSPNKAGTHDSHGAPLGDAEIALTREQLGWKYAP-FEIPSEIYAQ 2 9 3
K--------------------------LYSSLREGGKKVFSGVPPIKELLKRTEEHIKG----------MWPGTLFEE 2 4 5
• *  * • *  ★ • ••
COLI-TKT
COLI-DXS
WDAKEAG- -QAKES -  -  AWNEKFAAYAKAYPQEAAEFTRRMKGEMPSDFDAKAKEFIAKLQ 3 4 9  
LGFNYIGPVDGHDVLGLITTLKNMRDLKGPQFLHIMTKKGRGYEPAEKDPITFHAVPKFD 3 0 5
*  • . . . .  * * . . .  *
COLI-TKT
COLI-DXS
ANPAKIASRKASQNAIEAFGPLLPEFLGGSADLAPSNLTLWSGSKAINEDAAGN---------------4 0 3
P S  SGCLPKSSGGLPSYSKIFGDWLCETAAKDNKLMAITPAMREGSGMVEFSRKFPDR 3 6 2
COLI-TKT
COLI-DXS
YIHYGVREFGMTAIANGISLHGG-FLPYTSTFLMFVEYARNAVRMAALMKQRQVMVYTHD 4 62  
YFDVAIAEQHAVTFAAGLAIGGY— KPIVAIYSTFLQRAYDQVLHDVAIQKLPVLFAIDR 4 2 0
COLI-TKT
COLI-DXS
SIGLGEDGPTHQPVEQVASLRVTPNMSTWRPCDQVESAVAWKYGVERQDGPTALILSRQN 5 2 2  
AGIVGADGQTHQGAFDLSYLRCIPEMVIMTPSDENECRQMLYTGYHYNDGPSAVRYPRGN 4 8 0  
. *  * *  * * *  • •  •*
COLI-TKT
COLI-DXS
LAQQERTEEQLANIARGGYVLKDCAGQPELI FIATGSEVELAVAAYEKLTAEGVKARWS 5 8 2  
AVGVELTPLEKLPIGKG-- IVKRRGE- - KLAILNFGTLMPEAAKVAESLNATLVDMRFVK 5 3 6
COLI-TKT
COLI-DXS
MS S TD AFDKQD AAYRE S VL PKAVT ARVAVEAGI AD YWYKYVGLNGAI VGMTTFGESA- P 6 4 0  
PLDEALILEMAASHEALVTVEENAIMGGAGSGVNEVLMAHRKPVPVLNIGLPDFFIPQGT 5 9 6
COLI-TKT
CO LI-DXS
AELLFEEFGFTVDNWAKAKELL -  - 
QEEMRAE LGLDAAGMEAKIKAWLA-
6 6 3
6 2 0
RED residues non-conserved. 
BLUE residues conserved.
* - Identical residue.
: - Conservative substitution.
. - Semi-conservative substitution.
Figure 5.1. ClustalW alignment of amino acid sequences of Escherichia coli TK and 
DOX-P Synthase.
ClustalW software, (Chenna et al., 2003), at http://www.ebi.ac.uk/clustalw/.
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the TK active site residues. Many of those mechanistically important residues, 
previously observed to be conserved between transketolases from different sources, can 
also be seen to be conserved in DOX-P Synthase. This taken together suggests some of 
those residues which might form parts of the active site of DOX-P Synthase. Whilst this 
does not prove these residues do form part of the active site in DOX-P Synthase, it is now 
possible to begin hypothesising about those residues which may be expected to be 
present.
Since most of the mechanistic work on TK has been carried out with S. cerevisiae TK, 
the results of these studies will be described. However in all cases described, there are 
homologues in E. coli TK. These have been named, and can be observed in the 
determined crystal structure of E. coli TK, (Isupov et al., 1999). The crystal structure 
shows the two enzymes to have the same architecture, and the two sequences themselves 
indicate 46% identity. Despite small differences, for example in Km, there is particularly 
high sequence identity observable within the active site. Figure 5.2 shows a schematic 
diagram, taken from a previous study, (Lindqvist et al., 1992), of the interactions formed 
between TPP and the residues in the active site of S. cerevisiae TK. All these residues 
are conserved in E. coli, as well as many other species, underlining their functional 
importance. The crystal structure of E. coli TK reveals the same active site architecture 
as in S. cerevisiae, with all these key residues being structurally conserved, (Isupov et al., 
1999). Additionally many of these residues, as highlighted later, are also conserved in 
DOX-P Synthase. The two, perhaps, most important residues functionally, are those 
responsible for the initial deprotonation at C2 of the pyrimidine ring. These
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Figure 5.2. Schematic diagram of the interactions of TPP at the cofactor binding site 
of transketolase.
Residues provided by the second subunit indicated by an asterisk. Suggested hydrogen 
bonds indicated by dashed lines. From Lindqvist, et al., 1992. Residues conserved in 
DOX-P Synthase marked by x.
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residues are, as might be expected, conserved. These are residues Glutamate-418 and 
Histidine-481 of S. cerevisiae TK, (Glutamate-411 and Histidine-473 of E. coli TK), and 
are seen to be conserved in E. coli DOX-P Synthase as Glutamate-370 and Histidine-431.
While these residues are responsible for activating TPP, similarly important are those
2 1
residues which are necessary for binding TPP into the active site. The cofactor Mg 
plays a key role in this, chelating the phosphate groups of TPP. Certain enzyme amino 
acid residues are then responsible for this Mg cofactor chelation. Of these, Aspartate- 
157, Glycine-158 and Asparagine-187 of S. cerevisiae TK, (Aspartate-155, Glycine-156 
and Asparagine-185 of E. coli TK), are all clearly conserved in E. coli DOX-P Synthase 
as Aspartate-152, Glycine-153 and Asparagine-181. A full list of key functional residues 
is shown in Table 5.1, showing also the identical residues in both E. coli TK, and where 
present, in E. coli DOX-P Synthase.
Figure 5.3 shows another schematic diagram, taken from (Fiedler et al., 2002), this time 
showing the reactions formed between the reaction intermediate, dihydroxyethyl-TPP and 
the residues of the active site. Again, highlighted on the diagram are the residues 
conserved in DOX-P Synthase. Histidine-103 of S. cerevisiae TK, (Histidine-100 of E. 
coli TK), can be seen to bind the C3 hydroxyl group, which would not be present were 
pyruvate the substrate, as with E. coli DOX-P Synthase. Glycine-116 and Histidine-69 of 
S. cerevisiae TK, (Glycine-114 and Histidine-66 of E. coli TK), can be seen to chelate a 
water molecule, which also helps bind the C3 hydroxyl. Of these residues, only 
Histidine-103 is shown to be conserved in E. coli DOX-P Synthase, as Histidine-105. 
Therefore, of the three C3-hydroxyl-binding residues, only one is present in DOX-P
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S . c e r e v is ia e  TK E . c o l i TK E . c o li  DOX-P Synthase
His 30 His 26 Homologue not present.
His 69 His 66 Homologue not present.
His 103 His 100 His 105
Gly 116 Gly 114 Homologue not present.
Asp 157 Asp 155 Asp 152
Gly 158 Gly 156 Gly 153
Asn 187 Asn 185 Asn 181
lie 191 lie 189 He 185
His 260 His 258 Homologue not present.
His 263 His 261 Homologue not present.
Arg 359 Arg 358 Homologue not present.
Ser 386 Ser 385 Homologue not present.
Glu 418 Glu 411 Glu 370
Phe 445 Phe 437 Phe 395
Asp 477 Asp 469 Asp 427
His 481 His 473 His 431
Table 5.1. List of active site residues in S. cerevisiae TK, showing the homologous 
residues in both E. coli TK, and where present, in E. coli DOX-P Synthase.
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Phe 445
Gly 116 \
His 481
TPP
His 103
A sp 477
His 263
His 30
Figure 5.3. View of the surroundings of the reaction intermediate dihydroxyethyl- 
TPP in the active site of transketolase.
Hydrogen bonds, (distances <3.1 A), indicated by dashed lines. From Fiedler, et al., 
2002 .
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Synthase. This lack of C3 hydroxyl-binding residues could perhaps explain why DOX-P 
Synthase does not accept hydroxypyruvate as a keto donor, and perhaps reintroduction of 
equivalents of these residues could alter DOX-P Synthase to be a pyruvate acceptor too. 
Interestingly, Histidine-481 of S. cerevisiae TK, (Histidine-473 of E. coli TK), the only 
residue suggested to form a specific interaction with that hydroxyl group formed from the 
C2 carbonyl group, is conserved in E. coli DOX-P Synthase, as Histidine-431. Unlike 
the C3 hydroxyl, the C2 carbonyl is present in both hydroxypyruvate and pyruvate, 
allowing the same substrate binding at this position by DOX-P Synthase as with TK.
Of the other residues shown in the schematic to be in the vicinity of the active site, 
Phenylalanine-445 and Aspartate-477 of S. cerevisiae TK, (Phenylalanine-437 and 
Aspartate-469 of E. coli TK), are shown to be conserved in E. coli DOX-P Synthase, as 
Phenylalanine-395 and Aspartate-427. On the other hand, Histidine-30 and Histidine-263 
of S. cerevisiae TK, (Histidine-26 and Histidine-261 of E. coli TK), are not shown to be 
conserved in E. coli DOX-P Synthase. Possibly these changes could prove to be 
unimportant, but alternatively these differences could be found to explain some of the 
functional differences between TK and DOX-P Synthase, such as rate of activity and 
substrate specificity. Those residues not even directly involved in substrate or cofactor 
binding can indeed have a significant effect on enzyme activity, through, for example, 
altering the flexibility or movements of structural elements.
Viewing the E. coli TK X-ray crystal structure, using Accelrys DS Modelling, see Figure 
5.4, other residues present in the close vicinity of the active site, or in the cleft entrance to
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Figure 5.4. View of E. coli transketolase active site.
View created from PDB structure 1QGD, (Isupov et al., 1999), using Accelrys DS 
Modelling, showing centre of active site. Active site located residues shown in stick 
form, rest in space filling form. Cleft residues highlighted in blue.
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the active site, can also be observed. Of these, those which do not seem to have been 
conserved in E. coli DOX-P Synthase are residues Histidine-258, Arginine-358 and 
Serine-385 of E. coli TK. Again, perhaps these differences could also help explain some 
of the observed differences between TK and DOX-P Synthase.
Previous work on TK redesign has also shown the importance of other residues more 
distant from the active site, but which form part of the cleft walls leading into the active 
site. These can play an important part in dictating substrate specificity. For example the 
side chain of Isoleucine-189 in E. coli TK juts out into this cleft. Shortening the side 
chain of this residue, by mutation to valine or alanine, was shown to increase TK activity 
towards larger aldehyde acceptors, such as pyridinecarboxaldehydes. Presumably, 
previously the side chain of Isoleucine-189 was preventing such larger aldehydes from 
entering the active site. Interestingly, Isoleucine-189 is conserved in E. coli DOX-P 
Synthase as Isoleucine-185. Perhaps it similarly prevents larger aldehydes from entering 
the active site of DOX-P Synthase. The successful alteration of TK activity through 
mutagenesis suggests similar success might be possible through mutagenesis of DOX-P 
Synthase. All of those DOX-P Synthase mutants which might be interesting or useful to 
produce are now considered.
5.04 Identification of Mutations
In 5.03 above, various residues of the TK active site have been pinpointed which do not 
seem to have functional equivalents in DOX-P Synthase, as concluded from protein
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sequence alignment. Of the E. coli TK residues, these are the C3-hydroxyl-binding 
residues, Histidine-66 and Glycine-114; and other residues local to the active site, 
Histidine-26, Histidine-258, Histidine-261, Arginine-358, and Serine-385.
It is hypothesised here, that the lack of equivalents of these TK residues in DOX-P 
Synthase is, at least in part, responsible for some of the differences in activity between 
TK and DOX-P Synthase. These differences being firstly, the preference of DOX-P 
Synthase for pyruvate, as opposed to hydroxypyruvate with TK; the higher rate of 
activity of TK; and the broader substrate range of TK. This hypothesis will be explored 
by attempting to introduce equivalents of these TK residues into the DOX-P Synthase 
structure, by site-directed mutagenesis. Lacking an X-ray crystal structure for DOX-P 
Synthase, the first step then is to work out where these equivalents should best be 
introduced, for them to be present in a structurally equivalent location. This shall be 
done by looking for alignment of conserved residues surrounding the absent residue in 
question. Alignments of the areas surrounding each of these areas are shown in more 
detail in Figure 5.5, enabling an estimation of structurally where best to introduce the 
residues in question.
For example, an estimate has been made that Leucine-28 of DOX-P Synthase is in an 
equivalent position, with respect to the substrates and active site, to Histidine-26 of TK. 
Altering this leucine residue to a histidine, may therefore introduce a Histidine-26 
functional equivalent, and perhaps alter DOX-P Synthase to be functionally more like 
TK. Leucine-28 has been selected as, like Histidine 26, it is flanked by conserved Serine
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i. Histine-26 
COLI-TKT 
COLI-DXS
AKSGHPGA
PKESLPKL
ii. Histine-66
COLI-TKT
COLI-DXS
VLSNGHGSMLI
YVYNTPFDQLI
iii. Glycine-114
COLI-TKT
COLI-DXS
AGVETTTGPLGQ
GESEYDVLSVGH
iv. Histine-258 and Histine-261
COLI-TKT
COLI-DXS
SPNKAGTHDSHGAPL
SLREGGKKVFSGVPP
v. Arginine-358 
COLI-TKT
COLI-DXS
PAKIASRKASQNAI
PSSGCLPKSSGGLP
vi. Serine-385
COLI-TKT
COLI-DXS
DLAPSNLTLWS
AAKDNKLMAIT
RED selected active site residue.
PIN K  residues selected for mutagenesis. 
BLUE residues identical.
G REEN  residues similar.
Figure 5.5. Partial alignments of E. coli DOX-P Synthase sequence with E. coli TK 
sequence showing selected active site residues.
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and Proline residues; (for Leu28, at the (n-2) and (n+1) positions respectively). The 
L28H mutant would then be characterised as has wild-type DOX-P Synthase, looking for 
any increase in rate of substrate turnover or widened substrate range.
For each of the TK residues to be introduced, however, it is always difficult to estimate 
exactly which DOX-P Synthase residue might be occupying the equivalent structural 
position. For these reasons, in each case, more than one DOX-P Synthase residue has 
been nominated for alteration, usually aiming not to select changes which might be so 
drastic such that they might be more likely to have a significant detrimental effect on 
folding.
In addition to the residues selected for mutagenesis in this way, two other DOX-P 
Synthase alterations suggest themselves, in order to mirror the shortening of Isoleucine- 
189 as demonstrated on E. coli TK. This residue is conserved as Isoleucine-185 in 
DOX-P Synthase, so this residue will also be altered by site-directed mutagenesis, to 
either alanine or valine.
This suggests the full list of mutations shown in Table 5.2. The four mutations, P70H, 
F71H, VI17G, and LI 18G, are designed to alter the substrate range of DOX-P Synthase 
to accept hydroxypyruvate. Whilst a DOX-P Synthase which accepted hydroxypyruvate 
might not be immediately useful as a synthetic tool, since TK is already available for this 
task, these mutants could give us useful information about how DOX-P Synthase and TK 
discriminate between pyruvate and hydroxypyruvate. The two mutations, I I85A and
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E . c o li TK Role E . c o li dxs mutants
His 26 
His 66 
Gly 114 
lie 189
His 258 / His261 
Arg 358 
Ser 385
Ketol Binding Pocket 
Hydroxyl Binding Residue 
Hydroxyl Binding Residue 
Cleft Residue 
Ketol Binding Pocket 
Ketol Binding Pocket 
Ketol Binding Pocket
L28H; K30H 
P70H; F71H 
VI17G; LI 18G 
I185A; I185V
K213H; K214H; V215H; F216H 
L311R; P312R; K313R 
D336S; N337S; K338S
Table 5.2. Full list of mutations of DOX-P Synthase to be created.
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1185V, are designed to alter the substrate range to accept bulkier substrates. The other 
mutations are designed to alter the architecture of the DOX-P Synthase active site such 
that it is more like that of TK, in the hope that this might lend DOX-P Synthase some of 
the characteristics of TK, such as higher activity and broader substrate range.
5.05 Creation of Mutants
The 18 suggested DOX-P Synthase mutants were to be created by site-directed 
mutagenesis by PCR amplification, as described in 2.03.1.4. The stages of this process 
are: 1. production and isolations of methylated plasmid DNA; 2. PCR amplification of 
whole plasmid using oligonucleotide primers; 3. Dpril digestion of methylated non­
mutated parental plasmid DNA template; 4. ligation of nicked ends of mutated PCR 
produced plasmid; 5. transformation of mutated plasmid into E. coli DH5a to produce 
colonies of E. coli DH5a carrying the mutated plasmid. This process is shown in 
diagrammatical form in Figure 5.6. Following this, cultures of the transformed E. coli 
were grown in liquid broth to demonstrate protein production and to produce and isolate 
larger quantities of mutated plasmid for DNA sequencing. DNA sequencing of the whole 
gene would verify that the plasmids carried the desired mutation, but not any undesirable, 
unexpected mutations.
The oligonucleotide primers used are shown in Figure 5.7. Of the 18 desired mutants, 13 
were successfully made. The PCR reactions to produce P70H, V215H and L311R 
mutants could not be successfully carried out to produce any colonies. The PCR
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1. Mutant s trand  syn thesis
Perform thermal cycling to:
• denature DNA template
• anneal mutagenic primers 
containing desired mutation
• extend and incorporate primers 
with PfuUftra DNA polymerase
2. Dpn\ d igestion  of tem plate
Digest parental methylated and 
hemimethylated DNA with Dpni
3. Transform ation
Transform mutated molecule 
mto competent cells for n ek repair
Figure 5.6. Diagram explaining Site-Directed Mutagenesis.
Taken from QuikChange manual, Invitrogen.
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i. L28H Forward and Reverse primers:
CGACTGTTGCCGAAAGAGAGTCATCCGAAACTCTGCGACG
CGTCGCAGAGTTTCGGATGACTCTCTTTCGGCAACAGTCG
ii. K30H Forward and Reverse primers:
GCCGAAAGAGAGTTTACCGCATCTCTGCGACGAACTGCGCCGC
GCGGCGCAGTTCGTCGCAGAGATGCGGTAAACTCTCTTTCGGC
iii. P70FI Forward and Reverse primers:
GTCTACAACACCCACTTTGACCAATTGATTTGGG
CCCAAATCAATTGGTCAAAGTGGGTGTTGTAGAC
iv. F71H Forward and Reverse primers:
GTCTACAACACCCCGCATGACCAATTGATTTGGG
CCCAAATCAATTGGTCATGCGGGGTGTTGTAGAC
v. VI17G Forward and Reverse primers:
GCGAATATGACGGATTAAGCGTCGGGC
GCCCGACGCTTAATCCGTCATATTCGC
vi. LI 18G Forward and Reverse primers:
GCGAATATGACGTAGGAAGCGTCGGGCATTCATCAACCTCC
GGAGGTTGATGAATGCCCGACGCTTCCTACGTCATATTCGC
vii. 1185A Forward and Reverse primers:
CGACAATGAAATGTCGGCTTCCGAAAATGTCGGCGCGC
GCGCGCCGACATTTTCGGAAGCCGACATTTCATTGTCG
viii. 1185V Forward and Reverse primers:
CGACAATGAAATGTCGGTTTCCGAAAATGTCGGCGCGC
GCGCGCCGACATTTTCGGAAACCGACATTTCATTGTCG
ix. K213H Forward and Reverse primers:
GCGCGAAGGCGGGCATAAAGTTTTCTCTGGCG
CGCCAGAGAAAACTTTATGCCCGCCTTCGCGC
x. K214H Forward and Reverse primers:
GCGCGAAGGCGGGAAACATGTTTTCTCTGGCGTGCCGCC
GGCGGCACGCCAGAGAAAACATGTTTCCCGCCTTCGCGC
xi. V215FI Forward and Reverse primers:
GCGCGAAGGCGGGAAAAAACATTTCTCTGGCGTGCCGCC
GGCGGCACGCCAGAGAAATGTTTTTTCCCGCCTTCGCGC
xii. F216H Forward and Reverse primers:
GCGCGAAGGCGGGAAAAAAGTTCACTCTGGCGTGCCGCC
GGCGGCACGCCAGAGTGAACTTTTTTCCCGCCTTCGCGC
xiii. L 311R Forward and Reverse primers:
CCCTCCAGCGGTTGTAGGCCGAAAAGTAGCGGCGG
CCGCCGCTACTTTTCGGCCTACAACCGCTGGAGGG
xiv. P312R Forward and Reverse primers:
CCCTCCAGCGGTTGTTTGCGGAAAAGTAGCGGCGG
CCGCCGCTACTTTTCCGCAAACAACCGCTGGAGGG
xv. K313R Forward and Reverse primers:
CCCTCCAGCGGTTGTTTGCCGAGAAGTAGCGGCGG
CCGCCGCTACTTCTCGGCAAACAACCGCTGGAGGG
xvi. D336S Forward and Reverse primers:
GT GC GAAAC GGCAGC GAAAT C CAAC AAGC T GAT GGC G 
CGCCATCAGCTTGTTGGATTTCGCTGCCGTTTCGCAC
xvii. N337S Forward and Reverse primers:
GTGCGAAACGGCAGCGAAAGACAGCAAGCTGATGGCG
CGCCATCAGCTTGCTGTCTTTCGCTGCCGTTTCGCAC
xviii. K338S Forward and Reverse primers:
GTGCGAAACGGCAGCGAAAGACAACAGCCTGATGGCGATTACTCCGG
CCGGAGTAATCGCCATCAGGCTGTTGTCTTTCGCTGCCGTTTCGCAC
RED residues denote site o f introduced mutation.
Figure 5.7. Full list of primers for Site-Directed Mutagenesis.
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reactions to produce R337S and K338S mutants did successfully produce colonies, but in 
no cases was mutant plasmid successfully generated, only parental DNA was present.
5.06 Production of Modified DOX-P Synthase
Once mutant DOX-P Synthase expression plasmids had been created, the next step was to 
exhibit expression of these mutant DOX-P Synthase genes, and production of the mutant 
DOX-P Synthase enzyme. The mutant plasmids were transformed into the expression 
host BL21 DE3, and grown and expressed as before with the wild type DOX-P Synthase 
expression plasmid, pCC16.
As before, the transformed expression host was then grown in IPTG-induced 150 mL 
cultures to an OD6oo of 3.0, with dilution where necessary. Mutant DOX-P Synthase was 
then extracted as before, using BugBuster and Benzonase, 2.03.7.2.
These extracts were then checked by SDS-PAGE analysis for soluble DOX-P Synthase 
protein production. The resulting gels are shown in Figure 5.8. These show that all the 
mutant dxs genes were expressed as soluble protein of the correct DOX-P Synthase size, 
except for the L28H, L118G; and K214H mutants, which were expressed as insoluble 
protein, in two cases truncated in size. The ten correctly expressing plasmids were then 
sequenced to verify the desired mutations had been successfully introduced. This proved 
to be the case, and the 10 mutant DNA sequences are shown in Appendix 1, with mutated 
residues in red.
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Figure 5.8. SDS-PAGE gel image showing expression of mutant dxs genes.
150 mL cultures of each E. coli BL21 pCC16 as stated below, grown in orbital shaker at 
37 °C, with addition of IPTG to 1 mM at 2 h. 10 mL samples taken at 5 h after dilution 
to OD600 of 3.0, centrifuged, pellets washed and resuspended in reaction buffer. Protein 
extracted by lysozyme digestion and BugBuster / Benzonase treatment. Sample then 
centrifuged to make soluble and insoluble cell fractions. Soluble cell fraction diluted 1 - 
in-3 in SDS sample buffer for SDS-PAGE. Insoluble cell fraction pellet resuspended in 
3 mL SDS sample buffer for SDS-PAGE. 15 pL each sample analysed by SDS-PAGE. 
Photo shown. Lanes showing soluble fractions of: a. L28H; b. K30H; c. F71H; d. 
V117G; e. L118G; f. K213H; g. K214H; h. F216H; i. P312R; j. K313R; k. D336S; 1. 
I189A; m. 1189V. Lanes showing insoluble fractions of: n. L28H; o. LI 18G; p. K214H;
x. NEB Broad Range Protein Marker.
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With the exception of those mutants expressed as insoluble protein, the presence of the 
mutation did not affect either total protein concentration in the extract, nor percentage of 
protein expressed as DOX-P Synthase. This was measured by Coomassie Plus protein 
assay and SDS-PAGE densitometry, and is shown in Table 5.3, showing a relatively 
constant enzyme concentration of around 135 - 150 pg.mL'1, as observed with wild-type 
DOX-P Synthase.
5.07 Activity Assays with Glyceraldehyde and Pyruvate
This has left 10 DOX-P Synthase mutants to assay for enzyme activity. These were all 
assayed for pyruvate turnover, as with the wild type DOX-P Synthase in 3.19, by HPLC 
analysis, as described in 2.03.13. Initial rates of pyruvate turnover were calculated, and 
from the above calculated enzyme concentration, the apparent specific activities of the 
mutants. These are shown in Figure 5.9 and Table 5.4. Three mutants show zero 
activity, (K30H, F71H, and V117G); four show activity reduced by varying amounts, 
(F216H, P312R, I185A, and II85V); one shows no change in activity, (K313R); and two 
show increased activity, (K213H, and D336S).
Of the three inactive mutants, there could be two explanations for this loss of activity. 
Either the mutations have removed functional groups from the active site essential for
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Sample [Protein]gg/mi
% Density 
of Mutant 
DxpS
[Mutant
DOX-P
Synthase]
Lig/ml
Wild-Type 1456 9.8 142.7
K30H 1491 9.7 144.6
F71H 1478 10.1 149.3
V117G 1396 10.2 142.4
I185A 1396 9.7 135.4
1185V 1482 9.9 146.7
K213H 1456 10.0 145.6
F216H 1414 9.6 135.7
P312R 1482 9.6 142.3
K313R 1450 10.2 147.9
D336S 1498 9.7 145.3
Table 5.3. Cell density, total protein production and DOX-P Synthase production at 
3 h post-induction.
150 mL LB broth in 1 L conical flask - inoculated with overnight culture of stated E. coli 
BL21 pCC16 mutant to O D 6oo of approximately 0.15. Incubated in the orbital shaker at 
37 °C, and induced with 1 mM IPTG at 2 h. 10 mL samples taken at 3 h after induction, 
at OD600 equilibrated to 3.0, and soluble cell fraction extracted. Analysed by Coomassie 
Plus Protein Assay to give total protein concentration values. Analysed by SDS-PAGE, 
and gel photo image analysed by gel band densitometry using Syngene Gene Tools, to 
calculate percentage of protein represented by mutant DOX-P Synthase. Mutant DOX-P 
Synthase concentration was then calculated, as the product of these two values.
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2.5
Wild-Type K30H F71H V117G K213H F216H P312R K313R D336S I189A 1189V
DOX-P Synthase Mutant
Figure 5.9. A pparent specific activity of DOX-P Synthase mutants.
Soluble cell fraction extracted from stated E. coli BL21 pCC16 mutant. Reaction mix: 20 
mM DL -glyceraldehyde / 10 mM pyruvate in Tris.HCl(aq) buffer, pH 7.0, with 9 mM 
MgCh, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell fraction, 
containing 135 - 150 pg.mL'1 mutant DOX-P Synthase, added in 1 mL reaction mix. 
Incubated for 24 h at 37 °C. 150 pL samples taken at 0 h; 1 h; 4 h; and 24 h. Diluted 1:1 
with 0.2% TFA. Analysed by HPLC using Aminex 87H column at 60°C, mobile phase 
0.1% TFA, flow rate 0.6 mL.min'1. UV detection with Dionex AD20 UV detector 
module; electrochemical detection with Dionex ED40 electrochemical detector module. 
Peak areas at 9.7 min on UV trace (pyruvate); 11.6 min on ECD trace (glyceraldehyde); 
and 12.2 min on ECD trace (1-deoxyxylulose), integrated and converted to substrate 
concentrations using Chromeleon 6.0 HPLC software, (Dionex). Timecourse of substrate 
turnover plotted and initial rate of pyruvate turnover calculated. From mutant DOX-P 
Synthase concentration in extract, an apparent specific activity for each mutant was 
calculated, as plotted above. Reactions were carried out in triplicate.
C M Chudziak 205
Production. Characterisation and Modification of DOX-P Synthase as a Biocatalvst
Apparent Specific 
Activity 
(pmol/min/mg)
Total Pyruvate 
Turnover at 
24 h (%)
Wild-Type 1.49 100
K30H 0 0
F71H 0 0
V117G 0 0
K213H 2.11 100
F216H 0.93 42
P312R 1.31 93
K313R 1.48 100
D336S 2.33 100
1189 A 0.81 35
1189V 0.78 34
Table 5.4. Apparent specific activity of DOX-P Synthase mutants, and percentage 
pyruvate turnover achieved within 24 h.
Soluble cell fraction extracted from stated E. coli BL21 pCC16 mutant. Reaction mix: 
20 mM DL-glyceraldehyde / 10 mM pyruvate in Tris.HCl(aq) buffer, pH 7.0, with 9 mM 
MgCh, 1 mM TPP, 1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell fraction, 
containing 135 - 150 pg.mL'1 mutant DOX-P Synthase, added in 1 mL reaction mix. 
Incubated for 24 h at 37 °C. 150 pL samples taken at 0 h; 1 h; 4 h; and 24 h. Diluted 1:1 
with 0.2% TFA. Analysed by HPLC using Aminex 87H column at 60°C, mobile phase
0.1% TFA, flow rate 0.6 mL.min1. UV detection with Dionex AD20 UV detector 
module; electrochemical detection with Dionex ED40 electrochemical detector module. 
Peak areas at 9.7 min on UV trace (pyruvate); 11.6 min on ECD trace (glyceraldehyde); 
and 12.2 min on ECD trace (1-deoxyxylulose), integrated and converted to substrate 
concentrations using Chromeleon 6.0 HPLC software, (Dionex). Timecourse of substrate 
turnover plotted and initial rate of pyruvate turnover calculated. From mutant DOX-P 
Synthase concentration in extract, an apparent specific activity for each mutant was 
calculated, as noted above. Also noted above is the total pyruvate turnover observed at 
the 24 h timepoint. Reactions were carried out in triplicate.
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activity, or the mutation has had a global structural effect on the protein, preventing it 
from folding properly. Neither of these two explanations for loss of activity can be 
determined from this data. However, because the mutated genes are expressed as soluble 
protein, it could be inferred that there is some folding occurring, as non-folded proteins 
tend to present hydrophobic surfaces, leading to protein insolubility.
The seven other extracts are shown to have varying levels of significant DOX-P Synthase 
activity, implying protein folding to form functional enzyme has occurred. The K313R 
mutation seems to have had no effect on activity, suggesting the Lysine-313 residue may 
be unimportant in either protein folding or enzyme function. The F216H, P312R, 1191A 
and II91V mutations seem to have reduced activity. Only two mutations, the K213H and 
D336S mutations, seem to have increased DOX-P Synthase activity. This apparently low 
level of success should not be a surprise as mutations are, through probability, much 
more likely to be deleterious than advantageous. However, the fact that two mutations 
have increased activity per cell does lead to the question as to why E. coli did not evolve 
such a faster DOX-P Synthase, since such a simple mutation was all that was required. 
One can only surmise that there were other evolutionary pressures to maintain DOX-P 
Synthase as it was. For example, as DOX-P Synthase is an enzyme of secondary 
metabolism, as opposed to TK being an enzyme of primary metabolism, it may be 
important not to divert too much glyceraldehyde substrate down the route towards 
isoprenoid biosynthesis at the expense of energy production.
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5.08 Activity Assays with Pyruvate and Non-Native Keto Acceptors
The various mutant DOX-P Synthase extracts were then tested with substrates other than 
DL-Glyceraldehyde. Pyruvate was used as the keto donor, while DL-Glyceraldehyde was 
replaced as keto acceptor by D-Glyceraldehyde; L-Glyceraldehyde; glycolaldehyde; D- 
Erythrose; D-Glucose; D-Mannose; and for the two Isoleucine-185 mutants, 3- 
Pyridinecarboxaldehyde and 4-Pyridinecarboxaldehyde. (See Figure 5.10 for structures 
of the two pyridinecarboxaldehydes). The percentage turnover achieved after 24 h, by 
each mutant, is shown in Table 5.5.
As can be seen the mutants created all have very similar substrate spectra for the keto 
acceptor to the wild type DOX-P Synthase. Interestingly some mutations, (K213H, 
F216H), seem to have preferentially knocked out the ability to use glycolaldehyde as an 
acceptor, without an appreciable effect on erythrose turnover. In addition, the 1185A and 
II85V mutations have knocked out glycolaldehyde turnover, with erythrose turnover only 
reduced. Of these four, the F216H mutation also seems to have significantly reduced 
normal D-Glyceraldehyde turnover, without any significant effect on erythrose turnover.
Unfortunately for hopes to develop the substrate range of DOX-P Synthase through 
rational redesign, none of the mutants were able to turn over D-Glucose, D-Mannose, or 
for the two Isoleucine-185 mutants, 3-Pyridinecarboxaldehyde or 
4-Pyridinecarboxaldehyde. However three mutants, (K213H, P312R and I I91 A), do
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i. 3-Pyridinecarboxaldehyde 
O
H
N
ii. 4-Pyridinecarboxaldehyde
Figure 5.10. Structures of pyridinecarboxaldehydes.
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Alternative Acceptors
D-Glyceraldehyde L-Glyceraldehyde Glycolaldehyde D-Erythrose
Turnover (%) Turnover (%) Turnover (%) Turnover (%)
Wild-Type 100 0 32 70
K30H 0 0 0 0
F71H 0 0 0 0
V117G 0 0 0 0
K213H 100 4 0 81
F216H 42 0 0 75
P312R 93 2 13 80
K313R 100 0 15 83
D336S 100 0 12 77
I189A 35 2 0 46
1189V 34 0 0 44
Alternative Acceptors Alt. Donor
D-Glucose D-Mannose 3-Pyridine-
carboxaldehyde
4-Pyridine-
carboxaldehyde
HPA
Turnover (%) Turnover (%) Turnover (%) Turnover (%) Turnover (%)
DxpS 0 0 N /A N /A 0
K30H 0 0 N /A N /A 0
F71H 0 0 N /A N /A 0
V117G 0 0 N /A N /A 0
K213H 0 0 N /A N /A 0
F216H 0 0 N /A N /A 0
P312R 0 0 N /A N /A 0
K313R 0 0 N /A N /A 0
D336S 0 0 N /A N /A 0
I189A 0 0 0 0 0
1189V 0 0 0 0 0
Table 5.5. Percentage substrate turnover with mutant DOX-P Synthase extract in 24 
h, for variety of acceptor and donor substrates.
Soluble cell fraction extracted from E. coli BL21 pCC16 mutant. Reaction mix: 10 mM 
stated acceptor substrate, / 10 mM pyruvate, or 10 mM stated donor substrate / 20 mM 
DL-glyceraldehyde, in 50 mM Tris.HCl(aq) buffer, pH 7.0, with 9 mM MgCl2 , 1 mM TPP, 
1 mM DTT and 0.1 mM PMSF. 50 pL soluble cell fraction, containing 140 pg.mL'1 
DOX-P Synthase, added in 1 mL reaction mix. Incubated for 24 h at 37 °C. 150 pL 
samples taken at 0 h and 24 h. Analysed by HPLC using Aminex 87H column at 60°C, 
mobile phase 0.1% TFA, flow rate 0.6 mL.min'1. UV detection with Dionex AD20 UV 
detector module; electrochemical detection with Dionex ED40 electrochemical detector 
module. Peak areas on UV trace 8.2 min (hydroxypyruvate); 9.7 min (pyruvate). Peak 
areas on ECD trace 9.4 min (glucose); 9.9 min (mannose); 11.6 min (glyceraldehyde); 
11.7 min (erythrose); 12.2 min (1-deoxyxylulose). Integrated and converted to substrate 
concentrations using Chromeleon 6.0 HPLC software, (Dionex). Percentage turnover of 
stated substrate after 24 h recorded. Reactions carried out in triplicate.
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show evidence of trace activity towards L-Glyceraldehyde. Turnover was very low, but 
the HPLC trace did show a small peak of 1-deoxyxylulose at 12.2 minutes.
5.09 Activity Assays with DL-Glyceraldehyde and Hydroxypyruvate
All the mutant extracts were also assayed using DL-Glyceraldehyde as keto acceptor, but 
substituting with hydroxypyruvate as the keto donor, as opposed to pyruvate. Two of the 
mutants in examination, (F71H and V117G), had been created in order to reintroduce 
residues of TK which bind the C3-hydroxyl group of hydroxypyruvate, not present in 
pyruvate. However, none of the mutants exhibited any activity whatsoever towards 
hydroxypyruvate as a keto donor. This perhaps suggests that none of the mutations are 
sufficient on their own. Perhaps both mutations are required to be combined in the same 
protein to permit DOX-P Synthase turnover of pyruvate.
5.10 Utility of Modified DOX-P Synthases
The mutants produced, unfortunately, show little utility as biocatalysts, over that 
achieved by DOX-P Synthase. The K213H and D336S mutants would perhaps be of the 
most interest, if increased rate of reaction were desired. Unfortunately, none of the 
mutants would be especially useful if a broader substrate range of DOX-P Synthase is 
sought. However all the mutants could prove to be useful starting points for further 
mutagenesis studies, introducing second mutations which might improve substrate range
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further, especially those three mutants which do show some trace activity towards 
L-Glyceraldehyde. This will be expanded upon in Chapter 6, the Discussion.
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6 Discussion
6.01 Introduction
Previous studies have shown the enzyme, transketolase, to be a useful catalyst in 
stereospecific carbon-carbon bond forming reactions, (Bolte et al., 1987;Effenberger et 
al., 1992). In vivo, transketolase carries out an Aldol Condensation-type reaction, with a 
ketol group transferred from a donor, such as the ketose sugar, fructose-6-phosphate, to 
an acceptor, such as the aldose sugar, glyceraldehyde-3-phosphate, in this case leaving 
the aldose, erythrose-4-phosphate, and creating the ketose, xylulose-5-phosphate, (de la 
Haba et al., 1952). In doing so, it connects the glycolytic and pentose phosphate 
pathways of cellular carbon metabolism, (Boiteux et al., 1981). In vitro, transketolase 
can be extracted and purified, and used as a catalyst with non-native substrates, such as 
the ketol donor, hydroxypyruvate, thus setting up an irreversible reaction, as ketol 
transfer from hydroxypyruvate liberates carbon dioxide, (Racker et a l, 1953). 
Production has been optimised for extraction of large quantities for use as an industrial 
biocatalyst, (Lilly et al., 1996), and the enzyme been extensively studied and described 
for use in organic synthesis, (Takayama et a l, 1997;Humphrey et al., 2000). Lately 
mutagenesis studies have also aimed to improve its characteristics as a biocatalyst, 
(Bacon, 2001).
More recently, a closely related enzyme to transketolase has been discovered, namely 
l-Deoxy-D-Xylulose-5-Phosphate Synthase, (DOX-P Synthase), (Sprenger et al., 1997).
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This transfers a non-hydroxylated keto group from the non-hydroxylated donor, pyruvate, 
to glyceraldehyde-3-phosphate, to produce l-deoxyxylulose-5-phosphate, whilst 
liberating carbon dioxide. Like transketolase, there is potential for use of this enzyme as 
a biocatalyst in organic synthesis. Unlike transketolase however, production of
l-Deoxyxylulose-5-Phosphate Synthase had not been optimised, and the operating 
characteristics of the enzyme were relatively poorly described. There was therefore work 
to be done on this enzyme, to put it on an equal footing as transketolase for use as a 
biocatalyst. Once this has been done, preliminary efforts were then to be carried out on 
alteration of the enzyme by mutagenesis, to look at its plasticity towards improvement as 
a biocatalyst.
The three areas of research focussed upon in this thesis have therefore been:
1. Production of biocatalyst: Optimisation of expression, production and extraction of 
DOX-P Synthase, and development of activity assay techniques.
2. Description of biocatalyst: Characterisation of conditions for DOX-P Synthase
activity, and of substrate range.
3. Improvement of biocatalyst: Creation and characterisation of modified DOX-P
Synthases, generated by rational mutagenesis.
The findings in these research areas are now discussed in greater detail below.
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6.02 Production of biocatalyst
Due to the high endogenous expression of the enzyme, production of transketolase as a 
biocatalyst has often been relatively simple. Simple extraction from yeast or spinach will 
supply suitably high quantities for use as biocatalyst, (Demuynck et a l , 1990). DOX-P 
Synthase however is naturally expressed at much lower quantities, so, to study the 
enzyme, it has often been necessary to clone its gene into a recombinant expression 
system, where high levels of expression can be driven, (Sprenger et al., 1997;Kuzuyama 
et al., 2000). This can enable production of larger, more useful quantities of enzyme.
In order to best facilitate ease of production, a simple, but effective, expression system 
was desired here. Therefore the fast growing host strain, E. coli BL21, (Stratagene), was 
used in conjunction with the high copy number plasmid, pET21a, (Novagen), capable of 
simple IPTG-inducible expression of high levels of protein. The DOX-P Synthase 
expression plasmid, pCC16, was created and transformed into E. coli BL21. Growth in 
LB media for 5 h at 37 °C, with IPTG addition to 1 mM at 2 h, was capable of producing 
over 140 pg of soluble enzyme in 1 mL extract from 10 mL broth, as estimated by 
Coomassie protein assay and scanning polyacrylamide gel band densitometry. This is a 
reasonable level of production, which could easily be used, and perhaps scaled up, for 
large-scale biocatalyst production.
However, there is clearly room for improvement in production level when compared with 
the up to 82 mg.mL'1 achievable for transketolase from an overnight culture, (French and
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Ward, 1996). There are several areas it might be worthwhile looking at in order to 
improve level of DOX-P Synthase production. For a start, one could address the 
instability o f the vector, shown in Figure 3.11, which would allow growth to proceed for 
longer, allowing the higher optical densities reached over 24 h to translate into higher 
DOX-P Synthase production. This could be done by using, for example, a kanamycin 
selective marker as opposed to an ampicillin selective marker. As the inactivating 
kanamycin kinase is intracellular, unlike the ampicillin inactivating p-lactamase, this 
means higher levels of antibiotic are maintained in the broth for longer.
Also, one could look at the promoter used to drive DOX-P Synthase expression. Whilst 
the T7 expression system is one of the strongest systems in terms of mRNA production, it 
is not necessarily the best in terms of protein yield at an industrial scale. T7 RNA 
Polymerase produces mRNA at a much faster rate than E. coli ribosomes can move along 
the mRNA. Over time, as mRNA builds up, this can lead to gaps in the mRNA which 
can lead to mRNA degradation. Therefore slower transcription systems, which can keep 
going for more extended periods, can lead to higher yields. (Makarova et al., 1995). 
DOX-P Synthase production could be assessed using a slower tac or lac expression 
system, to see if higher enzyme yield could be attained over 24 h. Alternatively, high 
levels of transketolase production have been observed to be driven from the native 
transketolase promoter, (French et al., 1996). The gene for DOX-P Synthase, dxs, could 
be cloned into a vector carrying this promoter system, tailored as it is to the similar gene 
for transketolase.
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In addition, one big advantage for large-scale fermentation might be the use of promoters 
which don’t need IPTG for induction, or stable vectors which do not need antibiotic 
selection to maintain copy number. Various E. coli promoters enable constitutive 
expression, such as the transketolase promoter just mentioned. Although heat induction 
would be expensive, these alternative expression systems also exist, (Andrews et a l, 
1996). Various stable low copy number plasmids exist, based on the F plasmid, PI 
plasmid, or RK2 plasmid. Stabilisation of higher copy number plasmids has also been 
achieved by incorporation of stabilising sequences, such as the cer fragment of Co/El, 
(French et a l, 1995). Repressor titration systems have also been developed, which 
ensure maintenance of high copy numbers, being required to titrate out repressors of a 
selectable marker, (Williams et a l, 1998).
Different host strains might also be worth investigating. The high levels of TK 
overexpression were achieved using the host strain E. coli JM107. Beyond this one could 
look at different media, aeration levels and other growing conditions, to allow for the 
attainment of higher optical densities during growth. Also, codon usage, especially 
around the N-terminus, could also be investigated.
After fermentation, the next stage of the process is to extract the active protein. It was 
found that a simple preparation of clarified lysate could be used as a crude enzyme 
extract capable for use in biocatalysis. The key techniques used in the process were 
simply separation by centrifugation; lysozyme and detergent based lysis; nuclease 
digestion of DNA; then further clarification by centrifugation. This means an active
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extract can be prepared simply, with only a small number of steps. This simplicity is 
important when considering scaling up the process to enable large-scale biocatalyst 
production, as these processes are all scalable. At an industrial scale the extraction 
process might even be simplified further, passing the culture through a homogeniser, then 
clarifying the extract in a continuous centrifuge.
However, it was shown in Table 3.3 that significant quantities of produced enzyme were 
still being lost in the insoluble fraction during extraction. Reduction in rate of expression 
is commonly targeted in attempts to reduce the quantity of expressed protein which is 
insoluble, usually through reducing temperature or IPTG concentration. However this 
has been attempted in this study and has to be weighed against a reduction in both soluble 
and insoluble protein concentration. For example, growth at 25 °C was shown to slightly 
increase the percentage of expressed enzyme which was soluble, but at the expense of 
reduction in actual quantity. Alternatively, co-expression with a chaperone protein 
system, such as GroES-GroEL (Nishihara et al., 1998), could be tried, or use of a 
different host strain with a more oxidizing cytoplasmic environment, such as E. coli 
AD494 or Origami, (Novagen). Alternatively in vitro attempts could be made to 
solubilise this fraction through use of reducing agents, such as urea, followed by dialysis, 
(De Bemardez Clark, 1998).
Significant quantities of DOX-P Synthase were, though, shown at least to be easily 
producible. The next step was to verify the enzyme activity. Previous studies had 
assayed enzyme activity by assaying concentration of the native product, 1-deoxy-
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xylulose-5-phosphate, (Altincicek et al., 2000). This used the enzyme, 1-Deoxy- 
Xylulose-5-Phosphate Reducto-isomerase, and followed NADH oxidation. However, 
this method would not be usable where non-native products were to be produced. 
Similarly, 3,5-diaminobenzoic acid, (DABA) has been used as a fluorescent indicator of 
l-deoxy-xylulose-5-phosphate, (Querol et al., 2001a). This method relies on the finding 
that DABA reacts with 1-deoxysugars in an acidic medium to form fluorescent 
quinaldine derivatives. However, this method, for a start would not be usable where one 
was attempting to produce novel products which were not 1-deoxysugars. In addition 
this method does not work as well with non-phosphorylated products, which will be 
produced in this study. This project then looked at developing assays based on TLC, or 
the tetrazolium salt colour reagent, XTT, (Pauli et al., 1988). TLC is ideal as a rapid 
technique for separating out the substrates and products in this reaction, and was 
successfully used to show DOX-P Synthase catalysed reaction occurring. However, 
quantification of rate of reaction using TLC is not simple, and neither is TLC suited to 
high-throughput use. The tetrazolium salt, XTT, works through reaction with secondary 
alcohols to produce an orange dye. This is ideal for high-throughput quantification, 
which can be carried out by spectrophotometry. However, lack of specificity of the 
reagent meant there were difficulties with high levels of background activity. This meant 
that the XTT method was not immediately suitable for use. It is possible however, that 
further work in this area could lead to the development of a useful new analytical 
technique here.
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The requirement for a simple technique which could assay activity in the presence of a 
variety of non-native substrates, and which could be easily modified for high-throughput 
when assaying large numbers of substrates and mutants simultaneously led to the 
development of an HPLC-based assay. With the right solvent, column and detection 
system, HPLC is capable of revealing all substrate and product species, and is easily 
automated for high-throughput use. HPLC had previously been used, employing a 
sulphuric acid solvent and refractive index detection, (RI), (Kuzuyama et a l , 
2000;Schurmann et a l , 2002). A similar system was developed for use here, using a 
trifluoroacetic acid solvent and electrochemical detection, (ECD). This method was then 
successfully used to follow the course of the DOX-P Synthase catalysed reaction, 
forming 1-deoxy-xylulose from glyceraldehyde and pyruvate. This was done by 
following change in substrate and product concentration, over the course of the reaction. 
In the test conditions of pH 7.0 and 37 °C, an apparent specific activity of 1.50 pmol. 
min'1 .mg'1 was observed. In 1 mL of a 10 mM pyruvate / 20 mM DL-glyceraldehyde 
solution, addition of 5 % extract, containing 140 mg.mL1 DOX-P Synthase, was able to 
achieve an initial rate of substrate turnover of 0.6 mM.h'1, with complete substrate 
turnover achieved in 24 h. This compares to a previously reported specific activity of 
4.3 pmol.min''.mg'1 for purified enzyme, (Schurmann et a l , 2002), suggesting some 
degree of inhibition or substrate sequestration by impurities in the extract, but 
nonetheless confirmed the successful production of an active DOX-P Synthase extract, 
usable as a biocatalyst.
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6.03 Description of the biocatalyst
After the successful production of active biocatalytic extract, the next stage in the process 
was to describe the applicability of the biocatalyst. The chemical engineer designing a 
synthetic process needs to know both the working and optimal reaction conditions for the 
biocatalyst to be used, as regards pH, temperature and cofactor concentration. It is also 
necessary to know about the robustness of the enzyme -  how long it remains active, both 
during reaction and in storage conditions. In addition, it will be useful to be able to 
describe the substrate range of the biocatalyst. This can suggest further reactions and 
processes to which the enzyme can be applied beyond the simple native reaction.
This study looked at several variables in reaction conditions. The first condition looked 
at was pH. The pH dependence of enzyme catalysis is a function of the many ionisable 
groups found in a large protein, and due to the fact that usually only one ionic form, with 
respect to the catalytically important residues of the enzyme, is active, (Fersht, 1999). 
Those catalytically important residues will involve both residues directly involved in 
catalysis in the active site, and groups elsewhere, responsible for maintaining active 
enzyme conformation and overall enzyme solubility. The requirement will be for some 
groups to be protonated and others to be deprotonated, which would result in a bell­
shaped curve describing the influence of pH on enzyme activity. For DOX-P Synthase it 
was found here that enzyme activity peaks between 7.0 and 7.5, with residual activity of 
greater than 80 % at pH 6.5 and 8.0, but quickly dropping to 0 % outside this range. This 
agrees with the previously described pH optimum of 7.5, (Kuzuyama et al., 2000), but it
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has also been possible to add extra information to this, to describe the fuller pH range of 
6.5 to 8.0 in which useful catalytic activity can be found.
The second reaction condition studied was temperature. At lower temperatures, enzyme 
catalysed reactions behave like most other reactions upon change in temperature. 
Increasing temperature increases energy in the system and thence rate of reaction. 
However, unlike with most chemical reactions, in enzyme catalysed reactions this effect 
is altered as temperature increases beyond a critical point, usually between 30 °C and 
40 °C. Enzymes are proteins, with multiple interactions holding the enzyme in the 
correct, active conformation. As energy in this system increases with increase in 
temperature, proteins become unstable and denature beyond a certain point. Simple 
chemical interactions, which normally hold the protein together, such as salt bridges, 
hydrogen bonds and van der Waals forces, are no longer strong enough, and the active 
conformation of the enzyme is lost irreversibly. The point at which the enzyme denatures 
is a function of the various intermolecular bond strengths within the active conformation 
of the enzyme, but usually an enzyme will have evolved to maximise activity at its 
normal operating condition. For an enzyme, such as DOX-P Synthase, evolved to work 
in the conditions inside an E. coli cell, one would expect an optimum temperature close 
to the range of 36 to 39 °C, the common temperature of a mammalian gut, the normal 
habitat of E. coli. Therefore, it is a little surprising to find that the highest initial rate was 
observed at 42 °C, although this was in agreement with previous studies, (Kuzuyama et 
al., 2000). However, this study enabled further information to be added to this picture. 
Firstly that significant turnover, (48% of the rate observed at 37 °C), could still be
C M Chudziak 222
Production. Characterisation and Modification of DOX-P Synthase as a Biocatalvst
observed as low as 25 °C. Secondly, and perhaps more importantly, it was found that 
whilst initial activity may be higher at 42 °C, in the longer term yield is actually 
increased at 37 °C. This is possibly the result of a higher level of denaturation gradually 
taking its toll on the activity of the biocatalyst. Likewise, it was also found that 
biocatalytic activity reduces over the course of a 24 h reaction. This suggests that in 
order to get the best product yield it might be necessary to seed the reaction with fresh 
extract at points during the reaction. In addition, storage at room temperature, or even 
4 °C, was found to be poor at maintaining activity of extract. It was found that storage at 
-20 °C would be better for periods of up to a week. For longer periods, use of a 
cryoprotectant, such as glycerol, might be useful.
The third and final condition examined here was cofactor concentration. Cofactors are 
small non-protein molecules, which bind an enzyme tightly, and are necessary for 
catalysis. These bind into the enzyme active site, sometimes covalently, providing 
interactions which the amino acid residues themselves are incapable of providing. These 
include coordinated metal ions, and larger vitamin-based coenzymes. DOX-P Synthase 
has two cofactors, magnesium, Mg2+, and thiamine pyrophosphate, TPP. This study 
looked at the dependence of DOX-P Synthase activity upon the concentration of these 
two cofactors. This would be a function of the cofactor affinity for its enzyme binding 
site, where higher affinity would lead to reduced influence of cofactor concentration on 
enzyme activity.
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As the concentration increases, cofactor binding sites come closer to saturation. This 
effect is seen here when the effect on activity of increasing Mg2+ concentration from 9 
mM to 30 mM, or TPP concentration from 1 mM to 2.5 mM is observed. The increase in 
activity upon more than trebling Mg2+ concentration is only 13 %, whilst there is no 
significant increase upon more than doubling TPP concentration. This suggests that at 
1 mM TPP is already saturating, whilst at 9 mM, Mg2+ is not. This shows TPP has a 
higher affinity in these conditions for DOX-P Synthase than Mg does. This information 
enables decisions to be made about cofactor concentration when setting up a biocatalytic 
process, i.e. a TPP concentration of <1 mM, and a Mg2+ concentration of >9 mM for 
highest activity. Further work should be carried out, however, to calculate the saturation 
point more accurately.
In the absence of cofactors, the enzyme is present as inactive apoenzyme; with cofactor 
bound, it is present as active holoenzyme. It was found that when TPP is present in the 
extraction buffer, but absent from reaction buffer, enzyme is present as holoenzyme at 
only 45 % of the level found when TPP is present in both. When TPP is absent in the 
extraction buffer, and absent in the extraction buffer, enzyme is present as holoenzyme at 
only 33 % o f this level. Interestingly the reduction in activity caused by absence of TPP 
in the extraction buffer cannot be fully compensated for by presence in the reaction 
buffer, suggesting some degradation of DOX-P Synthase while present as apoenzyme.
After the reaction conditions have been described, the next stage in describing the 
applicability of DOX-P Synthase as a biocatalyst is to describe its substrate range. Like
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transketolase, DOX-P Synthase was shown to be stereospecific towards the D-form of the 
keto acceptor, glyceraldehyde. Unlike transketolase, (Hobbs et a l , 1993), DOX-P 
Synthase was shown to have a very narrow substrate range. No biocatalytic activity was 
observed towards the longer chain sugars, glucose and mannose, the non-hydroxylated 
propionaldehyde, or the aromatic benzaldehyde. Likewise, no activity was shown 
towards the alternative keto donor, hydroxypyruvate. This mirrors transketolase, which 
shows no activity towards pyruvate as a ketol donor, (Usmanov et a l,  1983). The only 
alternative substrates with which DOX-P Synthase does show activity are glycolaldehyde 
and erythrose. At 24 h, 32% and 70% turnover are seen respectively, in the test 
conditions of 1 mL of a 10 mM pyruvate / 10 mM glycolaldehyde or a 10 mM pyruvate / 
10 mM D-erythrose solution, and upon addition of 5 % extract containing 140 pg.mL'1 
enzyme.
Turnover of these substrates has also been assessed in a previous study, (Schurmann et 
al, 2002). The study of substrate range here went further than in this previous study, by 
testing a wider range of substrates. As with this study, activity towards glycolaldehyde 
and erythrose was observed, and at a lower rate than that observed with the native 
substrates. However, relative activity was different to that observed here. Higher activity 
was observed towards glycolaldehyde by Schurmann, whereas this study here observes 
higher activity towards erythrose. This could be due to the different measure of activity 
being observed, turnover at 24 h in this study, as opposed to initial rate in the previous 
study, or could be due to different reaction conditions, which have not been fully 
described for the earlier study. The work in this study on buffers has shown the effect
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this can have on rate, and it is possible this could be a differential effect dependent on the 
substrate involved. There is however quantitative agreement -  that erythrose and 
glycolaldehyde can be used as substrates, albeit not as effectively as glyceraldehyde. 
And this study goes further, by describing the limitations of the substrate range of the 
enzyme DOX-P Synthase more fully, showing no activity towards substrates such as 
glucose, mannose, benzaldehyde or propionaldehyde, which have been shown to be 
turned over to varying extents by TK. Although the substrate range has been shown here 
to be limited, this will be useful information in the application of DOX-P Synthase as a 
biocatalyst, whilst the next useful step would be to measure the Km and Vmax o f those 
substrates which are turned over.
6.04 Improvement of biocatalyst
In determining the substrate range of DOX-P Synthase, it became clear that the enzyme 
had a much narrower substrate range than the similar enzyme, TK, and therefore much 
reduced utility as a biocatalyst in organic synthesis. Substrate range is essentially 
determined by the internal structure of an enzyme's active site, and the interactions that 
can be formed between the substrate and the active site. In successful catalysis a series of 
interactions will form, which stabilise the turnover of substrate into product. When 
comparing the two enzymes, DOX-P Synthase and transketolase, one might propose that 
transketolase is able to catalyse the turnover of a wider set of substrates because it is 
better able to form those interactions necessary for catalysis.
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The next stage is then to identify where those differences arise. The enzyme-substrate 
interactions formed in the transketolase active site have begun to be defined by a series of 
different X-ray crystallography studies, but no X-ray crystallography studies of DOX-P 
Synthase existed at the commencement of this work. Due to the similarity in primary 
structure of the two enzymes, similarity in catalytic function, and likely shared 
evolutionary heritage, it was decided to take the TK structure as a starting point upon 
which to map the active site interactions which might be formed by DOX-P Synthase. 
The efficacy of this approach can be evaluated both in the light of the results, and in the 
light of the very recently published crystal structure of E. coli DOX-P Synthase, (Xiang 
et al., 2007).
A series of residues have been identified by several studies as being important in the 
interaction of TK with its substrates, (Lindqvist et al., 1992;Nikkola et a l , 1994;Wikner 
et al., 1995;Schneider et al., 1998;Fiedler et a l, 2002). The equivalent residue positions 
were identified in DOX-P Synthase by amino acid sequence alignment, and those that did 
not have homologues in DOX-P Synthase were targeted for “reintroduction ” by 
mutagenesis. In order to alter DOX-P Synthase activity, and improve it along the lines of 
the activity of TK, it was decided to attempt to "reintroduce" these "missing" residues. 
Other mutants were also generated along the lines of successfully generated TK mutants 
which had increased substrate range.
The ten successfully generated mutants were then assayed, as previously, for increased 
rate; increased substrate range; and activity towards hydroxypyruvate, as opposed to
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pyruvate, as a keto donor. The results of this mutant testing is discussed below, but first 
the recently published crystal structure of E. coli DOX-P Synthase is discussed.
6.04.1  C rystal stru ctu re o f  DOX-P S y n th a se
The crystal structure of DOX-P Synthase of E. coli and Deinococus radiodurans has been 
determined to 2.4 A resolution, (Xiang et al., 2007). The structure is shown in ribbon 
form in Figure 6.1. Crystallization of the E. coli enzyme required proteolysis by a fungal 
protease. The result of this was that unfortunately two areas of the protein had no 
electron density, residues 183-238 and 292-317, as they had been removed by the fungal 
protease. Crystals of the D. radiodurans enzyme, (46% identical in amino acid sequence 
to the E. coli enzyme), were crystallized without proteolysis, and this enabled more of the 
structure to be determined. Electron density for residues 199-242, however, could still 
not be determined in D. radiodurans DOX-P Synthase, as this region seemed to be 
disordered. Despite these small segments missing from the enzyme structure, a vast 
amount of data can still be gleaned from the structure.
As expected, the structure has been reported to be most closely similar to that of TK, as 
identified using the structure comparison programme, Dali, (Holm and Sander, 1993). 
The structure contains three domains, (I, II and III), each of which shows homology to 
the equivalent TK domain. However, it is suggested, although it is not yet certain, that 
the active site is positioned between domains I and II of the same monomer, rather than 
between domains I and II at the interface of the dimer, as with TK. It is suggested this
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Figure 6.1 E. coli DOX-P Synthase.
Ribbon diagram of E. coli DOX-P Synthase from its X-ray crystal structure, (Xiang et al., 
2007), showing C2 symmetry and similarity to E. coli TK structure. Dimer shown with 
polypeptide chain 1 in red, chain 2 in yellow.
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difference is due to the shorter length of linker between domains I and II in DOX-P 
Synthase, (20 residues), than in TK, (95 residues). The uncertainty is due to the absence 
of these residues in the E. coli DOX-P Synthase crystal structure; the D. radiodurans 
DOX-P Synthase crystal structure does however show the linkage of the two domains as 
suggested.
As with TK, the active site which is formed, though, does show strong homology to that 
of TK. The TPP is bound in a V-conformation, with the pyrophosphate group interacting 
with domain I and the amino-pyrimidine ring interacting with domain II. As with TK, 
the TPP ring is buried within the enzyme, with only the thiazolium ring, in particular the 
C2 atom, accessible to solvent. This is consistent with DOX-P Synthase sharing the same 
mechanism as TK, where the thiazolium C2 plays a critical role in the first step of 
catalysis, in a nucleophilic attack on the substrate carbonyl. As with TK, Mg2+ is shown 
to be present, coordinating TPP binding into the active site.
In addition to showing that DOX-P Synthase has a similar overall structure to TK, the 
crystal structure of DOX-P Synthase also shows that the predictions made in Chapter 5 
about the architecture of the enzyme’s active site had a reasonably high degree of 
accuracy. To begin with, those key residues in S. cerevisiae TK, Glutamate-418 and 
Histidine-481, responsible for the initial activation of TPP by deprotonation of the C2 
atom of the thiazolium ring, were predicted to be conserved in E. coli DOX-P Synthase 
as Glutamate-370 and Histidine-431. The crystal structure shows that not only are these 
two residues present in the active site, but that they are located in close proximity to the
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C2 atom of the thiazolium ring of TPP. The three Mg chelating residues of TK were 
predicted to be conserved in E. coli DOX-P Synthase as Aspartate-152, Glycine-153 and 
Asparagine-181, and indeed these residues are shown in the crystal structure chelating the 
cation. Phenylalanine-395 and Aspartate-427 were both also predicted correctly to be 
located in the proximity of the active site. It cannot be certain that Isoleucine-185 in 
E. coli has also been structurally conserved, as predicted, as this residue is missing from 
the crystal structure, as explained. However, the equivalent residue in D. radiodurans 
DOX-P Synthase, Isoleucine-187, was shown to be located in a similar area of the active 
site to Isoleucine-189 in E. coli TK. Of two of those residues from S. cerevisiae TK 
predicted not to be conserved, Arginine-358 and Serine-385, the published crystal 
structure seems to agree with this judgement. O f two other residues predicted not to be 
conserved in the published crystal structure, Histidine-258 and Histidine-261, it is not 
possible to say as the crystal structure for this region is undetermined.
One important discrepancy, however, relates to those residues responsible in TK for 
chelating that C3-hydroxyl group of hydroxypyruvate not present in pyruvate. In 
S. cerevisiae TK, Histidine-103 carries out this role directly, along with Histidine-69 and 
Glycine-116 via a chelated water molecule. Only Histidine-103 was predicted to be 
conserved in E. coli DOX-P Synthase, as Histidine-105. However, Histidine-105 is not 
in fact located within the active site, but on the enzyme surface. This may actually better 
explain why DOX-P Synthase is unable to catalyse the turnover of hydroxypyruvate, 
whilst TK can, if it lacks the only residue responsible in TK for direct binding of that C3- 
hydroxyl group which differentiates hydroxypyruvate from pyruvate. This difference
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could in fact be a key factor in explaining this, the primary difference between TK and 
DOX-P Synthase. In addition it could explain why no DOX-P Synthase mutants 
succeeded in turning over hydroxypyruvate, as, not realizing Histidine-105 was not 
actually located in the active site, no attempt was made to reintroduce a Histidine-103 
equivalent. This will be discussed further later. Meanwhile, the other two residues 
implicated in binding the C3-hydroxyl, albeit indirectly, Histidine-69 and Glycine-116 of 
S. cerevisiae TK, were predicted, based upon amino acid sequence comparison, not to be 
present in E. coli DOX-P Synthase. The crystal structure however shows Histidine-80 
and Glycine-121 to take up these roles in E. coli DOX-P Synthase. This has implications 
for the analysis of those mutants which were generated in an attempt to reintroduce these 
residues whilst not realizing they weren’t actually missing. This will be discussed further 
later.
There was also one other discrepancy, which though perhaps less significant generally, is 
significant to this study. Histidine-30 of S. cerevisiae TK, which is located centrally in 
the active site, had not been predicted to be conserved, but is in fact shown to be 
conserved in E. coli DOX-P Synthase, as Histidine-49. This is actually a residue which 
had previously been shown to be an essential residue in DOX-P Synthase, (Querol et al., 
2001b). That it is located centrally within the active site begins to explain why the 
residue is essential, and that the residue is not in fact missing perhaps explains why 
mutations made in attempts to reintroduce this residue did not have the desired effect.
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Therefore, of the nine TK residues predicted to be structurally conserved in DOX-P 
Synthase based on a comparison of amino acid sequences, eight of these actually were 
conserved in the crystal structure. This shows that given detailed mechanistic and 
structural knowledge of one enzyme, reasonable predictions can be made about the active 
site of a catalytically different enzyme, where there is as low as 44% amino acid 
sequence similarity.
However, of the seven residues which were predicted, from a comparison of amino acid 
sequences, to be missing from E. coli DOX-P Synthase, only two of these were missing 
based upon an actual crystal structure of the enzyme. These are Arginine-358 and 
Serine-385 of E. coli TK. This could rise to four, to include Histidine-258 and Histidine- 
261 of E. coli TK, if further structural data became available, but three residues which 
had been predicted to be missing were shown by the crystal structure to in fact be present. 
These are Histidine-30, Histidine-69 and Glycine-116 of S. cerevisiae TK, which were 
shown to be present in E. coli DOX-P Synthase, as Histidine-49, Histidine-80 and 
Glycine-121. Part of the reason for this low success rate is that it is clearly easier to 
recognize presence of homologous active site residues from a sequence comparison than 
the absence of homologous residues. This has implications for the use of mutagenesis to 
reintroduce residues deemed missing from an enzyme, as will be discussed later. 
However, it also has to be borne in mind that in drawing up a list of residues to 
reintroduce, a certain amount of caution is necessarily required, it being better to create 
too many mutants than too few, better to attempt to reintroduce residues which are not
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missing than miss those which are. This also has had a significant impact on the 
mutation programme as will be discussed below.
In addition to presenting the crystal structure of DOX-P Synthase, the catalytic activities 
of some mutants were presented in the same paper. A Glutamate-370-Alanine mutant 
was shown to have zero activity. This agrees with the prediction of its role as being 
crucial in the activation of TPP. It could be predicted that its removal would prevent the 
initial activation of TPP, thus preventing catalysis from occurring at all. Histidine-431 
was predicted to be the basic partner of acidic Glutamate-370 in this activation. 
However, a Histidine-431-Alanine mutation was found to have minimal impact on 
catalytic activity. Rather, an Argininine-398 residue was shown to be the basic partner of 
Glutamate-370 in the activation role. This was closer in the structure to both Glutamate- 
370 and the critical C2 atom of the thiazolium ring of TPP, and an Arginine-398-Alanine 
mutation was shown to knock out activity. This finding is not crucial to this study, but 
does present another significant difference in active site architecture between TK and 
DOX-P Synthase.
6 .0 4 .2  L oca tion  o f  m utated  r e s id u e s  w ithin DOX-P S y n th a se  crysta l 
stru ctu re
Three mutants were produced in attempts to introduce residues thought to be missing in 
E. coli DOX-P Synthase active site, which upon consideration in the light of the recently 
published crystal structure may now be thought of as a false premise. These are the
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mutants K30H, F71H, and VI17G. The crystal structure in fact shows the three residues, 
Lysine-30, Phenylalanine-71 and Valine-117, to be distant from the active site. None 
were shown to be surface residues.
Two mutants were created to shorten the side chain of Isoleucine-185, which was 
predicted to be an active site cleft residue, equivalent to Isoleucine-189 in E. coli TK. 
The crystal structure did indeed show Isoleucine-185 to reside in the active site cleft, 
located in an equivalent position to Isoleucine-189 in E. coli TK.
Two mutants were created in an attempt to reintroduce an equivalent of the E. coli TK 
residues, Histidine-258 or Histidine-261, in the active site. These were K213H and 
F216H. It is impossible to say from the crystal structure whether Lysine-213 or 
Phenylalanine-216 are in fact located in the proximity of the active site as these residues 
are absent from the crystal structure.
Two further mutants were created in an attempt to reintroduce an equivalent of the E. coli 
TK residue, Arginine-358, into the active site. These were P312R and K313R, and again 
it is not possible to say whether Proline-312 and Lysine-313 are in fact located close to 
the active site, as these residues are not present in the E. coli DOX-P Synthase crystal 
structure. However, the crystal structure of DOX-P Synthase from D. radiodurans does 
show a similar stretch of residues to be located relatively close to the bound TPP 
cofactor.
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One final mutant was created to reintroduce an equivalent of the E. coli TK residue 
Serine-385 into the opening of the active site. This was the mutant, D336S. The crystal 
structure however shows Aspartate-336 to be located on the enzyme surface, reasonably 
close to, but unfortunately not actually in, the active site opening.
Therefore, of the mutants created, it was likely four of them, K30H, F71H, V117G and 
D336S would not reintroduce the missing residues as expected, and the results from 
assays of their activity will have to be interpreted accordingly. It should be borne in 
mind, though, that not only mutations in the active site can have an effect on enzyme 
activity. A previous random mutagenesis study of a-amylase from Bacillus 
stearothermophilus showed that mutation of residues outside the active site can also have 
a significant impact on enzyme activity, particularly if located in key structural features 
of the enzyme. Even mutations of surface exposed loop residues were shown 
occasionally to impact on enzyme activity. (Holm et al., 1990). The positions of the four 
residues which were mutated are indicated on the protein structure in Figure 6.2.i. In 
Figures 6.2.ii-iv are representations of how the three residues closest to the active site 
might look when mutated.
6 .04 .3  E ffect o f  m u ta g e n e s is  on  rate o f  reaction
Most of the mutants generated had reduced rate of reaction, including three of which 
were totally inactive. This low success rate could be expected, as effect of mutation is 
statistically much more likely to be deleterious than otherwise. In fact the success rate is
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Figure 6.2 Positions of mutated residues in DOX-P Synthase crystal structure.
Views created from PDB structure 2 0 IS, (Xiang et al., 2007), using Accelrys DS 
Modelling. Dimer shown in stick form with polypeptide chain 1 in red, chain 2 in 
yellow. Named residues in blue. i. Locations of mutated residues K30, F71, V I 17 and 
D336 on DOX-P Synthase structure, indicating proximity to active site cleft, ii-iv. Close 
up of area around active site cleft showing F71, V I 17 and D336 backbones respectively 
substituted for Histidine, Glycine and Serine.
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much higher than would be expected to be the case with random mutagenesis, 
highlighting one of the benefits of rational mutagenesis. Two mutants from ten were 
generated which had increased rate of reaction -  a 20% success rate for rational 
mutagenesis, even carried out in the absence of a crystal structure. On top of this, two 
more mutants, another 20%, maintained similar activity to wild-type enzyme.
The first of the successful mutations, K213H, aimed to reintroduce a Histidine residue, to 
an area of the active site, which in transketolase possesses two such residues, Histidine- 
258 and Histidine-261. No clear role for Histidine-258 in transketolase has been 
suggested, whilst the S. cerevisiae homologue of Histidine-261, (Histidine-263), has been 
suggested to help binding of the pyrophosphate group of TPP. It is possible that this 
could lead to an explanation for how the K213H mutation has led to an increase in rate of 
catalysed reaction. If Lysine-213 is, as proposed, located in that part of the DOX-P 
Synthase site responsible for TPP phosphate binding, it is possible that histidine in this 
position proves better at chelating phosphate than lysine, increasing the affinity of TPP 
for the enzyme active site, and thereby increasing the rate of the catalysed reaction. As 
explained earlier, it is impossible to verify from the crystal structure whether Lysine-213 
is located close to TPP phosphate, so therefore it is impossible to speculate further, at this 
stage, on whether this is in fact the effect being seen.
The second of the successful mutations, D336S, aimed to reintroduce a Serine residue, 
Serine-385, identified in the E. coli TK structure to be positioned in the opening of the 
active site. No interactions formed with the substrate or cofactors have been proposed. It
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is more difficult to say, therefore, why this mutation might have increased rate of 
reaction, especially since the crystal structure goes further to show that Aspartate-336 is 
not even located in the active site opening. It is possible that a reorganisation near the 
active site opening, required to accommodate a serine residue in place of an aspartate 
residue, may have just slightly opened up that opening, enabling easier access into the 
active site for substrates.
As well as the suggested local effects, mutations introducing new residues anywhere 
within a protein will cause rearrangements locally to accommodate these introductions. 
These rearrangements can ripple out across the whole protein, having distant effects on 
structure, including on the active site. This can explain why the three mutations K30H, 
F71H and VI17G, managed to knock out activity at a distance from the active site, and 
without causing protein denaturation, which would have been noticed as an alteration in 
soluble protein concentration.
Of the other mutants, three, F216H, I I85A and II85V, had a deleterious effect on 
activity. Isoleucine-185 is known from the crystal structure to be, as predicted, close to 
the active site. The side chain is not predicted to be involved in catalysis directly, but it is 
quite possible that local rearrangements, to incorporate the mutated residue, could disrupt 
TPP or substrate binding, leaving key residues slightly further apart or at slightly less 
favourable angles for binding. The same could be the case for the F216H mutation. It is 
not known from the crystal structure exactly where Phenylalanine-216 lies, but if it is, as
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thought, close to the active site, similar local rearrangements could slightly disrupt the 
binding of the cofactor or substrate, thus lowering catalytic activity.
The final two mutants, P312R and K313R, seemed to have little effect on activity. Both 
these mutations aimed to introduce an equivalent of the E. coli TK residue, Arginine-358. 
No catalytic role was actually suggested for this residue, and it was only reintroduced as 
it was noticed to be present in close proximity of the E. coli TK active site. It is therefore 
quite possible that Arginine-358 does not in fact play an important role in TK catalysis, 
and as a result its reintroduction into DOX-P Synthase has had similarly little effect.
The mutation programme therefore, whilst not 100% accurate, which could, of course, 
not be expected, particularly in the absence of a crystal structure, did manage to improve 
rate of catalysed reaction significantly. Even the improved DOX-P Synthase mutants, 
though, are still considerably slower than the similar enzyme, TK. However, the mutants 
generated here could well prove to be first steps along a pathway of mutations which 
might improve rate further. A starting point would be to combine the two mutants 
already created, to produce a K213H / D336S double mutant, which might catalyse 
turnover at an even faster rate. In addition to this, it would be good now to use the 
published crystal structure to suggest further more appropriate mutations.
C M Chudziak 240
Production. Characterisation and Modification of DOX-P Synthase as a Biocatalyst
6 .0 4 .4  E ffect o f  m u ta g e n e s is  on  su b str a te  ran ge
In terms of broadening the substrate range of DOX-P Synthase, less success was 
achieved. In fact all mutations reduced activity towards one of the already accepted 
alternative substrates, glycolaldehyde. Seven mutations knocked out activity towards 
glycolaldehyde, three reduced turnover by over 50%. This, in itself, is perhaps not 
unusual, as again, effect of mutation is statistically much more likely to be deleterious 
than otherwise. However, the same mutations did not all have the same effect on the 
native substrate, glyceraldehyde, where two actually increased activity. Neither did they 
have the same effect on that other already accepted alternative substrate, erythrose, where 
five even slightly increased activity. The reduction in activity towards glycolaldehyde 
could be due simply to its smaller size as a substrate. It is possible that with 
glycolaldehyde being smaller than the native substrate glyceraldehyde, the extent of 
interactions it forms, which binds it into the active site, is less intensive. And since all 
mutations would be expected to have, at least slight, global effects on the positions of 
even distant residues, small changes, in the positioning of those residues responsible for 
this more limited number of interactions, could lead, more easily, to a loss of the ability 
to bind glycolaldehyde.
On the other hand it is perhaps unusual to see that 50% of the mutants generated had 
improved activity toward erythrose, even if only by a small amount. Of these, one was 
the K213H mutation, which also increased activity towards native glyceraldehyde. It was 
proposed that this mutation may simply play its effect through increasing active site 
affinity for TPP. The resulting positive effect on glyceraldehyde turnover may simply
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translate into a similar positive effect on turnover of the similar substrate erythrose. 
Another of the mutations, D336S, also had a similarly positive effect on activity towards 
the native substrate, glyceraldehyde. It was suggested that, in this case, this may be 
caused by a general opening up of the active site entrance, increasing ease of substrate 
access. This could be especially true for larger-than-native substrates like erythrose. 
This explanation could also be true for the three other mutations, F216H, P312R and 
K313R. These were created in attempts to reintroduce the transketolase residues 
Histidine-261 and Arginine-358, neither of which have any suggested role in forming 
active site interactions, and were only identified through being located nearby the active 
site, in the active site entrance. It is possible that these mutations, in themselves, or 
indirectly via global rearrangements to accommodate their presence, opened up the active 
site, reducing the tightness of the fit for smaller substrates, whilst easing the fit for 
slightly larger substrates, hence the selective effect of these three mutations in increasing 
activity towards erythrose, whilst simultaneously reducing activity towards the smaller 
substrates, glyceraldehyde and glycolaldehyde.
Most intriguing perhaps is the very small, but measurable, activity observed by three of 
the mutants towards the "wrong" stereoisomer of glyceraldehyde, L-glyceraldehyde. This 
was observed with the K213H, P312R and 1185A mutants. In L-glyceraldehyde, the C2- 
hydroxyl group faces the opposite direction to that in D-glyceraldehyde. Structural 
studies of transketolase mechanism have demonstrated the interactions formed by the 
hydroxypyruvate donor in the active site, but have not currently been able to show how 
the acceptor substrate, glyceraldehyde, binds into the active site. However, it could be
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that this C2-hydroxyl group of glyceraldehyde forms critical interactions in the active 
site, essential to substrate binding and catalytic mechanism. The result of this could be 
that DOX-P Synthase might exhibit no activity at all towards L-glyceraldehyde, as 
residues involved in binding the C2-hydroxyl might only be present on the D-face of 
glyceraldehyde, where the C2-hydroxyl would be expected. Faced with L-glyceraldehyde 
as a substrate, mechanistically essential C2-hydroxyl binding interactions might not form, 
with the result that turnover might not occur.
The first two mutants, K213H and P312R, aimed to reintroduce Histidine-258 and 
Arginine-358 residues of transketolase, neither of which is proposed to be involved in 
substrate binding, and the third, 1185A, simply aimed to shorten a residue in the active 
site entrance, which is also not proposed to be involved in substrate binding. The most 
likely cause for this beneficial effect on activity towards L-glyceraldehyde, may be that 
the mutations altered active site architecture through global rearrangements required to 
accommodate the mutations. This could have the result that residues capable of 
hydroxyl-binding were moved closer to the position in which the C2-hydroxyl of 
L-glyceraldehyde would sit upon entry into the active site, such that stabilisation of the 
turnover of the L-form of glyceraldehyde could occur. Alternatively it is possible that the 
mutants, and the K213H mutant in particular, may have had a more direct effect on 
L-glyceraldehyde turnover. Indeed it is noticeable that the highest activity towards 
L-glyceraldehyde is seen with this particular mutant. The active site of transketolase is 
rich in histidine residues, a common side chain for binding hydroxyl residues through 
hydrogen bonding, as seen with amylases and other sugar-binding enzymes, (MacGregor
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et a l, 2001). It is possible that some of these histidine residues in transketolase and 
DOX-P Synthase are involved in binding the C2-hydroxyl on the D-face of 
glyceraldehyde. It is then possible that the K213H mutation introduces a similar 
Histidine residue on the opposing face of the glyceraldehyde molecule, allowing a small 
degree of C2-hydroxyl binding to occur with the L-form of glyceraldehyde.
Overall, whilst the effect on substrate range may not have been as high as had been 
hoped, some small improvements have been made, which could form the basis of 
secondary mutations to further broaden substrate range. In particular, the mutants which 
displayed increased activity towards erythrose, may have been moving in the right 
direction in terms of opening up the active site to bulkier substrates. Perhaps 
combinations of these mutations together may have enabled activity to be shown towards 
even longer chain aldehydes, such as glucose or mannose, or even aromatics, such as 
benzaldehyde or phenylacetaldehyde. Similarly, combining the mutations which 
permitted activity towards L-glyceraldehyde, may have enabled an even higher rate of 
this activity. Unfortunately, no mutations were found to relieve the requirement for the 
keto-acceptor to be hydroxylated, as demonstrated by the lack of activity observed 
towards propionaldehyde.
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6 .0 4 .5  E ffect o f  m u ta g e n e s is  o n  activ ity  to w a r d s  h yd ro x y p y ru v a te  a s  k eto -  
d o n o r
Whilst moderate success was achieved in broadening DOX-P Synthase specificity 
towards the keto-acceptor, no success was achieved in broadening DOX-P Synthase 
specificity towards the keto-donor. None of the mutants showed any activity towards 
hydroxypyruvate. In designing the mutation programme two sets of mutations were 
suggested specifically which might permit activity towards hydroxypyruvate. These 
were the reintroduction of the S. cerevisiae TK residues, Histidine-69 and Glycine-116, 
as the interaction had been demonstrated of these residues with the C3-hydroxyl group of 
hydroxypyruvate, that hydroxyl group found specifically in hydroxypyruvate and not in 
pyruvate. To this end, unfortunately, only two mutants, F71H and V117G, were 
generated. This small number of mutants actually generated limited the chance of 
success in any case, and unfortunately both of these exhibited zero enzyme activity. As 
will be discussed next however, this result could perhaps have been foreseen, in the light 
of the recently published crystal structure for E. coli DOX-P Synthase.
Initially, three residues were identified in S. cerevisiae TK as responsible for binding the 
C3-hydroxyl of hydroxypyruvate. These were Histidine-103 which interacted directly 
with the hydroxyl group, and Histidine-69 and Glycine-116, which were shown to bind 
the hydroxyl via a chelated water molecule. Amino acid sequence comparisons of TK 
and DOX-P Synthase were then used to suggest that of these three residues, two, 
Histidine-69 and Glycine-116, were absent in E. coli DOX-P Synthase. This led to the 
generation of the two sets of mutants as described above, in order to reintroduce these
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residues. The recently published crystal structure of E. coli DOX-P Synthase, however, 
sheds more light on the problem. Specifically, the crystal structure shows that, on the 
contrary, Histidine-69 and Glycine-116 equivalents are present in E. coli DOX-P 
Synthase, as Histidine-80 and Glycine-121, while, in fact, no equivalent of the key 
Histidine-103 residue is present. Due to these false predictions which had been made 
about the DOX-P Synthase active site, it is therefore not unexpected that success was not 
achieved in creating a DOX-P Synthase mutant capable of turning over hydroxypyruvate. 
Neither mutant created would actually be reintroducing a missing residue, and moreover 
no mutant was created to reintroduce that one residue, Histidine-103, which was actually 
missing. It would be interesting to see now, in the light of the crystal structure, whether 
more success could be had through reintroduction of the missing Histidine-103 residue 
used in TK for hydroxypyruvate binding, and whether this would have any success in 
altering DOX-P Synthase to turnover hydroxypyruvate.
6 .0 4 .6  G eneral d is c u s s io n  o f  m utation  stra teg y
The mutation strategy used here was drawn up in the absence of a crystal structure for 
E. coli DOX-P Synthase, and the recent publication of the crystal structure allows an 
appraisal of the methods used. Three key lessons can be learnt:
1. It is generally easier to recognize conserved residues and mutate these, than to 
recognize non-conservation of important residues. This is shown by the case of
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Isoleucine-189 of E. coli TK which was correctly identified as Isoleucine-185 of 
E. coli DOX-P Synthase.
2. It is better to create too many mutants and reintroduce residues which are not 
missing than to create too few and miss those which are. For example, at the risk 
of attempting to reintroduce more non-missing residues, it would have been better 
to have attempted to reintroduce Histidine-103 along with the F71H and V117G 
mutants than not to have created any of them at all.
3. When a residue has not been conserved, it is very difficult to determine from an 
amino acid sequence comparison exactly which residue has taken its place. As a 
result it would be better to create more mutants by attempting to reintroduce the 
same residue multiple times along a stretch of the amino acid sequence.
Despite the difficulties encountered in using this approach to rational mutagenesis, it 
cannot be overlooked that a certain degree of success was encountered. Bearing in mind 
the lessons suggested above, therefore, this method can be considered a useful method for 
rational mutagenesis where only a crystal structure of a functionally related enzyme is 
available to work with.
6 .0 5  C o n c lu s io n
To sum up, the applicability of DOX-P Synthase as a biocatalyst has been described. A 
reasonable level of protein production was achieved with just simple media, and a 
relatively short fermentation. Laboratory-scale extraction was achieved quite simply,
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using methods which could easily be scaled up to enable large-scale production. And a 
robust high-throughput method for assaying activity was developed.
It was then found that the extract was simple to use on a laboratory scale. Operating pH 
was found to be limited to pH 6.5 to 8.0. Operating temperature was found to be optimal 
at 37 °C. Cofactor concentrations of <1 mM for TPP and >9 mM for Mg2+ were found to 
be necessary for highest activity. It was also found, though, that DOX-P Synthase has a 
narrow substrate range, particularly when compared to the similar enzyme, transketolase. 
Reduced activity was shown towards glycolaldehyde and erythrose as keto-acceptors, 
with no other acceptors found beyond this. A strict requirement for pyruvate, over 
hydroxypyruvate, as the keto-donor was observed.
It was then shown how rational redesign by site-directed mutagenesis, even in the 
absence of a DOX-P Synthase crystal structure, might improve the applicability of DOX- 
P Synthase as a biocatalyst. Two of the ten mutants created showed increased rate of 
reaction, one, a D336S mutant, by over 50%. Activity towards erythrose was increased 
in five of the mutants. A very low level of activity towards L-glyceraldehyde was even 
observed in three of the mutants. Unfortunately though, substrate range was not 
broadened as much as would have been desired, in particular towards hydroxypyruvate 
and larger substrates. However, progress was made which could be used as stepping 
stones towards further improvements which could be made in a secondary round of 
mutagenesis, especially in the light of the very recently published crystal structure of E. 
coli DOX-P Synthase.
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In summary then, it was shown that DOX-P Synthase does have a place in the pantheon 
of biocatalysts. It can be produced at reasonable levels and used quite simply. Its 
applicability may be limited by its substrate range, but it has been shown how rational 
mutagenesis might improve on this.
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Appendix 1 
dxs K30H
A T G A G T T T T G
C C A G G A G TT A
AACTGCGCCG
G CCTCCGGGC
C A A CA CCCCG
C G C A T A A A A T
AAAGGCGGTC
A T T A A G C G T C
C G G TTG CTG C
GGCGATGGCG
GGGCGATATC
C G A T T T C C G A
TCCGGTAAGC
TGGCGTGCCC
AAGGCATGGT
ATCGGCCCGG
GAACATGCGC
AAGGTCGTGG
G TG C C T A A A T
TTTG CCG AG C
C G AAAGACAA
GGCATGGTCG
AA T TG C C G A G
G G TACAA ACC
GATCAGGTGC
CATCG ACCG C
C T T T T G A T C T
CCGAGCGATG
TAA CG ATG G C
TGGAACTGAC
CGTCGTGGCG
AGCGGCGAAA
T T G TG A A A C C
GAAGCGCTGG
CGGCGTGAAC
A C A T TG G C C T
CGCGCCGAAC
C TG G CTG G CA
A T A T T G C C A A
C G A C TG TTG C
C T A T T T A C T C
TGGGCACGGT
T T T G A C C A A T
TTTG A C C G G A
TG C A C C C G TT
GG G CATTCAT
CG AAAAAGAA
CG ATTACCG C
C G TC C TG A TA
AAATG TCG G C
T T T A C T C T T C
C C A A T TA A A G
AGTGCCTGGC
TG GACGGTCA
GACCTGAAAG
TTA TG A A C C G
TT G A TC C C T C
T A T T C A A A A A
CAAG CTG ATG
A G T T T T C A C G
CAACACGCGG
C ATTG TCG CG
TG CATG ACG T
GCGGGCATTG
C T C T T A C C T G
A AAAC GA ATG
CCGTCAGCGG
GCCGCTGGAA
AGAAACTGGC
G TCGCCGAAT
G CTT G A TG A A
TC A C C G TA G A
GAAG TG CTG A
G CCG G ACTTC
TCG G CCTCG A
T AA
A T A C C C G A C C
CGAAAGAGAG
G ACAG CG TG A
CG A A C T G A C C
T G A T T T G G G A
CG CCG CG ACA
CCCGTGGCGC
C A A C C T C C A T
G G C A A A A A T C
AGG CATG G CG
TG C T G G T G A T
G C G C TC A A C A
A C T G C G C G A A
A G C T G C T C A A
A C G T T G T T T G
C G A TG T G C TG
G C C C G C A G T T
G CAG AAAAA G
C A G C G G TT G T
T C T T T G G C G A
G C G A T T A C T C
T A A A T T C C C G
T G A C C T T T G C
A T T T A C T C C A
G G C G A TT C A A
T T G G T G C T G A
C G C T G C A T A C
TC G C C A G A TG
TG C G C T A C C C
A A A C T A C C A A
G A T C C T T A A C
CG CTG AA CG C
G C G T T A A T T C
AG A A A A C G C C
TG G C C C A TC G
T T T A T T C C G C
TG C C G C T G G T
CTGGCACTGG
TTTACCGCAT
GCCGTTCCAG
GTGGCGCTGC
TGTGGGGCAT
AAATCGGCAC
GGCGAAAGCG
CAGTGCCGGA
GCCGCACCGT
TTTG AAG CG A
TCTCAACG AC
ACCATCTG G C
GGCGGGAAAA
ACGCACCGAA
AAGAGCTGGG
GG G CTTATCA
CC T G C A TA T C
ACCCG ATCAC
TTG CCG AAAA
CTGGTTGTGC
CGGCGATGCG
GATCG CTACT
TGCGGGTCTG
C T T T C C T G C A
AAG CTTCCG G
CGGTCAAACC
CGGAAATGGT
CTC TA TA C C G
GCGTGGCAAC
TTGGCAAAGG
TTTG G TAC CC
CACGCTGGTC
TGGAAATGGC
ATTATGGGCG
TAA ACCAG TA
AAG G AACTCA
ATGGAAGCCA
TCG AC TCCAC
CTCTGCGACG
CGGGCACTTC
A C T A T G T C T A
CAG G CTTATC
CATCCG TCAG
AA T A TG A C G T
A T T G G T A T T G
C T G T G T C A T T
TGAATCACGC
AA T G A A A TG T
AC A G C T G C TT
A A G T T T T C T C
G A A C A T A TTA
C T T T A A C T A C
CCACG CTAAA
ATG A C C A A A A
TTTC C A C G C C
GTAGCGGCGG
GAAACGGCAG
CGAAGGTTCC
TCGACGTGGC
GCGATTGGTG
ACG CG CCTAT
TCC TG TTCG C
CATCAGGGTG
C ATTATG AC C
G C TA T C A C T A
GCGGTCGGCG
CATTGTGAAG
TGATGCCAGA
G ATATG CG TT
CGCCAGCCAT
GCGCAGGCAG
CCCGTGCTGA
GGAAGAAATG
AAATCAAGGC
dxs F71H
A T G A G T T T T G  A T A T T G C C A A  A T A C C C G A C C  CTGGCACTGG TCG AC TCCAC  
C C A G G A G TT A  C G A C T G T TG C  CG AAAG AG AG  T T T A C C G A A A  C TC TG CG ACG  
A A C T G C G C C G  C T A T T T A C T C  G A CAG CG TG A G CCGTTCCAG CGGGCACTTC
C.M Chudziak 259
Ph. D. Thesis Development of DXP-S as a Biocatalvst
GCCTC CG GG C
CAACACCCCG
C G C A T A A A A T
AAAG G CG G TC
A T T A A G C G T C
C G G TT G C TG C
GGCGATGGCG
GGG CG ATATC
C G A T T T C C G A
TCC G G TAAG C
TGG CG TGC CC
AA G G C A TG G T
ATC GG CC CG G
GAACATG CG C
AAG G TCG TG G
G T G C C T A A A T
TT TG C C G A G C
C G AAAG ACA A
GGCATGGTCG
A A T TG C C G A G
G G TACAA ACC
GATCAGGTGC
CATCGACCGC
C T T T T G A T C T
CCGAGCGATG
TAA CG ATG G C
TG G AACTG AC
CGTCGTGGCG
AGCG G CG AAA
T T G TG A A A C C
GAAGCGCTGG
CGGCGTGAAC
A C A T T G G C C T
CG CGCCGAAC
CTG G C TG G C A
TGGGCACGGT  
CAT GACCAAT
TTTG A C C G G A
TG C A C C C G TT
G G G CATTCAT
CGAAAAA GA A
CG A TTA C C G C
C G TC C T G A TA
AAATG TCG G C
T T T A C T C T T C
CC A A T T A A A G
AG TG CCTG G C
TGG ACG G TCA
GACCTGA AAG
TT A TG A A C C G
TT G A T C C C T C
T A T T C A A A A A
C A AG CTG ATG
A G T T T T C A C G
CAACACGCGG
C A T TG TC G C G
TG C A T G A C G T
GCGGGCATTG
C T C T T A C C T G
A A A A C G A A TG
CCGTCAGCGG
G CCGCTGGAA
AGAAACTG G C
G TCG CCG AA T
G C TT G A TG A A
TC A C C G TA G A
GAAG TG CTG A
GCCG G ACTTC
TCG G CCTCG A
TAA
CGAACTG ACC
TGATTTGGGA
CGCCGCGACA
CCCGTGGCGC
C A A C C T C C A T
GGCAAAAATC
AGGCATGGCG
TG C TG G TG A T
G C G C TC A A C A
A C T G C G C G A A
A G C T G C T C A A
A C G T T G T T T G
C G A TG T G C TG
G CCCG CAG TT
GCAGAAAAAG
C AG CG G TTG T
T C T T T G G C G A
G C G A TT A C T C
T A A A T T C C C G
T G A C C T T T G C
A T T T A C T C C A
G G C G A TT C A A
T T G G T G C T G A
C G C TG C A TA C
T C G C C A G A TG
TG C G C TA C C C
A A A C T A C C A A
G A T C C T T A A C
CGCTG AA CG C
G C G T T A A T T C
A G AAAAC GC C
T G G C C C A TC G
T T T A T T C C G C
T G CCG CTG G T
GTGGCGCTGC
TGTGGGGCAT
AAATCGGCAC
GGCGAAAGCG
CAGTGCCGGA
GCCGCACCGT
TTTG AAG CG A
TCTCAACGAC
ACCATCTGGC
GGCGGGAAAA
ACGCACCGAA
AAGAGCTGGG
G G GCTTATCA
C C TGC ATATC
ACCCG ATCAC
TTG CCG AAAA
CTGGTTGTGC
CGGCGATGCG
G ATCG CTACT
TGCGGGTCTG
C T T T C C T G C A
AAGCTTCCGG
CGGTCAAACC
CGGAAATGGT
C TC TA TA C C G
GCGTGGCAAC
TTGGCAAAGG
TTTG G TAC CC
CACGCTGGTC
TGGAAATGGC
ATTATGGGCG
TAA ACCAG TA
AAGGAACTCA
ATGGAAGCCA
ACTATGTCTA
CAG G CTTATC
CATCCGTCAG
AA TA TG A C G T
A TT G G T A T T G
C TG T G TC A T T
TGAATCACGC
AATG A A A TG T
ACA G C TG C TT
A A G T T T T C T C
G A A C A T A TT A
C TT T A A C T A C
C CACG CTAAA
A TG AC CAAAA
TTTC C A C G C C
GTAGCGGCGG
GAAACGGCAG
CGAAGGTTCC
TCGACGTGGC
GCGATTGGTG
ACG CG CCTAT
TCC TG TTCG C
CATCAGGGTG
CA TTA TG A C C
G C TA T C A C T A
GCGGTCGGCG
CATTG TG AAG
TGATGCCAGA
G ATATG CG TT
CGCCAGCCAT
GCGCAGGCAG
CCCGTGCTGA
GGAAGAAATG
AAATCAAGGC
dxs V117G
A T G A G T T T T G
C C A G G A G TT A
AACTGCGCCG
G CCTCCGGGC
C A A C A C C C C G
C G C A T A A A A T
A AAG G CG G TC
ATTAAGCGTC
C G G TT G C TG C
GGCGATGGCG
G G G CG ATATC
C G A T T T C C G A
TC C G G T A A G C
A T A T T G C C A A
C G A C T G T TG C
C T A T T T A C T C
TGGGCACGGT
T T T G A C C A A T
T T TG A C C G G A
TG C A C C C G TT
GGGCATTCAT
C G AAAAA GA A
C G A TTA C C G C
C G T C C T G A T A
A A ATG TCG G C
T T T A C T C T T C
A TA C C C G A C C
CGAAAGAGAG
G ACAG CG TG A
C G A ACTG ACC
T G A T T T G G G A
C G CCG CG ACA
CCCGTGGCGC
C A A C C T C C A T
G G C AAAAATC
AGGCATGGCG
T G C T G G TG A T
G C G C TC A A C A
A C T G C G C G A A
CTGGCACTGG
TTTACCGAAA
GCCGTTCCAG
GTGGCGCTGC
TGTGGGGCAT
AAATCGGCAC
GGCGAAAGCG
CAGTGCCGGA
GCCGCACCGT
TTTGAAGCGA
TCTCAACGAC
ACCATCTGGC
GGCGGGAAAA
TCGACTCCAC
CTCTGCGACG
CGGGCACTTC
A C T A T G T C T A
CAG G CTTATC
CATCCG TCAG
AATATGACGG
A TT G G TA T TG
C TG T G TC A TT
TG AATCACGC
A ATGA AATG T
A CA G C TG C TT
A A G T T T T C T C
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TGGCGTGCCC
A AG G CATGG T
ATC GG CC CG G
GAACATGCGC
AAGGTCGTGG
G TG C C T A A A T
TTTG C C G A G C
CGAAAG ACA A
GGCATGGTCG
A A T TG C C G A G
G G TACAA ACC
GATCAGGTGC
CATCG ACCG C
C T T T T G A T C T
CCGAGCGATG
TAACGATGGC
TGGAACTGAC
CGTCGTGGCG
AGCGGCGAAA
T TG TG AAACC
GAAGCGCTGG
CGGCGTGAAC
ACATTG G CCT
CGCGCCGAAC
CTGGCTGGCA
C C A A T T A A A G
A G TG C C T G G C
T G G A C G G T C A
G AC C TG A A A G
T T A T G A A C C G
T T G A T C C C T C
T A T T C A A A A A
C A A G C T G A TG
A G T T T T C A C G
C AACA CG CG G
C A T T G T C G C G
T G C A T G A C G T
GCG G G CATTG
C T C T T A C C T G
A A A A C G A A T G
C C G TC AG CG G
G C CG CTG G AA
A G A A A C T G G C
G TC G C C G A A T
G C T T G A T G A A
T C A C C G T A G A
G A A G TG C T G A
G C C G G A C TT C
T C G G C C T C G A
T A A
A G C TG C TC A A
A C G T T G T T T G
CGATGTGCTG
G CCCGCAGTT
GCAGAAAAAG
CAGCGGTTGT
TC TTT G G C G A
G CG ATTACTC
T A A A TTC C C G
TG A C C TTTG C
A T T T A C T C C A
GG CG ATTCAA
TTG G TG CTG A
CG CTG CA TAC
TCGCCAGATG
TG CG CTACCC
A A A C T A C C A A
G A TC C TTA A C
CGCTGAACGC
G C G TT A A TT C
AGAAAACGCC
TGGCCCATCG
T T T A T T C C G C
TGCCGCTGGT
ACG CACC GA A
AAGAGCTGGG
G G G C TTA TC A
C C T G C A TA T C
A C C CG ATCAC
TTG C C G A A A A
CTG G TTG TG C
CGGCGATGCG
G A TC G C T A C T
TGCGGGTCTG
C T T T C C T G C A
A AG CTTCCG G
CGGTCAAACC
CGGAAATGGT
C T C T A T A C C G
GCGTGGCAAC
TTGGCAAAGG
TT TG G TA C C C
CACG CTG GTC
TGGAAATGGC
A TTATG G G CG
T A A A C C A G TA
AA G G A A C T C A
A TG G AAG CC A
GAACATATTA
C TTTA A C TA C
CCACGCTAAA
ATGACCAAAA
TTTCCACGCC
GTAGCGGCGG
GAAACGGCAG
CGAAGGTTCC
TCGACGTGGC
GCGATTGGTG
ACGCGCCTAT
TCCTGTTCGC
CATCAGGGTG
CATTATGACC
GCTATCACTA
GCGGTCGGCG
CATTGTGAAG
TGATGCCAGA
GATATGCGTT
CGCCAGCCAT
GCGCAGGCAG
CCCGTGCTGA
GGAAGAAATG
AAATCAAGGC
dxs K213H
A T G A G T T T T G
C C A G G A G TT A
AACTGCGCCG
GCCTCCGGGC
CAACA CCCCG
C G C A TA A A A T
AAAGGCGGTC
A TT A A G C G TC
CG G TTG CTG C
GGCGATGGCG
GGGCGATATC
C G A T T T C C G A
TCCGGTAAGC
TGGCGTGCCC
AAG G CATGG T
A TCGGCCCGG
G AACATGCGC
A AGGTCGTGG
G TG C C T A A A T
TTTG CCG AG C
CG AAAG ACA A
GGCATGGTCG
A A T TG C C G A G
A T A T T G C C A A
C G A C T G T T G C
C T A T T T A C T C
TG G G CACG G T
T T T G A C C A A T
T T T G A C C G G A
T G C A C C C G T T
G G G C A T T C A T
C G A A A A A G A A
C G A T T A C C G C
C G T C C T G A T A
A A A T G T C G G C
T T T A C T C T T C
C C A A T T A A A G
A G TG C C T G G C
TG G A C G G T C A
G A C C T G A A A G
T T A T G A A C C G
T T G A T C C C T C
T A T T C A A A A A
C A A G C T G A TG
A G T T T T C A C G
CAACA CG CG G
ATA C C C G A C C
CGAAAGAGAG
GACAGCGTGA
CG AACTGACC
TG A TTTG G G A
CGCCGCGACA
CCCGTGGCGC
C A A C C TC C A T
G G CAAAAATC
AGGCATGGCG
TG CTG G TG AT
G CG CTCA ACA
ACTGCGCGAA
A G C TG C T C A A
A C G T T G TT T G
CGATGTGCTG
GCCCGCAGTT
GCAGAAAAAG
CAGCGGTTGT
TC TTT G G C G A
G CG A TTA C TC
T A A A TTC C C G
TG A C C TTTG C
CTGGCACTGG
TTTACCGAAA
GCCG TTCCAG
GTGGCGCTGC
TGTGGGGCAT
AAATCG G CAC
GGCGAAAGCG
CAGTGCCGGA
GCCGCACCGT
TTTG A A G C G A
TCTC A A C G A C
A C C A TC TG G C
GGCGGGCATA
ACGCACC GA A
AAGAGCTGGG
G G G C TTA TC A
C C T G C A TA T C
A CC C G A TC A C
TTG CCG AAAA
CTG G TTG TG C
CGGCGATGCG
G A TC G C T A C T
TGCGGGTCTG
TCGACTCCAC
CTCTGCGACG
CGGGCACTTC
A C T A TG TC T A
CAGGCTTATC
CATCCGTCAG
AATATGACGT
ATTG G TATTG
CTG TG TCATT
TGAATCACGC
AATGAAATGT
ACAGCTGCTT
AAGTTTTCTC
GAACATATTA
C TTTAAC TAC
CCACGCTAAA
ATGACCAAAA
TTTCCACGCC
GTAGCGGCGG
GAAACGGCAG
CGAAGGTTCC
TCGACGTGGC
GCGATTGGTG
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G G TACAA ACC
G ATCAGG TG C
CATCG ACCG C
C T T T T G A T C T
CCGAGCGATG
TAA CG ATG G C
TG G AACTG AC
CGTCGTGGCG
AGCGGCGAAA
TT G TG A A A C C
GAAGCGCTGG
CGGCGTGAAC
A C A T T G G C C T
CGCGCCGAAC
CTG G CTG G CA
CA T T G T C G C G  
TG C A T G A C G T  
GCG G G CATTG  
C T C T T A C C T G  
A A A A C  GAAT G 
C C G TC AG CG G  
G C CG CTG G AA  
AG A A A C T G G C  
G TC G C C G A A T  
G C T T G A T G A A  
T C A C C G TA G A  
G A A G TG C T G A  
G C C G G A C TT C  
T C G G C C T C G A  
T A A
A T T T A C T C C A
GGCGATTCAA
TTG G TG CTG A
CG CTGCATAC
TCGCCAGATG
TGCGCTACCC
A A A C T A C C A A
GA TC C TTA A C
CGCTGAACGC
G C G TTA A TT C
AGAAAACGCC
TGGCCCATCG
T T T A T T C C G C
TGCCGCTGGT
C T T T C C T G C A
AAG CTTCCG G
CGGTCAAACC
CGGAAATGGT
C TC TA TA C C G
GCGTGGCAAC
TTGGCAAAGG
T T TG G TA C C C
CACGCTGGTC
TGGAAATGGC
A TTATG G G CG
TA A A C C A G TA
AA G G AACTCA
ATGG AAG CC A
ACGCGCCTAT
TCCTGTTCGC
CATCAGGGTG
CATTATGACC
GCTATCACTA
GCGGTCGGCG
CATTGTGAAG
TGATGCCAGA
GATATGCGTT
CGCCAGCCAT
GCGCAGGCAG
CCCGTGCTGA
GGAAGAAATG
AAATCAAGGC
dxs F216H
A TG A G T T T T G
CCAGGAGTTA
AACTGCGCCG
GCCTCCGGGC
CAACA CCCCG
CG C A T A A A A T
AAAGGCGGTC
A TT A A G C G TC
CG G TTG CTG C
GGCGATGGCG
GGGCGATATC
C G A T T T C C G A
TCC GG TAAG C
TGGCGTGCCG
AAG G CATGG T
ATCGGCCCGG
GAACATGCGC
AAGGTCGTGG
G TG C C TA A A T
TTTG CCG AG C
CGAAAG ACA A
GGCATGGTCG
A A T TG C C G A G
G G TACAA ACC
GATCAGGTGC
CATCG ACCG C
C T T T T G A T C T
CCGAGCGATG
TAA CG ATG G C
TG G AACTG AC
CGTCGTGGCG
AGCGGCGAAA
TTG TG A A A C C
A T A T T G C C A A  
C G A C T G T T G C  
C T A T T T A C T C  
TG G G CACG G T  
T T T G A C C A A T  
TT T G A C C G G A  
T G C A C C C G T T  
G G G C A T T C A T  
CG A A A A A G A A  
CG A TT A C C G C  
C G T C C T G A T A  
A A A T G TC G G C  
T T T A C T C T T C  
C C A A T T A A A G  
A G TG C C TG G C  
TG G A C G G TC A  
G A C C T G A A A G  
TT A T G A A C C G  
T T G A T C C C T C  
T A T T C A A A A A  
C A A G C T G A T G  
A G T T T T C A C G  
CA ACA CG CG G  
C A T T G T C G C G  
TG C A T G A C G T  
G CG G G CATTG  
C T C T T A C C T G  
A A A A C  G AAT G 
CC G TC AG CG G  
G C CG CTG G AA  
A G A A A C T G G C  
G TC G C C G A A T  
G C T T G A T G A A
ATA C C C G A C C
CGAAAGAGAG
GACAGCGTGA
CGAACTGACC
TG A T TT G G G A
CGCCGCGACA
CCCGTGGCGC
C A A C C T C C A T
G G CAAAAATC
AGGCATGGCG
TG CTG G TG AT
G CG CTCA ACA
ACTGCGCGAA
A G C TG C T C A A
A C G T T G T T T G
CG ATG TG CTG
G CCCG CAG TT
GCAGAAAAAG
CAGCGGTTGT
TC T TT G G C G A
G C G A TT A C TC
TA A A T T C C C G
TG A C C TTT G C
A T T T A C T C C A
GG CG ATTCAA
TTG G TG CTG A
CGCTG CA TAC
TCGCCAGATG
TGCG CTACCC
A A A C T A C C A A
G A TC C TTA A C
CGCTGAACGC
G C G TT A A TT C
CTGGCACTGG
TTTACCGAAA
GCCG TTCCAG
GTGGCGCTGC
TGTGGGGCAT
AAATCG G CAC
GGCGAAAGCG
CAGTGCCGGA
GCCGCACCGT
TTTG AAG CG A
TCTC A A C G A C
AC CATCTG G C
GGCGGGAAAC
ACGCACC GA A
AAGAGCTGGG
G G G C TT A TC A
C C T G C A TA TC
A C CCG ATCAC
TT G CCG AAAA
CTG G TTG TG C
CGGCGATGCG
GATC G C TA C T
TGCGGGTCTG
C T T T C C T G C A
AAG CTTCCG G
CGGTCAAACC
CGGAAATGGT
C T C T A T A C C G
GCGTGGCAAC
TTGGCAAAGG
T T TG G TA C C C
CACGCTGGTC
TGGAAATGGC
TCGACTCCAC
CTCTGCGACG
CGGGCACTTC
A C T A TG TC T A
CAGGCTTATC
CATCCGTCAG
AATATGACGT
ATTG G TATTG
CTG TG TCATT
TGAATCACGC
AATGAAATGT
ACAGCTGCTT
ATGTTTTCTC
G AACATATTA
CTTTAAC TAC
CCACGCTAAA
ATGACCAAAA
TTTCCACGCC
GTAGCGGCGG
GAAACGGCAG
CGAAGGTTCC
TCGACGTGGC
GCGATTGGTG
ACGCGCCTAT
TCCTGTTCGC
CATCAGGGTG
CATTATGACC
G CTATCACTA
GCGGTCGGCG
CATTGTGAAG
TGATGCCAGA
GATATGCGTT
CGCCAGCCAT
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GAAG CG CTG G
CG G CG TG AAC
A C A T T G G C C T
CG CG CCG AAC
C TG G C T G G C A
TC A C C G TA G A
GAAG TG CTG A
G CCGGACTTC
TCG G CCTCG A
T A A
AGAAAAC GC C
TG G CCCA TCG
T T T A T T C C G C
TG CCG CTG G T
ATTATGGGCG
TAA ACCAG TA
AAGGAACTCA
ATGGAAGCCA
GCGCAGGCAG
CCCG TGC TG A
GGAAGAAATG
AAATCAAGGC
dxs P312R
A T G A G T T T T G
C C A G G A G T T A
AACTGCGCCG
G CCTC CG GG C
C A A C A C C C C G
C G C A T A A A A T
AAAG G CG G TC
A T T A A G C G T C
C G G TT G C TG C
GGCGATGGCG
GGGCGATATC
C G A T T T C C G A
TCC GG TAAG C
TGGCGTGCCC
A AG G CATGG T
ATC GG CC CG G
G AACATG CG C
AAG G TCG TG G
G T G C C T A A A T
T T TG C C G A G C
C G A A A G A C A A
G G CATG G TCG
A A T T G C C G A G
G G TA C A A A C C
G ATCA GG TG C
C A T C G A C C G C
C T T T T G A T C T
CCG AG CG ATG
TA A C G A TG G C
TG G A A C T G A C
CG TCG TG G CG
AG CG G CG AAA
T T G T G A A A C C
GAAG CG CTG G
CGGCG TG AAC
A C A T T G G C C T
CG CG CCG AAC
C TG G C T G G C A
A T A T T G C C A A  
C G A C T G T TG C  
C T A T T T A C T C  
TGGGCACGGT  
T T T G A C C A A T  
T T TG A C C G G A  
TG C A C C C G TT  
G G G C A TT C A T  
CG AA A A A G A A  
CG A TT A C C G C  
C G T C C T G A T A  
AA A T G TC G G C  
T T T A C T C T T C  
C C A A T T A A A G  
AG TG CCTG G C  
TG G ACG G TCA  
GACCTGA AAG  
TT A TG A A C C G  
T T G A T C C C T C  
T A T T C A A A A A  
CA AG CTG ATG  
A G T T T T C A C G  
CAACACGCGG  
C A T TG TC G C G  
TG C A TG A C G T  
GCGGGCATTG  
C T C T T A C C T G  
A A A A C G A A TG  
CCGTCAGCGG  
G CCG CTG G AA  
AG AAACTG G C  
G TCG CCG AA T  
G C T T G A T G A A  
TC A C C G TA G A  
GAAG TG CTG A  
G CCG G ACTTC  
TC G G C C T C G A  
TA A
ATA C C C G A C C
CGAAAGAGAG
GACAG CG TG A
CG AA C TG A C C
T G A T T T G G G A
CG CCG CG ACA
CCCGTGGCGC
C A A C C T C C A T
G G CA A A A A TC
AG G CATG G CG
T G C TG G TG A T
G C G C TC A A C A
A C T G C G C G A A
A G C T G C T C A A
A C G T T G T T T G
CG A TG TG C TG
G C C C G C A G T T
GCAG AAAAA G
CAGCGGTTGT
T C T T T G G C G A
G C G A T T A C T C
T A A A T T C C C G
T G A C C T T T G C
A T T T A C T C C A
G G C G A TT C A A
T T G G T G C T G A
C G C TG C A TA C
TC G C C A G A TG
TG C G C T A C C C
A A A C T A C C A A
G A T C C T T A A C
CG CTG AA CG C
G C G T T A A T T C
AG AA A A C G C C
TG G C C C A TC G
T T T A T T C C G C
TG C C G C T G G T
CTGGCACTGG
TTTACCGAAA
GCCGTTCCAG
GTGGCGCTGC
TGTGGGGCAT
AAATCGGCAC
GGCGAAAGCG
CAGTGCCGGA
GCCGCACCGT
TTTGAAGCGA
TCTCAACGAC
ACCATCTGGC
GGCGGGAAAA
ACGCACCGAA
AAGAGCTGGG
GGGCTTATCA
CCTGC ATATC
ACCCGATCAC
TTGCGGAAAA
CTGGTTGTGC
CGGCGATGCG
G ATCGCTACT
TGCGGGTCTG
C TT TC C T G C A
AAGCTTCCGG
CGGTCAAACC
CGGAAATGGT
CTC TATA CCG
GCGTGGCAAC
TTGGCAAAGG
TTTG G TACCC
CACGCTGGTC
TGGAAATGGC
ATTATGGGCG
TAAACCAGTA
AAGGAACTCA
ATGGAAGCCA
TCG AC TCCAC
CTCTGCGACG
CGGGCACTTC
A C T A T G T C T A
CAG G CTTATC
CATCCG TCAG
A A T A TG A C G T
A TT G G T A T T G
C TG T G T C A T T
TGAATCACGC
AA TG A A A TG T
AC A G C TG C TT
A A G T T T T C T C
G A A C A T A TTA
C TT T A A C T A C
CCACG CTAAA
A TG A C C A A A A
TT TCCAC GC C
GTAGCGGCGG
GAAACGGCAG
CGAAGGTTCC
TCGACGTGGC
GCGATTGGTG
A CGCGCCTAT
TCC TG TTCG C
CATCAGGGTG
C ATTATG AC C
G C TA T C A C T A
GCGGTCGGCG
CATTG TG AAG
TGATGCCAGA
GATATG CG TT
CGCCAGCCAT
GCGCAGGCAG
CCCGTGCTGA
GGAAGAAATG
AAATCAAGGC
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dxs K313R
A T G A G T T T T G
C C A G G A G T T A
AACTGCGCCG
G CCTC CG GG C
C A A C A C C C C G
C G C A T A A A A T
AA AG G CG G TC
A T T A A G C G T C
C G G TTG C TG C
GGCGATGGCG
G G G CG ATATC
C G A T T T C C G A
TC C G G T A A G C
TG G CG TGC CC
AA G G C A TG G T
ATC GG CC CG G
GAACATG CG C
AAG G TCG TG G
G TG C C T A A A T
TTTG CCG AG C
CGAAAG ACA A
GGCATGGTCG
AA T TG C C G A G
G G TACAA ACC
GATCA GG TG C
C A T C G A C C G C
C T T T T G A T C T
CCG AG CG ATG
TA A C G A TG G C
TG G A A C T G A C
CG TCG TG G CG
A G CG G CG AAA
T T G T G A A A C C
GAAGCGCTGG
C G GCGTGAAC
A C A T T G G C C T
C G CGCCGAAC
C TG G C TG G C A
A T A T T G C C A A  
C G A C T G T TG C  
C T A T T T A C T C  
TGGGCACGGT  
T T T G A C C A A T  
T T TG A C C G G A  
TG C A C C C G TT  
G G G C A TT C A T  
CG AA A A A G A A  
CG A TT A C C G C  
C G T C C TG A T A  
AA A T G TC G G C  
T T T A C T C T T C  
C C A A T T A A A G  
AG TG C C TG G C  
TG G A C G G TC A  
G AC C TG A A A G  
T T A T G A A C C G  
T T G A T C C C T C  
T A T T C A A A A A  
C A A G C T G A TG  
A G T T T T C A C G  
CAACACG CG G  
C A T T G T C G C G  
T G C A TG A C G T  
GCG G G CATTG  
C T C T T A C C T G  
A A A A C  G AAT G 
CCG TCAG CG G  
G CCG CTG G AA  
AG A A A C TG G C  
G TCG CCG AA T  
G C T T G A TG A A  
T C A C C G T A G A  
G A A G TG C TG A  
G C CG G ACTTC  
TC G G C C T C G A  
T A A
ATA C C C G A C C
CGAAAGAGAG
G ACAGCGTGA
CGAACTGACC
TG A T TT G G G A
CGCCGCGACA
CCCGTGGCGC
C A A C C T C C A T
G G CAAAAATC
AGGCATGGCG
TG CTG G TG AT
G CG C TC A A C A
ACTG C G C G A A
A G C T G C T C A A
A C G T T G T T T G
CG ATG TG CTG
G CCCG CAG TT
GCAGAAAAAG
CAGCGGTTGT
T C T T T G G C G A
G C G A TT A C TC
T A A A T T C C C G
TG A C C T T T G C
A T T T A C T C C A
G G C G A TT C A A
TTG G T G C T G A
C G C TG C A TA C
TCG CC AG ATG
TG C G C TA C C C
A A A C T A C C A A
G A T C C T T A A C
CG CTG AACG C
G C G TT A A T T C
AG AAAAC GC C
TG G CCCA TCG
T T T A T T C C G C
TG CCG CTG G T
CTGGCACTGG
TTTACCGAAA
GCCGTTCCAG
GTGGCGCTGC
TGTGGGGCAT
AAATCGGCAC
GGCGAAAGCG
CAGTGCCGGA
GCCGCACCGT
TTTGAAGCGA
TCTCAACGAC
ACCATCTGGC
GGCGGGAAAA
ACGCACCGAA
AAGAGCTGGG
G G G CTTATCA
CCTGC ATATC
ACCCG ATCAC
TTGCCGAGAA
CTGGTTGTGC
CGGCGATGCG
G ATCG CTACT
TGCGGGTCTG
C T T T C C T G C A
AAGCTTCCGG
CGGTCAAACC
CGGAAATGGT
C TC TA TA C C G
GCGTGGCAAC
TTGGCAAAGG
TTTG G TAC CC
CACGCTGGTC
TGGAAATGGC
ATTATGGGCG
T AA ACCAG TA
AAGGAACTCA
ATGGAAGCCA
TCGACTCCAC
CTCTGCGACG
CGGGCACTTC
A C T A T G TC T A
CAGGCTTATC
CATCCGTCAG
AATATG ACG T
A TTG G TA TTG
C TG TG TCATT
TGAATCACGC
AATGAAATGT
ACAGCTGCTT
A A G TTTT C TC
G AACATATTA
C TT TA A C TA C
CCACGCTAAA
A TG ACCAAAA
TTTCCACGCC
GTAGCGGCGG
GAAACGGCAG
CGAAGGTTCC
TCGACGTGGC
GCGATTGGTG
ACGCGCCTAT
TCCTGTTCGC
CATCAGGGTG
CATTATGACC
G CTATCACTA
GCGGTCGGCG
CATTGTGAAG
TGATGCCAGA
GATATGCGTT
CGCCAGCCAT
GCGCAGGCAG
CCCGTGCTGA
GGAAGAAATG
AAATCAAGGC
dxs D336S
A T G A G T T T T G  A T A T T G C C A A  A TA C C C G A C C  CTGGCACTGG TCGACTCCAC
C C A G G A G TT A  C G A C T G T T G C  CGAAAGAGAG TTTACCGAAA CTCTGCGACG
AACTGCGCCG C T A T T T A C T C  G ACAG CG TG A G CCGTTCCAG CGGGCACTTC
G CCTC CG GG C TG GGCACGGT C G A ACTG ACC GTGGCGCTGC A C TA TG TC T A
C A A C A C C C C G  T T T G A C C A A T  T G A T TT G G G A  TGTGGGGCAT CAGGCTTATC
C G C A T A A A A T  T T T G A C C G G A  CG CCG CG ACA AAATCGGCAC CATCCGTCAG
AA AG G CG G TC T G C A C C C G TT  CCCGTGGCGC GGCGAAAGCG AATATGACGT
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A T T A A G C G T C
CG G TTG CTG C
GGCGATGGCG
GG G CG ATATC
C G A T T T C C G A
TCC GG TAAG C
TGGCGTGCCC
AAG G CATGG T
ATCGG CCCG G
GAACATGCGC
AAG G TCG TG G
G TG C C T A A A T
TTTG CCG AG C
CGAAATCCAA
GGCATGGTCG
AATTG C C G A G
GGTACAAACC
GATCAGGTGC
CATCGACCGC
C T T T T G A T C T
CCGAGCGATG
TAACGATGGC
TGGAACTGAC
CGTCGTGGCG
AGCGGCGAAA
TTG TG AAACC
GAAGCGCTGG
CGGCGTGAAC
A C A T TG G C C T
CGCGCCGAAC
CTG G CTG G CA
G G G C A TT C A T  
C G A A A A A G A A  
C G A T T A C C G C  
C G T C C T G A T A  
A A A T G TC G G C  
T T T A C T C T T C  
C C A A T T A A A G  
A G TG C C T G G C  
TG G A C G G T C A  
G A C C T G A A A G  
T T A T G A A C C G  
T T G A T C C C T C  
T A T T C A A A A A  
CAAGCTGATG 
A G T T T T C A C G  
CA A C A C G C G G  
C A T T G T C G C G  
T G C A T G A C G T  
G C G G G C A TT G  
C T C T T A C C T G  
A A A A C G A A T G  
CC G TC A G C G G  
G C C G C TG G A A  
A G A A A C T G G C  
G T C G C C G A A T  
G C T T G A T G A A  
T C A C C G T A G A  
G A A G T G C T G A  
G C C G G A C T T C  
TC G G C C T C G A  
T A A
CAACC TCCAT
GGCAAAAATC
AGGCATGGCG
TGCTGGTGAT
G CGCTCAACA
ACTGCGCGAA
AG CTG CTCAA
A C G TTG TTTG
CGATGTGCTG
GCCCGCAGTT
GCAGAAAAAG
CAGCGGTTGT
TC TTTG G C G A
G CG ATTACTC
TAA ATTC CCG
TG ACC TTTG C
A T T T A C T C C A
GGCGATTCAA
TTGGTGCTGA
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A A G G A A C T C A
A TG G A A G C C A
ATTG G TATTG
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TGAATCACGC
AATGAAATGT
ACAGCTGCTT
A A G TTTTC TC
GAACATATTA
C TTTAAC TAC
CCACGCTAAA
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GTAGCGGCGG
GAAACGGCAG
CGAAGGTTCC
TCGACGTGGC
GCGATTGGTG
ACGCGCCTAT
TCCTGTTCGC
CATCAGGGTG
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ACAGCTGCTT
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G AACATATTA
C TTTAAC TAC
CCACGCTAAA
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T T T G G T A C C C
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A A G G A A C T C A
A TG G A A G C C A
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GTAGCGGCGG
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CGAAGGTTCC
TCGACGTGGC
GCGATTGGTG
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TCCTGTTCGC
CATCAGGGTG
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GCGGTCGGCG
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CG G TTG CTG C
GGCGATGGCG
G G G CG ATATC
C G G T T T C C G A
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A A G G TC G T G G
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T T T G C C G A G C
C G A A A G A C A A
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TCCTGTTCGC
CATCAGGGTG
CATTATGACC
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CCG AG CG ATG
TAA CG ATG G C
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CG TCG TG G CG
AGCG G CG AAA
T T G T G A A A C C
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CG CGCCGAAC
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CCGTCAGCGG  
GCCGCTGGAA  
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G CGCAGGCAG
C C C G T G C T G A
GGAAG AAATG
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